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Definition of key terms
Anal sphincter: Sphincter muscle of anus.
Anal incontinence (AI): Involuntary loss of solid, liquid stool, flatus and urgency from the anal sphincter.
Anus: Opening that excretes faeces.
Faeces: Bodily waste product.
Interpretative phenomenology: A qualitative research methodology, ontological in nature. A research method 
that does not bracket thoughts and feelings, but acknowledges that we have prior knowledge and beliefs. Through 
language (verbal and nonverbal), people are aware of their existence, challenged and reshaped through experiences.
Hermeneutic circle: Utilised in interpretative phenomenology to gain a deeper understanding of the experience. 
Through language, a cyclic process occurs where preconceived beliefs are challenged with new experiences and 
from this, new beliefs are derived.
Levator ani muscle (LAM): A muscle group of the pelvic floor, which provides support and assists to maintain 
continence.
Multiparous: A woman who has given birth more than once.
Neuropathy: Dysfunction of one or more peripheral nerves. Neuropathy following childbirth can lead to numbness 
in the pelvic floor and affect continence status.
Nulliparous: A woman who has never given birth.
Obstetric anal sphincter injury (OASIS): Damage to the anal sphincter muscle following vaginal birth. Also 
referred to as 3rd and 4th degree tears and severe perineal trauma.
Occult OASIS: Indirect damage to the anal sphincter muscles. Also referred to as obstetric anal sphincter injury 
(OASIS) and severe perineal trauma. Occult OASIS is considered rare.
Pelvic floor dysfunction: A collective term for urinary and faecal incontinence, pelvic organ prolapse as a result 
of damage to musculature and nerves of pelvic floor.
Phenomenology: A research methodology, which seeks to derive a deeper understanding of a person’s world and 
experience.
Postnatal period: Days and weeks following birth until 6 weeks.
Post-partum: Refers to issues pertaining to the mother for a period following birth until 6 weeks.
Primiparous: A woman giving birth for the first time.
Pregnancy hand-held (PHHR): A written record held utilised by pregnant women worldwide and throughout 
Australia to assist in maintaining continuity of care and improving risk management.
Pudendal neuropathy: Damage to the pudendal nerve, which has a role in maintaining continence.
Quality of life: The term quality of life (QoL) defined by the World Health to include the multifaceted view of 
physical, emotional and social wellbeing and the perceptions of an individual which keep them engaged in every 
aspect of daily living.
Third and fourth degree tears: Also referred to as obstetric anal sphincter injury.
Van Manen: A phenomenological researcher, who built a framework of Martin Heidegger referred as the “the father 




Anal incontinence is a debilitating condition projected to increase by 2030 to 1,835,340 Australian 
people, of which 1,122,749 will be women. Multiple risk factors are associated with anal incontinence. 
Pregnancy and childbirth are considered the main risk factors with subsequent pregnancies and childbirth 
compounding injuries and worsening symptoms. There is a high prevalence of incontinence but poor 
reporting across the lifespan for women of reproductive age. Furthermore, there is little evidence 
that specific screening or screening tools exist for pregnant or postnatal women especially in the first 
trimester of pregnancy, where the initial planning and management for care has commenced and can 
reduce worsening symptoms.
To address the gaps in clinical practice, this thesis used a mixed method research design, which included 
four stages of research to explore the factors that influence the disclosure of anal incontinence in women 
of reproductive age. This approach assisted in the development and validation of a bowel-screening 
tool (BSQ). Qualitative research methods complemented and informed quantitative research findings, 
identifying omissions or misunderstanding of terms within current screening tools and assisted in the 
development of the new tool. 
The thesis findings established an overall high prevalence of anal incontinence. These findings are 
comparable to other studies that included rectal urgency. These findings differ to previous studies that 
report lower rates, largely because of the different clinical screening tools used, study sample and size, 
and how incontinence was determined.
The benefits of consumer participation in the development of the BSQ improved disclosure through the 
identification of symptoms and the transient nature of incontinence, which were important for women. 
Qualitative findings established further roadblocks for disclosure through the lack of screening by health 
professionals and difficulty comprehending screening tools. There was a significant disparity between 
the BSQ and clinical tools previously used, largely because of poor comprehension and symptom 
omission in tools. 
The BSQ reported a high prevalence of anal incontinence across all stages of the research (range 26% to 
68%). The screening tool identified that there was varied reporting of the symptoms of anal incontinence 
both in the past and during current screening of antenatal (68% vs 12.9%) and community women 
(5.1% vs 34.5%). Symptoms were less frequent in the current period for antenatal women suggesting 
that early pregnancy may alter the incidence of symptoms. The findings suggest that flatus, soiling 
and rectal urgency were predominant symptoms across both timeframes. These symptoms are known 
precursors for worsening function with subsequent births. Other obstetric factors, including caesarean 
section, second-degree perineal tear, intact perineum, ageing and increased body mass index, were also 
associated with incontinence. Ageing and increased body mass index were associated with incontinence 
and predominant factors in all stages of the research. The relative risk of experiencing anal incontinence 
increased with a yearly increase in age (OR = 1.02; 95% CI: 1.00, 1.05; P value = 0.0690). An increase 
by one unit on the body mass index further increased a woman’s risk by 2% (OR = 1.02; 95% CI: 0.98, 
1.05; P value = 0.3534). Over half the research participants (53%) were overweight with 32% of women 
with a BMI of 30 or more (obese). The risk of incontinence is heightened in obese women as they are 
more likely to have obstetric complications such as high blood pressure, gestational diabetes, larger 
babies, risk of instrumental delivery, perineal trauma and in particular, OASIS.
This work has identified a higher reporting of historical incontinence by antenatal women compared 
with women in the community. It has also reinforced that the aetiology of anal incontinence might 
be multifactorial, with factors other than birth trauma and direct injury to the anal sphincter, being 
associated with incontinence. These findings are similar to those reported in studies that recognise the 
influence of additional pre-pregnancy, and pregnancy factors, rather than just the consequences of labour 
and birth.
The prevalence of incontinence and the variability of symptoms is high in women of reproductive 
age. The BSQ can be used as a primary and secondary prevention strategy in clinical settings for 
early screening of at risk women through the identification of pre-existing symptoms, which may be 
overlooked in women who present with no current symptoms.  
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The control of faeces occurs for many at a young age and until that control is challenged through genetic 
cause, medical and surgical injury, trauma, health concerns and ageing, we take continence for granted 
and do not consider the effects of bowel incontinence. The inability to hold liquid and solid faeces 
and flatus has a debilitating effect on every facet of a person’s wellbeing. It is not only a complaint 
of the elderly; it is evident across the lifespan. Aptly named the last taboo, anal incontinence (AI) 
is often only discussed with humour as this avoids any serious disclosure. Conversation around any 
bodily functions, especially excreta, often cause great distress and shame. Therefore, do we actually 
know the true prevalence of this debilitating condition? There is a lower reporting of AI compared 
to urinary incontinence; however, this is questionable, as both symptoms often coexist and occur in 
a young population, especially in pregnancy and childbirth, which are known risk factors for AI and 
urinary incontinence. 
Twenty years of research has identified that women of reproductive age report flatus incontinence and 
rectal urgency, with these symptoms worsening with subsequent birth and ageing. There is variable 
reporting of the prevalence of AI and urinary incontinence in pregnant and postnatal women (between 
1.7% and 65%), with limited screening of this at-risk group. Further, the screening tools for bowel 
incontinence often include a wide variety and different weighting of symptoms. As a result, these tools 
often under-represent the two most common symptoms reported by women - incontinence and rectal 
urgency. 
The physical implications of AI are not the only factor to impact on a person’s wellbeing. Research has 
identified the immense social impact of AI results in women isolating themselves from their family, 
friends and partners because of this devastating complaint. Women further retreat from their working 
environment, which increases the financial burden on their lives. The social mores surrounding AI keep 
this condition hidden. Health providers are in a unique position to enquire about a topic that is typically 
regarded as taboo; however, there appears a lack of enquiry by health professionals and this contributes 
to worsening mental health, isolation and financial hardship. The ramifications are not solely for the 
woman and her family but the burden impacts on the wider community and reliance on the health 
purse to manage the physical, financial and psychological impact. In effect, the wider community is 
significantly impacted.
Anecdotally, my clinical practice has shown that there is a lack of routine screening in obstetrics and 
gynaecology of young women unless presenting to a speciality clinic for treatment of AI or bowel 
concerns. Additionally, there is no current screening tool developed specifically for AI that is routinely 
used in pregnant and postnatal women. To reduce the physical, social, financial and psychological impact 
of this condition for women in the short and long term it would make good clinical reasoning to develop a 
tool, which could screen women. Screening with a specific tool during pregnancy and postnatally would 
allow for better assessment, care and management of women in the short term, and would also improve 
their long-term health. The early identification of incontinence and referral to specialist perineal clinics 
allows for a thorough review of birth plans to modify the factors that may increase the risk of demise to 
the pelvic floor.
The overarching aim of this thesis is the development and validation of a bowel-screening tool for 
the use in women of reproductive age. The development and validation of a specific bowel-screening 
tool for this group of women requires an understanding of what factors impact on disclosing AI. The 
identification of these issues may assist in providing a tool, which will show the true prevalence of this 
condition. This provides the basis to investigate our research hypothesis that improved screening tools 
for AI are required for this group of women for the early detection and intervention of the condition. 
A review of the literature is first required to gain an understanding of the current prevalence of AI, its 
impact on quality of life, and current screening tools used for this group of women. 
Motivation and aims of this thesis
xxii
Three specific aims were identified to investigate and develop a screening tool: 
1. To determine whether routine screening of pregnant and postnatal women for anal incontinence 
utilising a modified St Marks Vaizey incontinence score (Vaizey score) improves identification 
of anal incontinence.
2. To identify and analyse the factors that impact on women of reproductive age disclosing anal 
incontinence to their health care providers.
3. To develop and validate a screening tool for anal incontinence in women of reproductive age.
These aims provide a stepwise process in confirming the development and validation of a specific tool 
to screen for AI. The nature of the mixed method research identifies that the aims are not separate but 
integral to each other.
Chapter Outlines
Chapter 1 provides a review of the literature and a discussion on the background, rationale, purpose and 
significance of this thesis. The literature review highlights a focus on the causation of anal incontinence 
but a lack of healt literature, which focuses on routine screening for anal incontinence in women of 
reproductive age. Paucity within the literature provides the impetus for which this research is based and 
development of the research study question and aims. 
Chapters 2 describes the chosen methodology, materials and methods, which underpins the mixed 
method research study. Justification of the chosen methodology in stages 1 to 5 of the research is given. 
Chapter 3 investigates whether women of reproductive age presenting with pelvic floor dysfunction 
have undisclosed anal incontinence. Retrospective research methods were adopted to identify if anal 
incontinence was ifentified at primary point of referral or after screening by the specialty service for 
pelvic floor dysfunction for women referred from obstetric care. The speciality service currently uses 
a generic bowel-screening tool (Vaizey score), which is utilised predominately in research settings, 
to actively screen women via phone consultations. A specifically designed data extraction sheet was 
utilised to identify anal incontinence and demographic details were also collected.
Chapter 3 is published as: Tucker, J., Grzeskowiak, L., Murphy, E.M.A., Wilson, A. & Clifton, V. 
L. (2016). Do women of reproductive age presenting with pelvic floor dysfunction have undisclosed 
anal incontinence: a retrospective cohort study. Women Birth, 30(1):18-22, http://dx.doi.org/10.1016/j.
wombi.2016.05.009.
Chapter 4 highlights the paucity of screening tools available to identify anal incontinence in women 
of reproductive age. Accordingly, this chapter shifts the focus of the research to the development and 
validation of an effective bowel-screening tool (BSQ) in a pregnant population. The newly developed 
BSQ uses two screening tools (Vaizey and Wexner scores) in conjunction with an antenatal visit at a large 
tertiary centre. The findings of this research allow for a comparison of symptoms between the tools, and 
further validation of the BSQ. The chapter concludes with recommendations for further development of 
the screening tool.
Chapter 4 is under submission as: Tucker, J., Steen, M., Edwards, S., Clifton, V.L. & Murphy, E. M. 
A. Development and validation of a tool to identify anal incontinence in women of reproductive age: 
mixed method research. Obstetrics and Gynaecology (in submission, July 2020).
Chapter 5 identifies the importance of investigating possible causes of disparity between bowel screening 
tools, and is directly aligned with the second aim of this thesis. Qualitative methods are used to provide 
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insight into the barriers for disclosing anal incontinence in the pregnant and post-natal population. The 
findings assist in refining the research bowel-screening tool developed in Chapter 4 (stage 3 of the 
research). Chapter 5 presents a discussion on the Hermeneutic phenomenology framework that guides 
this research, and the study design, in order to answer the research question “what factors impact on 
disclosure of anal incontinence in women of reproductive age?”. Ethical considerations, and the rationale 
for sample selection and recruitment strategies is also discussed. Van manen’s procedural framework 
guides data collection, analysis and interpretation. Discussion of methodological trustworthiness and 
credibility enables validation of the findings and interpretations of this study.  
Chapter 5 is published as: Tucker, J., Murphy, E. M. A., Steen, M. & Clifton, V. L. (2019). Understanding 
what impacts on disclosing anal incontinence for women when comparing bowels screening tools: a 
phenomenological study. BMC Women’s Health, 19(1):142-50. https://doi.org/10.1186/s12905-019-
0840-0.
Chapter 6 describes the use of a newly developed bowel-screening questionnaire (BSQ) to identify anal 
incontinence in a pregnant population attending their first antenatal booking at a large tertiary centre. 
Subsequent stages of the research describe utilisation of the BSQ in a community dwelling population. 
Findings from this research support the hypothesis that routine screening with a specific screening tool 
can effectively identify AI in pregnant and non- pregnant women. The results highlight the importance 
of recognizing the variability of symptoms of AI as evidence of probable existing pelvic floor demise in 
pregnancy and provides a basis for further research with the BSQ.
Chapter 7 concludes this thesis with a discussion of the key findings and an outline of recommendations 






1.1 BOWEL CONTINENCE - INTRODUCTION
The pelvic floor maintains pelvic floor support, anal and urinary continence through the interplay of 
muscles, connective tissue and nerve pathways(1)(Fig. 1A & B). The rectum terminates in the anal canal. 
Within the ischioanal fossae the anus is surrounded by loose adipose tissue both laterally and posteriorly, 
and the pudendal nerves pass over the ischial spines(2-4). The perineal body separates the anal canal from 
the vagina anteriorly(2-4). The anal canal consists of a inner epithelial lining, a vascular sub-epithelium 
(internal anal sphincter), and fibromuscular supporting tissue (external anal sphincter)(2). The lining of 
the anal canal varies along its length the proximal end is lined with rectal mucosa (columnar epithelium) 
called the columns of Morgagni and contains a terminal radical of the superior rectal artery and vein. The 
wall of the anal canal contains the sub-epithelial tissues (known as anal cushions) which seal the anal 
canal and help maintain continence of liquid stools and flatus(2-4). The area in the lower canal is supplied 
with sensory nerve endings and the upper canal lined by insensate columnar epithelium. The junction 
between the columnar and squamous epithelia is referred to as the anal transitional zone, which provides 
a sampling mechanism(2-4). The anal sphincter complex is approximately 3-4 cm in length comprised 
of two types of muscle fibre, each responsible for specific bowel control(2)(Fig.1.1). The internal anal 
sphincter is a continuation of the circular smooth muscle of the rectum(3). Its role is to sample contents 
in the rectum and importantly contributes to approximately 75% of anal resting tone(2, 3). The external 
anal sphincter (EAS) is comprised of striated muscle wrapped around the internal sphincter (IAS) and 
consists of a subcutaneous, superficial and deep layers(3). The external anal sphincter is responsible for 
25% of anal resting tone, and can increase in pressure under voluntary control to 60% of sphincter tone(3, 
4). Anal rest and squeeze pressures vary throughout the anal canal with rest pressures in women averaging 
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Figure 1A. Posterior view of the pelvic floor. Reprinted with permission from Springer Nature: 
Anatomy of the Perineum and the Anal Sphincter by Ranee Thakar and Dee E. Fenner. In: Perineal and 
anal sphincter trauma diagnosis and clinical management by Abdul H. Sultan, Ranee Thakar and Dee E. 
Fenner (editors) (2009).
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Figure 1B. Innervation of the pelvic floor. Reprinted with permission from Springer Nature: Anatomy 
of the Perineum and the Anal Sphincter by Ranee Thakar and Dee E. Fenner. In: Perineal and anal 
sphincter trauma diagnosis and clinical management by Abdul H. Sultan, Ranee Thakar and Dee E. 
Fenner (editors) (2009).
Figure 1.1. Schematic view of anal sphincter muscles. Reprinted with permission from Springer 
Nature: Anatomy of the Perineum and the Anal Sphincter by Ranee Thakar and Dee E. Fenner. In: 
Perineal and anal sphincter trauma diagnosis and clinical management by Abdul H. Sultan, Ranee 
Thakar and Dee E. Fenner (editors) (2009).
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50 ± 13 mm Hg and squeeze pressures 159 ± 45 mm Hg(3). Rest pressures higher in IAS compared to 
EAS with squeeze pressures higher in the EAS(3). This can be altered due to mechanical and neuropathic 
changes to the muscles(2-4). The sustainability of this action is shorter and notably the rest and squeeze 
pressures reduce with ageing. The puborectalis muscle forms a “u” shape from the pubic bone to the 
rectum and contraction of levator ani has a pivotal role in maintaining anal continence and controlling 
defecation(2, 5). Rectal compliance is achieved through the action of muscles and nerve pathways until 
sensory stretch receptors signal rectal fullness(2). This causes the IAS to initiate relaxation and the 
sampling process of faecal contents by sensory receptors(2). The EAS and puborectalis muscles remain 
contracted to maintain continence until a place and time to evacuate the bowel is socially convenient(2). 
The disruption to these muscles and nerves results in anal incontinence (AI) which is the involuntary 
loss of liquid, solid stool, flatus and rectal urgency(6). Specific types of symptoms can identify muscle 
or nerve dysfunction, such as internal anal sphincter injury resulting in flatus incontinence and passive 
soling whereas external sphincter damage is associated with rectal urge or urgency(2). 
Figure 1.2. Integrated lifespan analysis of pelvic floor function. Reprinted from Am. J. Obstet. 
Gynecol. 2008 December; 199(6), De Lancey J, Low L, Miller J, Patel D, Tumbarello J., Graphic 
integration of causal factors of pelvic floor disorders: an integrated lifespan model, 7 (2009), with 
permission from Elsevier.
Figure 1.3. Variations of birth damage and repair across the lifespan. Reprinted from Am. J. Obstet. 
Gynecol. 2008 December; 199(6), De Lancey J, Low L, Miller J, Patel D, Tumbarello J., Graphic 
integration of causal factors of pelvic floor disorders: an integrated lifespan model, 9 (2009), with 
permission from Elsevier.
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Deterioration of anorectal function and resultant AI is multifactorial however ageing is an important 
factor(2). Understanding the causative influences which determine normal decline of the pelvic floor 
function across the lifespan improves the assessment, treatment and prevention of factors which 
negatively impact on pelvic floor reserve(1). DeLancey and colleagues developed a lifespan model for 
women which identified the complexity of causation for pelvic floor dysfunction (PFD; Fig.1.2)(1). This 
conceptual model described three phases including the predisposing, inciting and intervening phases that 
effect a woman’s pelvic floor function, in this instance, bowel continence across her lifespan(1). Early 
growth, genetic code, nutrition and physical development as a child determine pelvic floor function of a 
woman later in life(1). For example, predisposing issues such as a collagen deficiency have been shown 
to contribute to weakening of the pelvic floor in women with no pregnancies or births (nulliparous) 
contributing to PFD(7, 8). A large prospective study supported this view, where 874 nulliparous women 
were screened for PFD and AI with reported outcomes for PFD and or AI in 49% (n = 425) of women 
prior to pregnancy, compared to 57% (n = 429) post birth(7). These findings were similar to a Chinese 
study which reported AI in 44% of nulliparous women in the first trimester, in 41.8% eight weeks 
postnatal and in 26.2% of women at 12 months postnatal(9). Both studies suggested AI was multifactorial 
with predisposing factors prior to the first birth a precursor for further worsening symptoms in subsequent 
births.
De Lancey and Colleagues referred to this as the predisposing phase where“ maximum capability” or 
“functional reserve” of the pelvic floor is achieved and continence maintained(1). There are multiple 
causative factors associated with the inciting phase with pregnancy and childbirth noted as major risk 
factors for damage to pelvic floor structures(1). A woman with optimal “functional reserve” may present 
with no symptoms conversely a woman with predisposing risk may have less “functional reserve” and 
this increased risk of incontinence following childbirth or even earlier across her lifespan(1, 10). Birth 
damage and recovery detailed in figure 1.3, identified a woman with less “functional reserve” as “C” 
and a woman with maximum capability “A” where her rate of decline in pelvic floor function and risk 
of AI is less.The third stage the intervening phase influenced the rate of pelvic floor demise and varied 
according to co-morbidities, lifestyle and obesity(1, 11). The three phases influenced pelvic floor structures 






Table1.1. Common aetiology of anal incontinence. .˄ OASIS (obstetric anal sphincter injury) †RMLE (right medial lateral 
episiotomy) 
 
Mechanical  Neurological Congenital Inflammatory Miscellaneous 
1. Anal sphincter  
Trauma:  








2. Rectal prolapse  
3. Neoplasms - rectal, 
brain, spinal  
4. Chronic constipation 
5. Impaction 
1. Multiple sclerosis 
2. Parkinson’s disease 





7. Brain or spinal 
injury 
1. Congenital anomaly  
2. Spinal Bifida 
3. Sacral agenesis 
4. Myelomeningocele 
5. Imperforate anus 






1. Collagen deficiency, 
2. Ageing 
3. Fragility and 
dependence 
4. Poor cognition and 
dexterity 





Table 1.1. Common aetiology of anal incontinence. ˄OASIS (obstetric anal sphincter injury), †RMLE 
(right medial lateral episiotomy).
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Fig. 1.5. A simulation of the head descending the pelvic floor during the second stage of labour. 
The top left photo shows the commencement of pushing; the bottom images show delivery. Adapted 
and reprinted with permission from Annual Reviews, Inc. provided by Copyright Clearance Centre 
from Annals of Biomedical Engineering. 2009 (11):163-76, Ashton-Miller J, DeLancey J. On the 
Biomechanics of Vaginal Birth and Common Sequelae, 291(2009).
Figure 1.4. Pelvic floor distension late second stage of birth. Adapted and reprinted with permission 
from Springer–Verlag London Ltd., The effects of pregnancy and childbirth on the pelvic floor by 
Baessler K and Schussler B. In: Pelvic Floor Re-education, principles and practice by Baessler K, 
Schussler B, Laycock J, Norton P and Stanton S (editors) (1994).
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1.2 AETIOLOGY OF ANAL INCONTINENCE
Research literature identified the aetiology of AI as complex with persons afflicted often having a 
combination of causative factors (Table 1.1)(6, 12-14). For women, hormonal changes in pregnancy and 
childbirth trauma are the main risk factors for PFD, which is a term used to describe symptoms of 
urinary or faecal incontinence, rectal and pelvic floor prolapse(15-17). Changes to pelvic floor supports 
and structures in pregnancy, childbirth and ageing can pre-empt PFD symptoms with as many as 91% 
of women noting abnormal bowel function, including AI after delivery(18, 19). During pregnancy and 
childbirth, the hormonal influence on maternal structures softens and elongates muscles and, ligaments 
to accommodate the growing foetus, and over distension of the pelvic floor muscles to assist in the birth 
of the baby (Fig. 1.4)(19-21). The pelvic floor muscles can stretch 2 to 3 times their length, when noting 
maximal stretch tolerated by non-pregnant animal muscle tissue is only 1.5 times (Fig.1.5)(22, 23). The 
over distension, compression and trauma to the anal sphincters, levator muscles and nerves leads to 
permanent scarring and injury resulting in neuropathy and risk of AI(19, 20). 
1.2.1 Types of trauma
Obstetric anal sphincter injury
Trauma to the anal sphincter is cited as a major cause of AI in women of childbearing age resulting in 
two thirds of women being symptomatic for loss of solid or liquid stool, flatus incontinence and rectal 
urgency(1, 15, 24). Disruption to the anal sphincter; obstetric anal sphincter injury (OASIS; Fig. 1.6) can be 
a result of direct or indirect trauma, with increased risk of PFD(7, 20, 25, 26). Figure 1.6 represents a 3D endo-
anal ultrasound image of the anal sphincters. Picture ‘A’ shows an intact IAS and EAS whereas picture 
‘B’ identifies a defect in both sphincters between nine and two o’clock. This may result in incontinence 
in the short-term and worsening function with increased age.
Various risk factors are associated with OASIS many of which many can coexist at the birth(27). Risk 
factors include parity(27-29), instrumental birth(30, 31), episiotomy(4, 17, 32, 33), maternal age(26, 34), ethnicity(35, 36), 
fetal macrosomia(30, 37, 38), and prolonged second stage for >1 hour(15, 39, 40). 
Figure 1.6. Endo anal ultrasound view of anal sphincter muscles. EAS (external anal sphincter) 
and IAS internal anal sphincter. (A) Normal sphincter; (B) Defect in both IAS and EAS, 9 to 2 o’clock. 
Reprinted with permission from Springer Nature. Imaging of the anal sphincter by Bartram C and Sultan 
A. H. In: Perineal and anal sphincter trauma diagnosis and clinical management by Abdul H. Sultan, 
Ranee Thakar and Dee E. Fenner (editors) (2009).
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Nulliparous woman are at increased risk of sphincter damage (4%) where the second stage of labour 
is greater than 1 hour (4%), or with an instrumental birth particularly with forceps (7%), or induction 
of labour (2%) and with a posterior position of the baby in the uterus (2%)(33, 38). Longer labour are 
associated with women’s request for epidural analgesia, and whilst not directly related to OASIS, this 
form of analgesia can slow the progress of labour and increase the risk of intervention and subsequent 
trauma to the sphincter (2%)(38). This was consistent with a prospective cohort study of primaparous 
women which identified the association between OASIS, epidural anaesthesia (58%) and prolonged 
second stage(41). An additional study by Simpson et al.(28) concurred with these findings and identified 
the coexistence of risk factors with the induction of labour, longer second stage, instrumental birth, 
epidural and episiotomy and thus increased risk of OASIS(28).  Smith et al.(42) observational study of 2,754 
singleton vaginal births confirmed the high prevalence of OASIS with forceps delivery, longer second 
stage greater than one hour, and higher birthweight. Additionally, a retrospective review of perinatal 
data in an Australian study between 2001 and 2009 reinforced that the strongest risk factors for OASIS 
include primaparity, instrumental delivery, larger birthweight and Asian ethnicity(34). The reported rate 
of OASIS in this study and association with episiotomy and forceps was lower when compared to 
other studies, which identified episiotomy as a significant risk factor for OASIS(15, 27, 34). The authors 
suggested this was a result of improved training with placement and cutting of the episiotomy(34). The 
rates of episiotomy differ worldwide and are often attributed to obstetric practices governing the medical 
centre(15, 33). A systematic review identified avoidance of episiotomies in clinical practice reduced rates 
of OASIS(43). On the other hand, there is considerable discussion within the literature that the rate of 
OASIS is dependent on the type and angles of episiotomy (midline versus medio lateral episiotomy)(44). 
Kalis et al.(44) suggested the angle of episiotomy from the midline of the perineum and selective use of 
episiotomy was a determinant in reducing OASIS. These findings were consistent with a randomised 
controlled trial, which recommended that selective use of episiotomy might reduce OASIS. The second 
Australian Atlas of Healthcare(33) suggested increased rates of OASIS may be due to episiotomy rates 
and technique. This was consistent with Peleg et al.(45) reported that OASIS occurred in 2.1% of women 
where no episiotomy was preformed, in 11% with a midline episiotomy and in 21% of women with 
midline episiotomy and instrumental delivery(45). Rates were lower in health settings which only utilised 
medio lateral episiotomy and reported (4.4%) compared to centres utilising midline episiotomy (11%)
(45, 46).
Asian ethnicity was stated to be related to an increased risk of OASIS due to a woman’s short stature and 
a perineal length less than 2.5 cm(15). Deering et al.(47) compared the perineal length of 234 women prior 
to delivery and delivery outcomes. The findings suggested women with perineal length less than 2.5 cm 
had a significant risk of OASIS(47). However, the relationship of perineal trauma and ethnicity remained 
unclear within the literature. Concerns the findings were not representative of Asian cultures and that 
additional factors may be attributable to perineal trauma other than perineal length(36, 48). A systematic 
review of the literature undertaken on research published from 2000 to 2010 assessed if Asian ethnicity 
was a risk factor for OASIS and found evidence that cultural and social expectation, including language 
barriers may increase the risk of PFD and trauma(48-50). The latter issue is vitally important and therefore 
needs consideration when screening all women for AI.
It is difficult to determine the true prevalence rates of recognised (direct) OASIS both in international or 
local settings with reported rates between 1.7% and 12%(4, 15, 33, 38, 51). The advent of endo anal ultrasound 
(EAUS) in screening for OASIS has increased the reporting from 20% to 41% of women(4). It is evident 
within Australia that further variation in reporting direct OASIS occurred across states and territories 
and within health institutions(33, 52, 53). A review of eighteen maternal hospitals in South Australia, between 
2002 to 2008 identified a wide variation in reporting which was attributed to poor recognition at birth 
and inadequate data collection methods(52). Additional research conducted in 13,455 Australian women 
in New South Wales found  rates of OASIS 1.7% to 1.9% in singleton births between 2001 and 2009(34). 
The trend and variation in reporting direct OASIS was not unique to Australia but seen across the world. 
The United Kingdom reported a threefold increase (1.8% to 5.9%) over a decade(33). However Australia 
had an above average rate of OASIS (2.4% to 7.3%) when compared to countries in the Organisation 
for Economic Co-Operation and Development (1.6% to 6.0%; OECD)(33). The evidence highlighted that 
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the true prevalence of OASIS was unclear and thus the accurate prevalence of AI remained unknown(34).
Fear of a subsequent OASIS and AI, or worsening symptoms, remains the main concerns for birthing 
women(4, 54-56). A systematic review by Dudding et al.(15) identified the risk of recurring OASIS was seven 
times greater in a woman with a previous history of OASIS compared to women with no history. Sultan 
et al.(4) recognised the repeated risk at 4.4% however this was influenced through the interplay of the risk 
factors as stated above. A study of 704 women with previous OASIS reported the risk of another OASIS 
as 2.1% (no episiotomy), 11% (midline episiotomy) and 21% (midline episiotomy and instrumental 
delivery)(45). 
Levator muscle trauma
Levator muscles (LAM) contribute to the support and strength of the pelvic floor(20). Trauma is associated 
with pelvic organ prolapse, urine incontinence (UI) and AI, however; it is often-unrecognised following 
vaginal delivery(20, 57). This remains a concern as practice as early as the 1940’s reported the importance 
of accurate assessment, management of PFD and provided preventative strategies to reduce LAM, yet 
this has not been adopted widely by health providers(20, 57). This is a result of lack of awareness of the role 
of the LAM in pelvic support and care is fragmented, where women are seen by a single speciality(58, 59). 
This is concerning as often UI and AI coexist(59). 
Importantly, OASIS and LAM share similar risk factors and are associated with an increased risk of AI(60). 
The significant relationship between this type of trauma and vaginal childbirth, episiotomy, perineal 
tears and length of second stage was demonstrated in a study of 513 women after their first baby(57). This 
was consistent with other studies which reported trauma and vaginal delivery (21%), episiotomy (3.1%), 
forceps (14.7%), epidural (0.9%) , epidural and induction with oxytocin (0.8% to 0.9%)(61, 62). The rate of 
LAM following first vaginal delivery (10% to 30%) tripled with age, and increased the risk of PFD(20, 63).
Neuropathy
The innervation of the IAS is from the lumbar (L5) and sacral (S2-S4) nerve roots and the inferior rectal 
branch of the pudendal nerve is responsible for innervating the EAS to enable rectal compliance to be 
maintained(4). The LAM are innervated by the levator ani nerve, which originates in females in the S3-S5 
sacral nerve roots(4).
The pudendal nerve is a mixed motor and sensory nerve where mechanical and neuropathic disturbances 
following birth can be associated neuropathy resulting in vaginal numbness or absent sensation to defecate 
resulting in AI(3). The anal mucosa is also highly innervated and sensitive to touch, pain, temperature, 
and movement and stretch injury or direct trauma during pregnancy and childbirth increases the risk of 
neuropathy(3-6).
Risk factors for neuropathy are similar to OASIS or LAM. The prolonged second stage of labour, 
instrumental delivery and delivery of macrosomia babies associated with the greatest risk of denervation 
to the pelvic floor and resultant neuropathy(64, 65). The pudendal nerves inability to stretch in labour 
increases the risk of denervation and resultant AI(66). This was consistent with several studies. Zetterstrom 
et al.(67) whom reported nerve damage in 19% of women with OASIS but asymptomatic of AI, compared 
to 43% of symptomatic women with occult OASIS showing no nerve injury(67). Snooks et al.(66) identified 
that occult denervation of the EAS in 33% of women, subsequently worsened over a 5 year timeframe 
the risk of UI and  or AI and increased and reported in 58% of women with neuropathy. Whilst pudendal 
neuropathy was reported to improve in 60% of women by 6 months postnatal, the effects of further 
compounding injury and ageing may impact their continence status and thus screening for symptoms is 
paramount(68).
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Occult injury
Thorough assessment and identification of pelvic floor trauma is critical, as clinically insignificant 
tears or undiagnosed anal sphincter injury (occult injury) results in underreporting. One study utilising 
EAUS in primaparous women before and after the first birth identified 33% occult injury(69). Rieger et 
al.(71) utilised anal manometry and  anal ultrasound in 53 primiparous women and identified vaginal 
birth adversely affected anal function in women with and without known OASIS. The advent of EAUS 
technology has increased the reporting of occult tears (20% to 41%)(70, 71). It is questionable if the rate 
of reporting direct OASIS has been historically accurate as Sultan et al.(4) identified improved training 
in the assessment of perineal trauma, increased the accuracy in reporting at primary repair. This was 
apparent in two prospective studies where two clinicians, the second a more experienced clinician 
reviewed the perineal tears following women having their first birth(70, 72).  Both studies utilised EAUS 
to assess sphincter integrity postpartum, Andrews et al.(70) found an increase in OASIS detection rate 
from 11% to 25% of deliveries with a more experienced clinician. Whereas Groom et al.(72) found that 
15% of small perineal tears were identified as OASIS when re-examined. Importantly many women 
who sustain either direct or indirect pelvic floor damage and maintain effective pelvic floor reserve may 
remain asymptomatic until later in life, therefore early recognition of trauma is paramount for future 
care and management(1, 19, 23, 73).  
1.3 PREVALENCE OF ANAL INCONTINENCE IN AUSTRALIA
AI is common within the general community and not only restricted to the elderly in aged care facilities. 
In the Australian population, more than one million people reported symptoms(74, 75). A recent Australian 
report in 2010 into the trend of AI within the Australian residential care and community settings reported 
1.34 million people(74). The report identified a projected increase of AI by 2030 to 1,835,340 people, 
of which 1,122,749 will be women(74). The prevalence of AI is greater when compared to other major 
diseases  which include heart disease (1.1 million), psychological stress (1.8 million), and mild asthma 
(2.3 million)(76). The prevalence of AI increases with age and it is a common precipitating factor for 
admission to residential aged care, AI is not isolated to the elderly but is reported widely across the 
Australian community(26, 77). The reported rates of AI within the community varied between 1.5% to 
50%, and reporting dependent on the study population, tools utilised in screening and how AI was 
defined(74, 78).
In the general Australian population several Australian studies reported the rate of AI between 6.9% 
to 20.7%(77, 79). Ho et al.(77) assessed the severity and prevalence of faecal incontinence (excluded rectal 
urgency) in an outpatient department in northern Queensland. The research included a specifically 
designed bowel questionnaire, which was pretested but not validated. The questionnaire included 
a severity scale and terms such as accidental bowel leakage and soiling, however it was difficult to 
differentiate between types of stool loss. The study included 435 male and female outpatients; overall 
20.7% reported AI with a higher prevalence of in women. The median age for this study was 53 years 
with a range of 41 to 66 years. As 60% of the sample were gynaecology patients, it was difficult to assess 
if PFD was a result of previous pregnancy or childbirth as no obstetric data was evident. Therefore the 
causation for AI may be presentive of ageing only(77). An additional cross sectional study undertaken in 
New South Wales by Kalantar et al.(79), included 990 male and females who completed a validated self-
administered questionnaire with dichotomous yes or no responses to assess rates of faecal incontinence. 
This research included solid, liquid stool and rectal urgency but excluded flatus and soiling. The overall 
prevalence rates of incontinence to solid stool (2%) and liquid stool (9%) appeared similar between 
men (10.8%) and women (11.6%)(79). Kalantar et al.(79) cite consistency between their findings and other 
Australian population studies such as that by Lam et al.(80) which  reported 15% of men and women with 
faecal incontinence. These rates were higher than other community studies reporting 2% to 7%, however 
Kalantar et al. surmised the definition of bowel loss and the methods employed in these studies may 
have contributed to the disparity in reporting(79).
The prevalence of AI is often dependent on the population type studied. Chiarelli et al.(26) study which 
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included high risk birthing women identified that at least one symptoms of AI in 32.4%. This was a 
large cohort of 568 women whom received an initial structured interview with a validated questionnaire 
followed by a telephone review at 12 months(26). Unlike Ho et al.(77), Chiarelli included only women 
of reproductive age (15 to 44 years) and assessed all types of stool loss, flatus incontinence, rectal 
urgency and soiling(26). The findings suggested an association of high-risk delivery, with  PFD and 
reported rates of flatus incontinence (24.4%), rectal urgency (14.8%), soiling (10.9%), liquid stool 
(4.9%) and solid stool (2.6%)(26).  The rates of liquid and solid stool loss were lower when compared to 
a multicentre study across New Zealand and the United Kingdom (8.2%). However the reporting flatus 
incontinence (18.8%) where similar between all studies. MacArthur et al.(31) study identified an increase 
in the reporting of  symptoms (42.7%, all symptoms) over a 12 year period and of interest, of the 3456 
women with no symptoms at 3 months post birth, 10.3% reported faecal incontinence (FI) at 12 years(31).
Additional research identified the relationship of gender and ageing, as women aged 45 years and over 
when compared to similar aged men were at eight times greater risk of AI  than women(14). These findings 
support the consensus within the literature as to the relationship between AI and gender, vaginal delivery 
and ageing. The impact of ageing on pelvic floor functional reserve previously discussed highlighted by 
the higher reporting of incontinence in women within aged care facilities(1, 74).The impact of pregnancy 
and childbirth is demonstrated with a higher rate of reporting of AI in pregnancy, the postpartum period 
and with ageing. The reporting of AI in gynaecology outpatients (16% to 28%) is higher when compared 
to the general population (4.4%)(11, 81, 82).
1.3.1 Prevalence of anal incontinence in women of reproductive age
The reported number of Australian women of reproductive age with anal incontinence was estimated to 
be approximately 359,876  in 2010 in a report from Deloitte Access Economics commissioned by the 
Continence Foundation of Australia(74). The deterioration of the pelvic floor reserve following childbirth 
and resultant OASIS, as previously mentioned are main causes of AI in one to two thirds of women(15, 26, 
54). The reported prevalence of AI varying between 6.9% and 61% for women with known trauma, and 
25% of women with no reported OASIS injury(17, 23, 54, 83, 84).
The reported literature highlighted the variation in the prevalence of AI in late pregnancy as between 
30% and 50%, with 16 to 49 % of women reporting AI in the post-partum period(81, 85, 86). The variation 
in reporting appeared to be a result of the different reporting tools used and how bowel incontinence was 
defined either AI or FI(86, 87). FI excluded rectal urgency and studies, which used this definition, reported 
lower rates of bowel incontinence compared to higher reporting when the definition of AI was utilised(86, 
88). Slavin et al.(88) utilised the definition FI in late pregnancy and identified solid stool loss (0%), liquid 
stool (2.1%) and flatus (5.9%). The overall prevalence of bowel loss is much lower than Johannsson 
et al.  who included symptoms of rectal urgency (13%) an identified an overall incidence of AI in 42% 
of women in late pregnancy(86). Rectal urgency is the most commonly reported symptom and indicates 
external anal sphincter disruption and often the only symptom present, signalling a compromised pelvic 
floor(17, 19, 73, 86, 87). However, symptoms are variably reported because of physiological changes following 
birth where the pelvic floor returns to the pre-pregnant state and symptoms in some cases are thus 
resolved until later in life(86).
Passive faecal soiling is a common and challenging problem within the general community and whilst 
the exact prevalence remains unknown, it was reported in 7% and 23% of women attending a hospital 
centre(89). Predisposing factors for passive soiling included obstetric injury, yet these symptoms were not 
captured in current screening tools(89).
The importance of screening for a history of AI in women of reproductive age is paramount given the 
relationship between first birth and AI(14). The cumulative effect of subsequent vaginal birth, obstetric 
trauma and ageing may compound symptoms(1, 90, 91). A prospective Norwegian study utilised a validated 
bowel-screening tool (St Mark’s faecal incontinence score, Vaizey score) to assess AI in 862 primaparous 
women. The findings identified that 22% of women were symptomatic of AI late in pregnancy with 18% 
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of this group still symptomatic at 12 months postpartum(92). The study did not breakdown symptom type 
and it is difficult to determine type and frequency of bowel concerns. Furthermore, passive soiling was 
not investigated with this tool.
AI was also reported over a 5 to 10 year timeframe by Evers et al.(93). The prospective study included 937 
first-time mothers with 10% of women reporting a history of OASIS and AI. Women completed multiple 
questionnaires (Epidemiology of Prolapse and Incontinence questionnaire (EPIQ) and Colorectal-Anal 
Impact Questionnaire (CRAIQ-7)). The EPIQ a complex tool with multiple questions that assessed all 
pelvic floor concerns whilst the CRAIQ assessed quality of life(93). There was an association between 
OASIS and a negative impact on quality of life 5 to 10 years after birthing(93). Across three groups flatus 
incontinence was reported in 31% of women who sustained an OASIS, 23% of all women having a 
vaginal birth, and 15% of women having a caesarean section. Lower reported rates of incontinence to 
liquid stool in 17%, 8%, and 7% respectively, and to solid stool in 4%, 0%, and 1% respectively(93). These 
trends were similar to other studies which suggested women with OASIS and who are symptomatic of 
AI in the postpartum period were eight times more likely to be at risk of persistent AI at five years(83). 
Additionally a prospective study of 242 nulliparous women by Pollack et al.(83) identified incontinence 
at five, and nine months and then five years post birth. The study utilised a self-report questionnaire 
for faecal incontinence and constipation, which included questions to ascertain incontinence to solid, 
liquid and flatus(83). These findings consistent with those of Evers et al.(93) and similar studies where the 
progression of worsening symptoms following OASIS were 44% at nine months and higher at five years 
(53%)(93).
Cornelisse et al.(94) recognised the impact of worsening AI over a 4 year timeframe for postnatal women. 
This study undertaken in the Netherlands, included 355 women and consisted of a control group with 
no history of OASIS (n = 194) and a group who sustained An OASIS (n = 141). Three questionnaires 
were utilised; Defecation Distress Inventory (DDI), Cleveland Clinic Fecal Incontinence Score, and 
Fecal Instrument Quality of Life (FIQOL)). This study identified that the reporting of AI  was double 
for the OASIS group (40%) compared to the control group (20%)(94). The latter an interesting finding 
that women with no known OASIS reported symptoms(94). These findings were consistent with those 
of Pollack et al.(83) who reported AI in women with no sphincter trauma at 9 months (25%)  and 5 years 
(32%). Additional studies, which evaluated the risk of AI for women with no history of OASIS, reported 
prevalence of flatus incontinence (11.7%), faecal incontinence (4.1%) and faecal urgency (12.3%) with 
no reported relationship to known risk factors for OASIS(73). In the absence of a history of OASIS, AI 
symptoms may be a result of occult OASIS, levator ani trauma or chronic pudendal neuropathy(73). 
However further evidence suggested that there are other predisposing factors which influenced pelvic 
floor function prior to first pregnancy and birth, and the outcome on continence status(1, 7).
A prospective study undertaken by Van Brummen et al.(95) investigated the impact of pregnancy and birth 
on defecation function utilising the DDI questionnaire. Defecation concerns reported in 487 nulliparous 
women in early pregnancy (3 months) and then at a further three time points. Flatus incontinence at 
3 months gestation was 34.6% compared with 42.3% at 36 weeks gestation, 31.9% at 3 months post-
partum, and 30.5% at 12 months post-partum. This study did not differentiate between liquid or solid 
incontinence, but overall FI was reported as 3.9% at 3 months gestation, 3.0% at 36 weeks gestation, 5.7% 
at 3 months post-partum, and 3.3% at 12 months postpartum. This further highlighted the importance 
for screening all women of reproductive age for AI and recognising women with no obvious trauma 
following vaginal delivery are at risk of PFD and AI(23, 73).  The onset of AI appeared to be variable 
occurring in pregnancy, after birth or anywhere from the third decade increasing in prevalence to the 
sixth decade with a moderate to severe impact on QOL(96, 97).
1.4 IMPACT OF ANAL INCONTINENCE ON QUALITY OF LIFE
Bowel control is assumed around 4 years of age and once attained the physiological aspects are often 
taken for granted(98). Continence is a learnt behaviour which is influenced by the social and cultural 
beliefs and behaviours of the society in which we live(98). How a person is socialised will influence their 
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attitude to continence matters. For example, a healthy attitude to excreta as a normal bodily function 
with no shame or disgust shapes how a person copes with incontinence(99, 100). However, bodily functions 
are often viewed in society as taboo topics and elicit emotional disgust(99). The thought, smell and sight 
of faeces places it uppermost on the list of disgust(100). This is not a problem until there is a challenge 
or change to one’s continence status, such as accidental soiling. A person struggles to cope with the 
physical impact of incontinence and challenges their self-image and identity within a social group(101, 102). 
A persons experience of AI is unique and complex often influenced by many aspect of a person’s life; 
the physical symptoms, emotional feelings associated with AI, social attitudes towards a person with 
AI, financial burden and isolation(103). AI is referred to as the last taboo, AI as a result of societal rules it 
is avoided in conversations and remains hidden and negatively impacts on a person’s quality of life(74).
Health seeking is complex involving a person’s understanding that AI is a problem, social beliefs, 
motivation for help and receptiveness of health professionals(104). Poor health seeking often associated 
with infrequent episodes of AI, or belief that AI was a normal consequence of birth whereas worsening 
symptoms a motivation for health seeking(56, 104, 105).
The term quality of life (QoL) is utilised extensively within clinical practice and research, yet there 
is no consensus on what defines QoL. The World Health definition included the multifaceted view of 
physical, emotional and social wellbeing and the perceptions of an individual which keep them engaged 
in every aspect of daily living(106).
QoL questionnaires are utilised in clinical settings to assess for AI in all population groups. These 
tools provided a valuable insight into living with accidental loss of bowel control, and highlighted the 
detrimental impact on daily functioning(53, 54, 103, 107-109). QoL tools have traditionally grouped concerns 
citing lifestyle, social functioning, financial burden, enforced social isolation, coping difficulties, 
depression, negative self-image, fear, embarrassment, anxiety due to unpredictability and sexual 
matters(55, 85, 110-114). A quantitative scale included in the questionnaires identified symptom bother with 
higher scores relating to worsening impact on quality of life(94, 111).
There are limitations within QoL tools in the assessment of AI, largely due to their development. 
These types of tools were clinically derived and have little to no participation from those afflicted by 
AI(53, 113). The lack of shared words or terms for AI are a barrier for health literacy and disclosure. 
Studies identified 60% to 70 % of women do not understand the term incontinence and suggested the 
use of common language used within communities should be utilised to describe stool loss(104, 115, 116). 
Furthermore, clinical tools have a tendency to undervalue the incidence or severity of symptoms for 
women with AI(117).  Women often report rectal urgency, flatus incontinence and soiling as predominant 
symptoms noting a profound impact on their QoL. However, clinically derived tools,often excluded or 
underrated questions pertaining to symptoms which contributed to inaccuracies in reporting(78, 118). The 
frequency and severity of solid stool incontinence often ranked higher by health professionals compared 
to other types of leakage, whereas those afflicted by AI, were conscious of all leakage and the associated 
embarrassment and negative impact on QoL(118-120). Considering the main risk factors for PFD and AI 
are associated to pregnancy and childbirth, understanding the understanding the deterioration in QoL 
provided strong evidence of the need for routine screening women of reproductive age for AI(74).
Qualitative research methodology provided an in-depth understanding within this area however it 
remains limited(53). Qualitative research identified that many women not only accept AI as a normal 
consequence of birthing but also learn to live with the negative consequences(118, 121, 122). Women living 
with AI struggled with simple daily tasks of shopping, working, travel and outings(118, 123). Often the 
unpredictable nature of AI heightened the anxiety associated with what were seen as simple every day 
activities(55, 56, 118, 123). The daily planning of what to wear, fear of odour, where they were going, and 
accessibility to toilets resulted in avoidance or postponing events in case accidental bowel leakage 
occurred(118, 123).
Rasmussen et al.(54) revealed the compounding negative impact of enforced isolation as a result of AI 
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on a woman’s mental health. Previous research by Tucker et al. concurred with these findings and has 
highlighted the fragility of young women’s mental health as “teetering near the edge”(56). The associated 
disgust and stigmatisation of AI in women of reproductive age has been shown to compound both the 
physical and mental burden which negatively affected their self-worth  and how they conceptualise 
themselves as a sexual partner, woman, and wife(54, 56).
Women will not initiate discussion around this sensitive topic, and avoided intimacy for fear of accidents 
and the dissatisfaction of significant others(54, 56, 118, 124). Fear of worsening symptoms in subsequent 
pregnancies and birthing further impacted on a woman’s psychological fragility(54, 125).
Research identified incontinence was an independent risk factor for worsening mental health with 
variable reporting with different types of incontinence(118, 126-128). Women with urinary incontinence 
reported both anxiety and depression, with lower rates of depression in 3% to 14% of women with stress 
urinary incontinence compared to 21 to 41% of women who reported urinary urge incontinence(127, 
129). Additional studies suggested there was a strong association between urinary incontinence and FI 
(double incontinence) and altered mental health(121, 130, 131).
A French study assessed the relationship of depression with the Edinburgh Postnatal Depression Score 
(EPDS) to FI and rectal urgency in 1632 post-partum women. Findings suggested that women who 
reported FI at 4 months post-partum were at greater risk of worsening mental health at 12 months with 
36% of women with FI, and 23% with rectal urgency compared to 14.8% of women with depression 
at 12 months but no FI and rectal urgency(128). The association of AI and mental health was reported by 
Brown et al.(132), who undertook a study of 5817 women which identified 1096 women with a history of 
bowel leakage. A third of women with bowel leakage identified feelings of depression and 40% of the 
total group reported a significant impact on QoL(132). Treatment failures for AI were strongly associated 
with worsening depressive symptoms(118). Meyer and Richter(118) concurred with these findings  and 
noted  psychological demise contributed  to poor health seeking and treatment. The low rates of health 
seeking due to stigma in Meyer et al. study consistent with other research(79, 97, 132, 133). However, studies 
which described the relationship between mental health and bowel incontinence remains limited and 
whilst further research is required in this area, there is  a recognised need for early screening women for 
AI.(102, 128, 134).
Figure 1.7. Total financial burden of incontinence in Australia for 2010. Source: Deloitte access 
economics-Continence Foundation of Australia. The economic impact of incontinence in Australia. 
ACT: 2011). †Indirect cost refer to living aids, pads, laundry and formal carer expenses. ‡Deadweight 
losses refer to lost revenue through transfers and lost taxation.
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Non-disclosure of AI to health professionals is complex and citied as being due to stigma, and lack 
of enquiry by health professionals. Limited understanding of questions in tools utilised to identify AI 
further limits accurate assessment of the true prevalence of this condition hidden(53, 54, 103, 116). The ability to 
comprehend questions within screening and assessment tools is paramount in the accurate identification 
of AI and improved QoL. Bartlett et al.(116) identified disagreement in terminology between two bowel 
screening tools, the Self-Administered Faecal Incontinence Questionnaire (SAFIQ) and the Cleveland 
Clinic Florida Faecal Incontinence Score (CCF-FI) as barriers to disclosure. Outcomes suggested direct 
enquiry by a health professional who utilised a questionnaire, which contained language women could 
understand could improve disclosure. Based on this information, this thesis aimed to address the gap in 
knowledge with the development of a novel bowel-screening questionnaire to identify AI.
1.5 ECONOMIC BURDEN OF ANAL INCONTINENCE IN AUSTRALIA
The economic burden of  incontinence included not only the impact on the afflicted person, but consisted 
of carer support and costs to the wider community (Fig.1.7)(74). Deloitte Access Economics on behalf of 
the Continence Foundation of Australia (CFA), estimated the total burden of incontinence in 2010 as A$ 
66.7 billion dollars or A$14014 per person(74). The projected increase for people living with incontinence 
by 2030 will be 6.2 million. Based on the daily individual cost (2010) A$14014 per person the burden on 
Australia equates to A$ 87 billion dollars(74). The total cost burden of AI incurred by a person, included 
health system costs (A$270.8 million), continence aids (pads, clothing)(A$321million) productivity 
losses (A$34.1 billion) , informal carer costs (A$2.7 billion), residential care costs (A$1.6 billion) and 
dead weight loss from lost taxation (A$3.8 million) and burden of disease (A$23.8 billion)(74, 135).
Women living within the community represent the largest group suffering from incontinence, reporting 
AI in 44% and urinary incontinence in 47% of women under 50 years of age(74). The impact on QoL 
apparent for women when the financial burden is considered. Women (73.5%) aged 15 to 64 years less 
financial earning capacity with lower workforce participation compared to men (83%)(136). Additionally, 




Anal or perineal graciloplasty 
with insertion of stimulator and 
electrodes 
887 32213 Sacral nerve leads 635.95 
2209 
Anal or perineal graciloplasty 
with insertion of stimulator and 
electrodes 
887 32214 Neuro-stimulator or receiver 321.3 
2210 Gracilis neo-sphincter pacemaker 245.8 32215 Sacral nerve electrodes 120.65 
32129 Anal Sphincter - direct repair 634.7 32216 Sacral nerve leads 571.1 
32203 Anal or perineal gracilopasty 610.95 32217 Neuro-stimulator or receiver 150.4 
32126 Anal incontinence Parks inter sphincteric procedure 465.65 32218 Sacral nerve leads 150.4 
32051 Ileostomy reservoir 1,648.75 32220 Insertion of artificial bowel sphincter 869.65 
32060 Ileostomy closure 2,228,80 32221 Removal or revision of artificial bowel sphincter 869.65 
32063 
Ileostomy closure with  
resection with long term follow 
up 
2,045.65 32047 Perineal Proctectomy   
32066 Ilesotomy closure with resection 541.95       
 
Table 1.2. Medicare costs for anal incontinence procedures (Source: MBS online, Medicare benefits scheme, 
Commonwealth of Australia, 2017, http://www9.health.gov.au/mbs/search.cfm?q=32216&sopt=S&=, 
permission from website accessed 21.6.2020) 
Table 1.2. Medicare costs for anal incontinence procedures. Source: MBS online, Medicare 
benefits scheme, Commonwealth of Australia, 2017, http://www9.health.gov.au/mbs/search.
cfm?q=32216&sopt=S&=, accessed 21.6.2020).
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women are more likely to be employed on a casual basis with less women working in full time employment 
(46.9%) this results in a 14.1% reduction in total earnings compared to male co-workers(136). This is 
further compounded by persons living with incontinence who have a higher unemployment rate(137). The 
burden of incontinence potentially resulting in higher absenteeism from paid employment(74, 137, 138). The 
reduction in earnings directly impacts upon personal income, reduced disposable income decreasing the 
direct and indirect tax revenue for government budgets(74, 138). The financial impact is not only personal 
but from a national perspective where the productivity losses from incontinence and subsequent loses in 
taxation revenue were reported in Australia in 2010  to be A$10.6 billion(74).
The financial impact of incontinence further disadvantaged women who are the predominant carers for 
others with incontinence. Two thirds of carers in Australia are women with 56% of carers aged 15 – 64 
years in paid work compared to 80% in unpaid work(139, 140). 
Whilst the cause of AI is multifactorial, extensive research identified known risk factors for AI as both 
pregnancy and childbirth worsening across the lifespan(1, 31, 90, 141). As previously outlined, there is variable 
reporting of direct and indirect anal sphincter injuries (OASIS). In 2017, Australia women birthing for 
the first time sustained an average OASIS rate of 5.3%, however there was variation in different states 
and territories ranging between 5% and 6.2%(142). National core maternity indicators reported an average 
of  3% for all women who birthed in 2016 and this is on par with state reporting of primary injury(142, 143). 
Direct health care costs associated with anal sphincter at primary repair for each woman is A$634.70 
for the anal repair alone (Table 1.2). The total cost for 3% of women with OASIS in 2016 would have 
equated to A$3,954,815.7, these figures do not include physician cost or facility cost for operating 
theatre, length of stay. There appears to be limited information on the lifetime financial costs for this 
group of women in Australia. An American study in 1996 undertaken by Mellgren et al.(144) identified 
the associated cost to the health facility following treatment for sphincter repair US$8555 per procedure 
with US$17,166 per woman with lifetime follow up. 
Research literature identified the benefits of first line treatments including behavioural, biofeedback 
and conservative therapies in successful management of AI prior to further surgical interventions(145-147). 
However, the implementation of therapies difficult because of the variable onset of symptoms and 
duration with many women not seeking assistance until later in the lifespan where a compounding 
of damage had occurred in subsequent childbirth. Additionally, AI symptoms often improve for many 
women in the postnatal period and are infrequent; women do not recognise the importance to disclose 
symptoms to a health provider. Furthermore, women presenting in a subsequent pregnancy are rarely 
screened for a history of AI unless they disclose previous symptoms(148, 149). 
When there is no improvement in bowel symptoms in six or more months of behavioural therapies, 
further management options are discussed. Sacral neuromodulation (SNM) considered the gold standard 
of choice with a product cost of A$18000(150). Failure rates of up to 5% to 20% and ongoing costs 
associated with battery replacement poses further financial strain for women(151). Importantly SNM is 
not offered at many Australian major public hospitals and the cost of the procedure means that SNM is 
out of reach for many Australians.
Communicating a history of AI in subsequent pregnancy and delivery is vital for the preservation of the 
pelvic floor function across the lifespan(10, 152). Active screening for AI by obstetricians, gynaecologist, 
general practitioners and midwives would promote early referral to services, which specialise in bowel 
management and allow obstetric care providers to assess and plan pregnancy care specific to a women’s 
needs. This would improve her quality of life in the short and long term(118, 148, 153).
1.6 ROUTINE ASSESSMENT AND SCREENING OF ANAL INCONTINENCE IN WOMEN 
OF REPRODUCTIVE AGE
The assessment and screening for AI in women of reproductive age requires a strategy that includes 
primary, secondary and tertiary approaches. A primary approach focuses on modification of risk factors 
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such as obesity, surgical and obstetric cause which increase the risk of trauma and resultant AI(118). It 
was evident within the literature that there are risk factors for PFD, and OASIS and relationship of AI 
following childbirth is clear. However, there are limited studies that provided a strategy for the reduction 
of perineal trauma, OASIS and screening for AI. Dietz (20) supported this view, stating there has been 
a hiatus over 40 years  in the development of therapeutic and clinical approaches for PFD especially in 
the disciplines of obstetrics and gynaecology.
There is evidence of clinical strategies to reduce OASIS in multicentre studies(154). A care bundle of 
evidenced based interventions which included angle of episiotomy and application, massage, warm 
packs, recognition and repair of perineal trauma have been enlisted to bring about change in practice 
thus reducing the risk of OASIS(154, 155). Each of the interventions were used as standalone strategies 
however; the advantage of the bundle is that it brings about change through consistency of application 
in clinical practice with each episode of care to reduce OASIS(155). Nevertheless, the strategy does not 
provide any evidence as to the importance of routine screening for AI. This omission inhibited the 
secondary screening approach and tertiary approach minimising risk and worsening impact on QoL. The 
scope of this thesis focuses on the secondary approach.
The secondary approach in the prevention of AI included screening women of reproductive age with 
a simple, quick easy to use tool(118, 148, 153).  However, disclosure is reliant on both women disclosing 
symptoms and active screening by health professionals. Disclosure of AI as previously outlined is 
complex with the nature and severity often influencing health-seeking behaviour(87, 118, 148, 156). This 
was consistent in a study by Bharucha et al.(97) which reported  the severity of symptoms influenced 
reporting in women (48%). This is of concern and indicated there are potentially more women who 
are symptomatic in the community who have not disclosed symptoms thereby affecting their care and 
management especially in a subsequent pregnancy. This was consistent with a study by Cornilesse et 
al.(94) which identified the overall rate of flatus incontinence in women with OASIS (44%)  and women 
with no OASIS (22.6%), was higher when compared to women citing severe bother in the OASIS 
(12.1%) and no OASIS (4.6%) group.
Research identified that the receptiveness of a health provider can influence discourse, with women 
preferring a general practitioner as they were perceived as receptive and non-blaming(56, 116, 118). Bharucha 
et al.(97) identified a pathway for reporting for women which included the general practitioner (56%) who 
appeared to be the preferred option to report compared to the junior doctor (19%), gynaecologist (27%), 
uro-gynaecologist ( 7%) and colorectal surgeon (7%)(97). However, many women rarely seek care more 
likely disclosing to a friend (51%) when compared to a doctor (10% to 30%)(97, 118, 121).  This preference 
for reporting was consistent with research by Fatlin et al.(157) who utilised a self-report questionnaire in 
1435 women attending outpatient appointments in a uro-gynaecology and maternity department. AI was 
reported in 4.4% to 15.9% of women, however only 20% of the overall group reported symptoms to a 
health provider(157).  
The lack of health provider enquiry identified in research negatively influenced disclosure, with women 
citing that health professionals lacked clinical knowledge and skill in screening, care and management 
of AI(54, 56, 148). Tucker et al.(56) qualitative study investigating women’s experiences following OASIS and 
AI, highlighted that the inattentiveness of health providers as a roadblock to disclosure. Inattentiveness 
was viewed as lack of knowledge and skill in the management of AI(56). Disclosure further discouraged 
by health providers who appeared to minimise the importance of AI(13, 158).
An additional roadblock in screening for AI lies in the discordance in ranking of symptoms between 
health professional and person afflicted(118). Clinical history, bowel diaries, QoL, screening tools are 
utilised to identify AI, yet patient symptoms are often undervalued by health professional, with specific 
disciplines placing greater significance on solid stool loss compared to liquid, flatus incontinence and 
rectal urgency(54, 56, 118, 148). Additionally, Rusvay et al.(148) international survey of 143 clinical specialities 
identified that, specialities involved with women of reproductive age; obstetricians, gynaecologists and 
uro-gynaecologists rarely routinely screen women for AI(148). 
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There is limited evidence within research, which identified the routine use of screening tools in women of 
reproductive age. A review of the literature identified two groups: clinical practice and clinical research. 
1.6.1 Clinical practice
There was paucity within the literature as to the routine use of screening tools in the pregnant and 
postnatal population. The pregnancy hand-held (PHHR), a written record held utilised by pregnant 
women worldwide assists in maintaining continuity of care and improving risk management(159-161). 
Whilst similarities are evident between the PHHR, it was obvious that no consistent format existed 
(Table 1.3)(162-166).
Four of the six Australian state and territory PHHR contained no prompt for bladder or bowel status (Table 
1.3). Queensland and Western Australia PHHR contained questions about continence status utilising 
words such as incontinence(162, 163). The Queensland PHHR was superior as it included questions on types 
of bladder function however bowel questions were limited to constipation and anal incontinence(162).
The ability to read and understand health literature and decipher AI questions for the health professional 
and woman may also be a barrier in eliciting information(56, 116). The lack of a shared vocabulary was 
evident in a prospective research by Bartlett et al.(116) which compared reporting of AI between a Self-
administered Faecal Incontinence Questionnaire (SAFIQ) and the Wexner Score (CCF-FI) in 262 men 
Table 1.3. Comparison of pregnancy hand held records in Australian and the United Kingdom.
Origin Document name     
NHS UK NHS Pregnancy notes 
National Health System 
United Kingdom 
A4 
Booklet Medical history 
Incontinence  









Personal history  
Obstetric problems   
No PFD nor OASIS 
Incontinence  
(urine or faeces, stress or 
urge) 





Bladder function:  
Frequency, urgency, 
dysuria voiding problems; 




SA Pregnancy record SA health A4 booklet 
Medical history 
No incontinence  
No PFD 
No 
ACT Maternity Record ACT government  A3 card No continence No 
NT Pregnancy Health  record NT 
A3 card 
bifold 
No continence  
No PFD No 
Victorian Maternity record Vic A4 booklet 
Postnatal going home 
No incontinence in 
pregnancy 
Urine bowel function 
 






Table 1.4. The Wexner score (Reproduced from Dis Colon Rectum, Aetiology and management of faecal 
Incontinence by Jorge JMN & Wexner SD, 36:77–97, 1993 with permission BMJ Publishing Group Ltd) 
 
 
The WEXNER SCORE 
A Frequency Assessment Tool 
Type of 
Incontinence Never Rarely Sometimes Usually Always 
Solid 0 1 2 3 4 
Liquid 0 1 2 3 4 
Gas 0 1 2 3 4 
Wear Pad 0 1 2 3 4 
Lifestyle altered 0 1 2 3 4 
 
Table 1.4 (left). Cleveland 
Clinic constipation score - the 
Wexner score. Reproduced 
from Dis Colon Rectum, 
Aetiology and management of 
faecal Incontinence by Jorge 
JMN & Wexner SD, 36:77–97, 
1993, with permission BMJ 
Publishing Group Ltd.
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and women attending colorectal and gynaecology outpatients in Queensland. The findings reported 
misinterpretation of questions as a major reason for nondisclosure(116). Brown et al.(115) concurred with 
these findings and suggested disclosure is enhanced through the type of screening tool (self-report versus 
clinician) and the use of terminology. The study involved 5817 women over the age of 45 years in the 
United States, and included an online questionnaire adapted from a validated bowel screening tools 
Faecal Incontinence Severity Index (FISI) and the Wexner score. Whilst the self-report format of the 
questionnaire enhanced reporting with 97% of women noting a history of AI in the last 12 months, there 
were issues surrounding terminology with 31% of women never had heard the term FI(115).
The use of clinical terminology and absence of questions to assess AI within the PHHR are limitations 
for the screening and assessment in women of reproductive age. Enquiry only apparent if a women 
presents with symptoms or the health care provider recognised the importance for screening in this 
group of women(167).
Social more’s influence enquiry by health professionals as discussed in previous sections and this can 
limit discussion. Shame and embarrassment are common  reasons for the concealment of stigmatised 
conditions(158). Non-disclosure is further compounded through the misguided acceptance by society 
that AI is a normal consequence of birthing and this negatively impacts on women’s management, 
compounding current PFD and poorer QoL(56, 168). 
A search of the literature over a 20-year timeframe revealed only three papers, which reported the 
use of screening tools in clinical practice to identify AI. The clinical areas included perineal clinics to 
review perineal trauma and OASIS. Each clinical setting utilised a different screening tool to identify 
incontinence however, each tool contained similar parameters to review type (solid, liquid, flatus 
incontinence and or rectal urgency) and severity of AI. 
The Modified Cleveland clinic score (Wexner score, Table 1.4) was utilised in an Irish population of 
399 women, referred for perineal concerns over a 2 year timeframe(169). The primary intention in the 
establishment of the clinic in 1995 was to review and treat women who sustained OASIS at 3 months 
postpartum but it had since grown to include other perineal complaints and therefore findings also 
reflected older women (range 18 to 77 years)(169). The referral pathway to this clinic followed the Royal 
College of Obstetrics and Gynaecology recommendations for health professionals to establish perineal 
clinics for the early identification and management of incontinence in women with OASIS(38). The 
Table 1.5. St Mark’s fecal incontinence score - Vaizey score. Reproduced from Dis Colon Rectum, 
Aetiology and management of faecal Incontinence by Jorge JMN & Wexner SD, 36:77–97, 1993 with 
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Vaizey Fecal Incontinence Score 
Type of Incontinence Frequency 
Never Rarely Sometimes Weekly Daily 
Incontinence for solid stool 0 1 2 3 4 
Incontinence for liquid stool 0 1 2 3 4 
Incontinence for gas 0 1 2 3 4 
Alteration in lifestyle 0 1 2 3 4 
 
 No Yes 
Need to wear pad or plug 0 2 
Taking constipating mechanisms 0 2 
Lack of ability to defer defecation for 15 
minutes 0 4 
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main pathway for referrals were maternity hospitals (79%), general practitioners (10%), other hospitals 
(7%) and self-referrals (4%). Fifty three percent of  women with a history of OASIS reported FI at 3 
months postpartum with flatus incontinence the main symptoms(169). However, the authors provided no 
breakdown of symptoms for the OASIS group. Discussion was provided for 56 (50%) of symptomatic 
women with rectal urgency which was interesting as the Wexner score does not include questions for 
rectal urgency, hence the definition of FI compared to AI(169).
An additional study by Pretlove et al.(170) reported on the first 18 months of a perineal clinic, established 
for perineal trauma and OASIS in the United Kingdom. Initial referral for women with OASIS was from 
the maternity setting. Referrals were initially low due to lack of awareness by staff and women failing to 
attend appointments. Referrals increased as staff and women saw the potential benefits.
The St Marks Faecal Incontinence Score (Vaizey score, Table 1.5) a validated screening tool was utilised 
to screen women for AI. However, the authors only identified incontinence with a Vaizey score of three 
or more, which is contrary, to the Vaizey scoring system where a score greater than zero identified 
symptom bother. During 2001 and 2002, 71 women attended the clinic, including 41 women with a 
history of OASIS, and 14 with no history of OASIS but a history of AI. The remaining women had 
other perineal concerns. The mean timeframe to report AI was 2 years. Forty-one women who sustained 
OASIS reported an overall prevalence of AI at 61%. This included nine women (22%) with solid and 
liquid stool compared with fourteen women (80%) with no history of OASIS reporting solid and liquid 
stool(170).  
Given the authors utilised the Vaizey score and included only a score greater than three; there was 
difficulty in reviewing the findings to ascertain the true prevalence of AI and symptoms of flatus or 
rectal urgency. Hypothetically, the additional 20% of women with no OASIS reported symptoms of AI. 
Omission in the discussion of these symptoms by the authors adds weight to comments within literature 
that health professionals put more importance in the reporting symptoms of solid and liquid stool(118).
Brincat et al.(171) American research details the experiences of the first four years of a postnatal clinic 
where 247 women presented with a range of perineal concerns. Referral patterns included a combination 
of maternity settings, obstetric doctors, general practitioners and self-referral. Numbers for referral had 
increased over the four years with the authors attributing this to recognition of early assessment and 
management and enhanced collaboration between professional bodies(171). The authors supplied no 
patient demographics or type of screening tool. Findings suggested 154 women with OASIS (63%) 
reported multiple symptoms (52%) with transient symptoms of FI (12.3%) reported in women attending 
their first appointment(171). As the authors referred to FI rather than AI, there was an assumption that 
rectal urgency was not included in their findings. 
Brincat et al.(171) clinic was modelled on the Mayday clinic in the United Kingdom . The Mayday clinic 
provided not only clinical reviews for women’s perineal concerns at 3 months postnatal but also antenatal 
review for subsequent mode of delivery(172). From July 2002 to July 2005, the Mayday clinic received 
433 referrals of which 50 were antenatal women and 373 postnatal women. 67% of women with OASIS 
were reviewed over this timeframe with 23 women who identified AI and urgency (6.2%)(172). Whilst the 
authors detailed the diagnosis and management of AI there was no reference to an initial screening tool 
only ongoing diagnostic testing with manometry and endo anal ultrasound(172).
The review of the perineal clinics identified that the primary aims were early assessment and management 
for women with OASIS. The importance of early referral through education and collaboration between 
health professionals and women resulted in increased referrals to the clinics. Whilst screening for AI 
and FI occurred, there was no uniform screening tool. The implementation and use of the various tool 
was reliant on the operator and in cases where the symptoms score was adjusted to meet the clinicians 
expected outcomes, AI was potentially is underreported.
The routine screening of pregnant and postnatal women in everyday clinical practice is limited. This 
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view is supported by the study of Rusavy et al.(148) which identified the use of AI scoring systems by 
143 researchers and clinicians in  north America, Asia and Europe. The findings revealed obstetricians 
and gynaecologists often neglected screening(148). The preferred tool identified by obstetricians and 
gynaecologists, were the Wexner score and Vaizey score(148). The lack of screening by these professional 
groups was alarming given the association of pregnancy and birth to PFD.
The assessment of  AI requires sensitive questioning to elicit a detailed history from those afflicted  and 
whilst there was evidence within the literature as to the development and refinement of many tools to 
assess bowel incontinence, there was minimal evidence of tools specifically developed for women of 
reproductive age(156, 173). Multiple screening tools are utilised to assess bowel incontinence (FI or AI) and 
are applied to pregnant and postpartum populations in clinical research(7, 19, 31, 73, 83, 86, 87, 90, 109, 114, 171, 174-181).
1.6.2 Clinical research
Questionnaires and screening tools utilised in research often focused on the relationship of pelvic floor 
compartments including bladder, bowel, prolapse and QoL. Whilst they are comprehensive in nature they 
have limitations as there is no standardisation of questions and often time consuming for both clinician 
and person afflicted(156). Zuchelo et al.(149) assessed tools utilised for PFD in the post-partum period, noting 
that the tools were not developed for this specific group of women, having been borrowed from other 
disciplines or developed for the general population(149). Thirty-three articles identified PFD questionnaires 
across the pregnancy continuum, of which one looked at nulliparous women before pregnancy and nine 
validated tools reviewed the postnatal period from three days to five years(149). Pelvic floor questionnaires 
included the Pelvic Floor Inventory-20 (PFDI-20), the Pelvic Floor Impact Questionnaire-7 (PFIQ-
7), the Australian Pelvic Floor Questionnaire ( FPFQ), the International Consultation on Incontinence 
Questionnaire (ICIQ-VS), the Electronic Personal Assessment Questionnaire(eQAQ-FF), the Pelvic 
floor Bother Questionnaire ( PFBQ) the Pelvic Floor Distress Index-46 (PFDI-46) and the Impact 
Questionnaire-31 (PFIQ-31)(149).
The most frequently tools utilised to assess PFD were PFDI-20, PFIQ-7 and ICI-VS. Each tool focused 
on a specific domains of PFD citing limitations of the ICIQ-VS as having no bowel questions and the 
PFIQ-7 focused only on QoL and not symptom identification or bother(149). The tools were complex 
and included a range of non-standardised sets of symptoms including bladder, bowel, prolapse, sexual 
function, vaginal and postpartum symptom bother and or QoL. Questions ranged from 14 to 118 with 
an average of 31 questions(149).
Research, which specifically assessed bowel function in women of reproductive age, identified 15 
frequently used questionnaires and screening tools (Table 1.6). These consisted of tools which addressed 
all pelvic floor compartments and included the PFDI-20,PFIQ-7(182), FPFQ(183), and symptom severity 
and QoL tools which included the Birmingham Bowel and Urinary Symptom Score (BBUSQ)(184), the 
Faecal Incontinence Quality of Life Tool (FIQoL- Rockwood scale)(111), the International Consultation on 
Incontinence Questionnaire Bowel (ICIQ-B)(185), Manchester Health Questionnaire (MHQ)(173). Whilst 
tools which had a primary focus on symptoms severity include the Danish Anal Sphincter Rupture 
Questionnaire (ASR)(186), the Faecal Incontinence Severity Index (FISI)(119); St Marks Incontinence Score 
(Vaizey Score)(187), Modified Miller Score (Rothenberger)(188), Cleveland Clinic Score (Wexner Score)
(14), Parks Score(189, 190), Pescatori Scale(191), and Rapid Assessment Faecal Incontinence Score (RAFIS(192).
The benefits of the QoL questionnaires are outweighed by their inherent weaknesses when utilised to 
screen for AI in women of reproductive age. Many are utilised in a known symptomatic population 
and there is a tendency to underestimate the true nature of the phenomenon at hand(53, 111). Importantly 
the formulation and validation of questionnaires requires the perspective of those afflicted, yet few 
tools have focused on the importance consumer participation in their development. Two QoL 
questionnaires, FIQoL scale and ICIQ-B included consumer participation in the pilot test and re-testing 
of their questionnaires(113, 119, 185). The development of these tools included men and women who were 
symptomatic of AI from the gastroenterology clinics, and were therefore limited to the wider population. 
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However the outcomes from these QoL tools detailed the negative impact of AI on lifestyle, depression, 
self-perception, embarrassment, social functioning and self-image(111, 113, 185).The ICIQ-B included 21 
questions to identify bowel control, pattern and quality of life and was used in clinical practice(113, 185). The 
tool superior to other QoL tools as it also included fear of leaving home, the shame and embarrassment of 
living with AI, not captured by other questionnaires(113). The importance of these types of questionnaires 
in the assessment of symptoms and impact on QoL should not be underestimated. Their length and 
complexity of these questionnaires however limit their usefulness as a quick and easy screening tool in 
the primary health care setting.
The RAFIS was a unique tool, which assessed the frequency of symptom loss in relation to the 
patients emotional response to AI using a visual analogue scale(192). Whilst a simple tool the RAFIS 
underestimates the frequency, severity and type of incontinence. Additionally the small sample size used 
in the development of the tool limits its useability.
The validation of a questionnaire by Reilly et al.(193) which measured FI and risk factors within the 
general community was a positive step to active screening for AI. The questionnaire’s usability was 
enhanced by being written at a sixth grade reading level, utilising lay terms and being formatted in large 
print(193). However, the intention of the questionnaire was not to solely screen and thus the length and 
complex nature of the questionnaire limits its usefulness in the primary screening and identification of 
AI in pregnant and postnatal women.
Alternatively Bugg et al.(194) developed the Manchester Health Questionnaire for screening AI in 
postnatal women. The questionnaire was successful in identifying 9.1% of postnatal women with AI(173). 
However, not unlike the ICIQ-B , the MHQ was limited by its purpose and length as it was designed 
with 32 questions for the assessment of AI and impact on quality of life(174). 
Symptom severity scores often contained fewer questions than QoL tools and objectively evaluated 
symptoms, yet in the past, these tools have often excluded the consumer perspective in their development. 
Whilst current development of screening tools have been in either male or female populations or 
community dwelling women, there appeared to be few tools developed specifically for women of 
reproductive age (Table 1.6). The Danish Anal Sphincter Rupture (ASR) questionnaire was the only 
tool which used women with a known history of OASIS in the development(186). The ASR, a validated 
questionnaire which specifically targeted women with known 3rd and 4th degree tears (OASIS) and 
included screening for quality of life, sexual and physical complaints such as anal pain(186). The benefits 
of the ASR was its simplicity, taking only 15 minutes to complete, however it was only utilised in a 
cohort with known sphincter damage, and does not include women who have had occult damage and 
limits its usefulness in the screening for AI in all women of childbearing age. Furthermore, the ASR has 
no frequency scale, which limits the ability to identify symptom severity.
Simple screening tools for AI have evolved through time and included similar parameters to  identify 
type of loss, frequency and severity(148, 195). Disappointingly there was no standardisation of AI symptoms 
(156). The Parks scale is the simplest tool containing four questions with a total score of one (continence) 
to 4 (incontinence)(189). This scale was limited as it excluded a frequency and severity scale, and 
importantly excluded rectal urgency(156). The Pescatori Scale included three questions including solid 
stool, liquid stool and flatus/mucous loss(191). A basic frequency and severity scale zero (continence) to 
six (incontinence) were included to assess symptom impact. The tool was limited as it  omitted rectal 
urgency and only assessed frequency daily to less than once per week(191). The variable nature of AI in 
women of reproductive age limited the ability of this tool to capture a history of AI.
The strengths of summary scoring systems like the Modified Miller score and FISI (Table 1.6) included 
questions on type of incontinence (solid, liquid stool and flatus), frequency  and severity scale(119, 195). 
The severity grading scale allowed for comparisons between  previous scores to assess improvement or 
correlate QoL(156, 195). However, both tools are limited with the exclusion of rectal urgency and greater 
weighting of solid and liquid stool over flatus loss. The uneven weighting of symptoms was reflected 
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in the literature, which revealed significant disparity in reporting symptoms comparing the clinician 
perspective to clients(118). This is of  concern as there was significant evidence in the literature that a 
woman’s perspective of impaired flatus control, soling and rectal urgency resulted in a debilitating 
impact on QoL(56, 118).
The Wexner score or Vaizey Score are  tools frequently used in clinical practice and research to assess 
AI(148, 196). Whilst there was a wide variation in screening tools used to identify AI in research in women 
of reproductive age, these two tools appeared to be the preferred tool(19, 86, 87, 90, 92, 174-176, 181).
1.7 TOOLS FREQUENTLY USED FOR ASSESSMENT AND SCREENING OF ANAL 
INCONTINENCE IN WOMEN OF REPRODUCTIVE AGE
The Wexner score and Vaizey score quantified and assessed the impact of AI. Both tools are superior 
to other AI tools as they are quick to use with five to seven questions on the type of incontinence and 
included a lifestyle impact, frequency and severity scale(14). 
The Wexner score used frequently in clinical practice, postnatal and longitudinal research was preferred 
for its simplicity and ease in implementation(148, 156). The scoring system cross tabulates symptom 
frequency to a total score between zero (no incontinence) to twenty (incontinence) (Fig. 1.4). There 
was equal weighting of symptoms however; a timeframe for symptom bother and rectal urgency are 
not included(148, 156, 195). The latter is interesting as rectal urgency may be the only symptom women of 
reproductive age present with(148). Whilst the Wexner score was commonly utilised in clinical practice 
the tool has not been formally validated, unlike the Vaizey score(148).
The Vaizey score is a validated and reliable tool and easy to implement which makes it superior to 
other symptom severity tools(176). The use of the Vaizey score in research was evident in late pregnancy, 
postnatal and longitudinal research(156). A cross sectional study which included 1500 postpartum 
primiparous women utilised the Vaizey score to identify AI(85). The results identified rectal urgency 
(37%), loss of flatus (16%) , more than 2 symptoms of AI (21%) and three or more symptoms (5%)(85). 
The recommendations from this research emphasised the importance of routine screening in women 
during pregnancy to identify the risk of PFD to improve outcomes in the postpartum period and across 
the lifespan(85).
The Vaizey score correlated highly to the health professionals clinical impression of patient symptoms 
when compared to the Wexner score and Pescatori scale(176). Unlike the Wexner score, the Vaizey score 
included additional items such as rectal urgency, pad use, constipation medications and a timeframe of 
last four weeks for symptom bother (Fig. 1.5)(156, 187). The scoring system assessed liquid, solid stool, 
flatus incontinence and lifestyle impact and included a five point system which ranks frequency of 
symptoms (never, rarely, sometimes, weekly, daily) from zero to four(187). A dichotomous scale with a 
scale of zero (no bother) or two (bother) assessed pad use, constipating mechanisms and zero (able to 
defer defecation for 15 minutes) or four (unable to defer for 15 minutes) with the combined score ranging 
between zero (no incontinence) to twenty four (total incontinence)(187). However the dichotomous items 
are not weighted evenly and there is a lack of a frequency scale for rectal urgency, which undervalued 
its importance on QoL and its recognition as a precursor for worsening AI across the lifespan(148, 156). 
Furthermore, the timeframe of four weeks limited an accurate assessment of current versus historical 
reporting of symptoms. The review of literature within this thesis has identified the variable nature of AI 
in women. Additionally, the inclusion of wearing pads is a further limitation for the Wexner score and 
Vaziey score to simply screen for AI, as pad use may be for urine incontinence and not for faecal loss.
Passive soiling often variable in nature is known to impact negatively on Qol yet the Wexner and 
Vaizey scores do not include passive soiling of mucous or faeces in symptom screening(113, 195). Whilst 
the inclusion of these symptoms are only noted within the ICIQ-B, MHQ, FISI and Pescatori scale the 
limitation of these tools as a quick and easy screening tool have also been outlined. 
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1.7.1 Strengths and limitations of the Wexner score to the Vaizey score
The preferred screening tools within clinical research in women of reproductive age included the 
Wexner and Vaizey scores. However, there appeared to be discrepancies between the tools as suggested 
by Rusavy et al.(87) study which investigated AI in 790 women with a history of episiotomy following 
childbirth. The research utilised both Wexner score and Vaizey score at 3 and 6 months postpartum. 
Both tools contained similar wording and scale for liquid, solid stool and flatus and therefore scores 
should have reflected similar outcomes. Additionally, the researchers graded the severity of incontinence 
by assigning limits to the Vaizey scores. A Vaizey score greater than four identified incontinence and 
greater than eight equated to severe incontinence. Findings for the mean and standard deviation for the 
Wexner score at 3 months (0.7 ± 1.2) and 6 months (0.4 ± 0.9) were lower when compared to the Vaizey 
score  for the same timeframe (1.0 ± 1.9), (0.6 ± 1.6)(87). The Vaizey score reported AI in 48 (7.3%) 
women at 3 months and 29 (4.4%) women at 6 months postnatal(87). It is difficult to refine the symptoms 
as the authors had only provided rectal urgency as an individual symptom prenatal (5%) and denovo 
at 3 months (7.8%) and 6 months (4.6%)(87). Disparity in reporting was identified in Sorensen et al.(90) 
study which reviewed 360 women with OASIS (n = 125) and without OASIS (n = 235) for FI utilising 
the Wexner score and the Vaizey score. Whilst there were no statistical significance differences found 
between the tools, the mean Wexner scores were lower in women with OASIS 1.7 (95% CI 1.3-2.1) and 
no OASIS women mean 1.1 (95% CI 0.7-1.4) compared to the mean Vaizey score 2.8 (95% CI 2.1-3.4) 
in the OASIS group and women with no history of OASIS, mean 1.4 (95% CI 1.0-1.9). The Vaizey score 
only reported rectal urgency in OASIS group (13%) compared to no OASIS (14%). The limitation of the 
Wexner score was the inability to screen for urgency. The Vaizey score was also limited in assessment 
of rectal urgency due to the dichotomous scoring of urgency. 
Traditionally these tools are utilised in clinical areas with implementation by a health professional, the 
Wexner  score preferred by clinicians for ease of use and lacked confusing terminology which are two 
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Table 1.7. Strengths and limitations of the Wexner score and Vaizey score. †QoL, quality of life. 
Wexner score Vaizey Score 
Strengths Limitations Strengths Limitations 
Frequently used in 
research includes women 
of reproductive age 
 Frequently used in research 
includes women of 
reproductive age 
 
Frequently used clinical 
practice 
 Frequently used clinical 
practice 
Wexner score preferred over 
Vaizey score by clinicians 
and researchers 
Not validated Not validated Validated tool  
Incontinence defined Faecal incontinence (FI) 
Excludes rectal urgency 
Incontinence defined  
Anal Incontinence (AI) 
 
5 point scale easy to use  7 point scale easy to use  
Frequency scale evenly 
weighted 0-4 
 Frequency scale for 4 items 
weighted 0-4 
Rectal urgency only 
weighted as either 0 or 4 
compared with a range of 0-
4 for other symptoms 
Scale range 0-20  Scale range 0-24  
QoL† 
Lifestyle and pad use 
Misinterpretation of pad 
use 
QoL† 
Lifestyle and pad use 
 
No rectal urgency Underscores importance 
of rectal urgency 
Includes rectal urgency No frequency range 
  3 item dichotomous scale, 
zero (no bother) or 2 (bother) 
Limits interpretation of 
frequency severity especially 
of urgency 
No timeframe  4 week timeframe Excludes variable nature AI 
No passive soiling/ 
mucous/staining 
Potential impact on QoL† No passive soiling/ 
mucous/staining 
Potential impact on QoL† 
Development Clinically derived Development Clinically derived and 
validated 
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common factors that limit disclosure(116). As discussed, the reporting of FI was lower when utilising the 
Wexner score in both studies, and the discordance between screening tools can be attributed to the fact 
that the tools were posted to participants and utilised as self-reporting tools. 
The Wexner score is preferred in clinical practice for its simplicity desspite that it is not a validated 
tool(148, 156). However, a major limitation of the Wexner score in the assessment of FI is that it excludes 
rectal urgency, whereas the inclusion of this important symptom in the Vaizey score better quantified AI 
(Table 1.7). Neither tool assessed the frequency of rectal urgency or passive soiling which are precursors 
for worsening function. These two symptoms of the three (flatus incontinence, rectal urgency and soiling) 
commonly reported symptoms within the literature over the past 20 years however; screening tools have 
not changed to include the frequency and severity of all of these symptoms.
Language utilised in both the Wexner score and Vaizey score are similar with the additions of plug 
and defer defecation in the Vaziey score (Tables 1.4 & 1.5). Given that both scores were clinically 
derived with limited consumer participation, the terminology within these tools has been identified as a 
potential barrier to a person’s health literacy further impacting on the disclosure of AI(168). The Wexner 
score contains no timeframes and therefore captures the historical perspective and given the variable 
reporting of AI in young women, this is an advantage compared to the Vaizey score, which is limited by 
a timeframe of the last four weeks. 
1.8 CONCLUSIONS
The review of literature has identified that AI is multifactorial, however; pregnancy and childbirth are 
main risk factors. There appeared to be a lack of opportunist screening for AI in this at-risk group. The 
risk of compounding injury with subsequent pregnancy, childbirth and ageing emphasises the need to 
develop a quick and easy screening tool for AI in women of reproductive age, which would improve the 
identification of AI, assist in access to clinical care and improve quality of life
Findings have established the benefits and limitation of screening tools for bowel incontinence. There 
was a preference for the Wexner score for its simplicity and ease of use over the Vaizey score. However, it 
was evident that there is a need for the development of screening tool specific for women of reproductive 
age, which embraced the strengths of each of the current tools, whilst acknowledging crucial inclusions 
of rectal urgency, soiling, and no timeframe and consumer participation in the development. 
The lack of mutually agreed definitions, complex language and terms ascribed to AI, are barriers in 
disclosure(103, 116, 123). It is crucial that the development and validation of a new screening tool for AI 
involves participation of those afflicted. A screening tool is required to be sensitive to a specific health 
group and utilisation of common terminology for bowel problems would be advantageous in improving 
the disclosure of symptoms in the screening and identification of AI(103, 116, 123). 
Therefore, this research thesis asks two questions, firstly; what factors influence the disclosure of AI in 
women of reproductive age? Secondly, would the identification of these issues assist in the development 
and validation of a bowel-screening tool to identify AI in this group of women? The research 
hypothesises that the development of a screening tool for this cohort would improve the early detection 
and intervention for bowel incontinence in women of reproductive age.
1.9 RESEARCH AIMS
The aim of the research is threefold. Firstly, to determine whether routine screening in a pregnant and 
postnatal population identifies AI. Secondly, analysis of the factors that affect disclosure of symptoms 
to health care providers. Thirdly, the development and validation of a screening tool for AI within a 
group of treating specialists and women of reproductive age. Further validation of the tool undertaken 
in a population of pregnant women and non-pregnant reproductive aged women to determine if the 
screening tool improves identification of AI within different populations.  
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A mixed method sequential design was utilised within the five stages of the research. Combining the 
quantitative and qualitative perspectives assisted in answering the research questions and the stated aims 
of the research as mentioned in Chapter 1. 
2.2 RESEARCH DESIGN
There was insufficient information available within the literature regarding factors that influenced 
disclosure of anal incontinence (AI) for women of reproductive age when utilising bowel-screening 
tools. The sequential design of the research allowed for an exploratory and integrative approach to 
address the research question, where a single quantitative or qualitative approach would not have 
provided a comprehensive understanding of factors influencing disclosure and negatively affected the 
development of the screening tool.  
The strengths and perspectives of both quantitative and qualitative approaches was important at each 
stage of the research and enhanced the reliability and validity of the findings(1, 2). The reconfiguration and 
interpretation of both the objective and subjective findings in the initial tool development subsequent 
phases of the research informed the subsequent stage in the development of a screening tool(2, 3). 
Quantitative research methodology allowed for the investigation of an at risk population for; women of 
reproductive age, to determine the incidence of screening and prevalence of AI(3, 4). The lack of clinical 
screening and wide variation in reporting of AI in prevalence studies provided an impetus to review 
local prevalence rates. For the purpose of this research, AI was defined as the accidental loss of any loss 
of liquid or solid stool, flatus, and rectal urgency. Whilst clinical terminology has been used throughout 
the discussion, the bowel screening tool-utilised language which women were familiar and preferred 
terms which included; liquid and solid poo, wind or gas and cannot hold on (need to rush to the toilet). 
The first stage of the thesis included a review of the literature and a retrospective study (stage 1). The 
retrospective study determined whether a disparity existed in reporting AI by health professionals who 
referred women to a specialist perineal clinic compared to screening undertaken within the speciality 
clinic. Prospective studies (stages 2, 4 and 5) determined if a newly developed screening tool for this 
research identified AI within women of reproductive age (Fig. 2.1).
The development and validation of the screening tool (stages 1 to 3) included participation from 
both health professionals involved in the care of pregnant and postnatal women, and women who 
were symptomatic of AI. Whilst few bowel screening tools have utilised women’s involvement in 
their development, this research was unique as it included qualitative methodology to elucidate the 
phenomenon at hand(5, 6).  The qualitative interviews provided a deeper understanding for the complex 
nature of disclosing AI when using screening tools. This differed to previous studies where a single 
method approach provided one perspective of the research focus that being development of a screening 
tool(3, 5). Phenomenological qualitative interviews informed by Van Manen methodological framework(5) 
was an appropriate framework as this assisted in the interpretation of the lived experience of AI from a 
person perspective of everyday life where otherwise it may be concealed(7, 8). 
2.3 STUDY SETTING
South Australia is the fourth largest state in Australia with 1.7 million population, of which 1.2 million 
live in the capital city of Adelaide(9). Areas of disadvantaged populations in the outer northern suburbs 
of Adelaide reflect high levels of unemployment (22%), low levels of completion of secondary 
education (40%), sole female parenting (22%) and a reliance on public housing (27%)(9). The poor 
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social determinants of health disadvantage for this population and contributes to poor health seeking 
behaviour and access to services(10, 11). The socially unacceptable nature of AI and stigmatisation within 
communities may further limit disclosure for these groups(12, 13). The importance of health literacy and 
comprehension of information was paramount for the development of the screening tool(11, 14). The mixed 
method approach and inclusion of qualitative interviews addressed these concerns.
The place of research for stages one to four of this study was in the northern suburbs of Adelaide, one of 


























Questionnaire development research team 
(JT, VC, EM) 
No Revisions 
Email to health professionals, n = 30 (primary researcher JT) 
Recruitment woman history AI by continence nurse, n = 20 
Stage 2- BSQ implementation, St Marks 
Vaizey and Wexner score  
Recruitment (by Midwives)  
n = 358 parous pregnant women, 1st trimester 
Antenatal visit, Jan 2015-Dec 2016 
 
Re-test stage 1 (2 to 3 weeks) 
Health professionals n = 25 
Symptomatic women n = 10 
Test phase stage 1 
Health professionals n = 30 
Symptomatic women n = 10 
 
Pilot test 
Symptomatic women n = 10 
Review bowel screening tools and literature 
Retrospective Study Stage 1 
Difficulty recruiting symptomatic 
women due to stigma - decision n = 10 
Health professionals excluded n = 5 
(no response) 
 
No Further revisions 
Stage 3- Qualitative interviews  
n = 16 recruitment (by Midwives) 
Jan 2015-May 2017 
Derive meaning barriers in disclosing AI with screening tools 
Modified BSQ - staining/soiling format 
 
Figure 2.1: Development of screening tool flow sheet 
*GP (General Practitioner) 
Stage 5 BSQ recruitment (by GP* or 
Researcher)  
n = 350 community women      
Nov 2017-March 2018 
 
Stage 4-BSQ recruitment (by Midwives)  
n = 354 parous pregnant women, 1st trimester 
Antenatal visit, July 2017-April 2018 
Figure 2.1. Development of screening tool flow chart. *GP (General Practitioner).
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was reported to be 20,263 births of which 3333 (16.5%) women birthed at the third largest maternity 
unit(15). The birth numbers have increased overtime within the maternity unit and in 2016 births recorded 
as 3837 (19.2%) of births in this metropolitan area(16). The fourth stage of the research also included a 
large community medical clinic within the same geographical area. 
This mixed method study occurred between May 2014 to April 2018. Where relevant, the following 
subsections in this chapter provided additional information on of specific theoretical frameworks, 
research sites, population samples, data collection and analysis. A detailed explanation of each stage is 
provided in chapters three to six. 
2.4 ETHICS
The University of Adelaide Human Research Ethics Committee and the Human Research Ethics 
Committee (HREC/14/TQEHLMHMH/58) approved ethics. The research commenced on successful 
granting of ethics from both ethics committee and participants (stages 2 to 5) obtained written consent 
(Appendices 1A, 1B, 2 & 5A). Participants through both written participant information forms and verbal 
discussion with the researcher, that their anonymity and confidentiality were assured. All information 
was de-identified through the removal of all information that could link a person’s information and a 
code assigned to individual data maintained confidentiality and anonymity. 
Information was stored on a Universal Serial Bus (USB) accessed only by the primary researcher (JT) 
and kept in a located filing cabinet in the Robinson Research Unit, Elizabeth South Australia. Retention 
and destroying data complied with the University of Adelaide data management plan and the State 
Records Act 1997 and the Australian Standard AS ISO 15489(17). 
Participants were aware of their rights and responsibility when consenting to participate within the 
study. Additionally how to contact the research team if they had any concerns and or wanted to withdraw 
from the research at any point, without any impact on their care (Appendices 1A, 1B & 5A). Each of the 
following subsections address further ethical considerations where relevant for each stage of the study.
2.5 DO WOMEN OF REPRODUCTIVE AGE PRESENTING WITH PELVIC FLOOR 
DYSFUNCTION HAVE UNDISCLOSED ANAL INCONTINENCE: A RETROSPECTIVE 
STUDY (STAGE 1)
2.5.1 Rationale for theoretical framework
Extensive literature has identified the relationship of pregnancy and childbirth with pelvic floor 
dysfunction (PFD)(18-20). Symptoms of PFD are often interrelated resulting in urinary and AI and pelvic 
organ prolapse (18, 20). Clinics, which specialise in PFD, may assess women for symptoms of PFD(21-
23). A Midwifery and Nurse led continence clinic (CNS) specialising in PFD within the research study 
setting routinely screened all women with PFD for AI, with a bowel-screening tool known as the St 
Marks Incontinence Score (Vaizey score). 
The Vaizey score; a symptom severity score consisted of two scoring systems with a five-point scale, 
which evaluated type and frequency of solid or liquid stool loss, flatus incontinence and impact on 
quality of life and scored 0 (never) to 4 (daily)(24, 25). Additionally, the Vaizey score addressed rectal 
urgency and use of pad or constipating medications utilising with a dichotomous scale (0 = no; 2 or 
4 = yes). The scores from both scales added together and denoted continence (0/24) and incontinence 
(>0/24). The Vaizey score assessed AI symptoms over the four weeks; however, given the variable 
history of AI in pregnancy and postnatal periods, it was common practice for all CNS staff to omit the 
four-week timeframe(26, 27). 
Selection of the retrospective design allowed for a comparison between women with known PFD who 
were assessed in the CNS clinic to determine whether midwives and obstetric doctors at the time of 
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referral did not identify AI and whether routine screening by the CNS identified AI. The advantage of 
utilising a retrospective design was the small sample size, ease in collecting data and a cost effectiveness(3, 
4). 
2.5.2 Research sample
The research sample involved a retrospective cohort study of 288 women referred to a CNS clinic with 
PFD from January 2011 until December 2013.Women who identified a minor PFD issue to a health 
professional while receiving antenatal or postnatal care (<6 weeks) were routinely referred to the CNS 
for telephone consultation. A review of 288 case notes during May 2014 until June 2015 was undertaken. 
2.5.3 Inclusion/exclusion criteria
Women referred to the CNS with a generic hospital referral noting PFD for antenatal or postnatal women 
(<6 weeks) during January 2011 to December 2013 were included in the study. Women were excluded 
who were non-obstetric or obstetric referrals where women were non-contactable by telephone. 
2.5.4 Data collection
Data extraction from the case notes utilised a systematic data collection tool (Appendix 1). Data 
collected included: socio-demographics, obstetric history, primary reason for referral, assessment of AI 
and attendance to CNS appointment. The primary researcher (JT) conducted extraction of data from the 
case notes, with a 10% sample also extracted by another researcher (JD) to evaluate for repeatability 
and reproducibility. 
2.5.5 Specific ethical considerations
Ethical considerations are discussed in ethics section (2.4).
2.5.6 Data analysis
Descriptive statistics were utilised to describe the frequency of AI and its relationship to urinary 
incontinence (UI). Comparison of means for continuous data between two groups utilised the independent 
sample’s t-test. The chi-square test compared categorical background data.  Mean utilised Statistical 
software package IBM SPSS version 20.0 (SPPS Inc. Chicago. Illinois. USA).
The Cohen’s Kappa measure of agreement was utilised to estimate the proportion of agreement between 
researcher’s findings. The Kappa Measure of Agreement value was 1.00, with a significance of P<0.0005 
and represents good agreement.
2.6 DEVELOPMENT AND VALIDATION OF SCREENING TOOLS FOR ANAL 
INCONTINENCE IN WOMEN OF REPRODUCTIVE AGE: A PROSPECTIVE COHORT 
STUDY (STAGE 2)
2.6.1 Rationale for theoretical framework
The retrospective review (section 2.5, chapter 3) of case notes identified a disparity in reporting AI 
by health professionals and the need to screen women. There are a number of tools utilised in clinical 
areas and research designed to identify AI(6, 28, 29). However, these tools are not specifically designed for 
pregnant and postnatal populations and often developed without consumer participation and may be a 
confounding factor in nondisclosure of AI(6, 30). The tool length and omission of symptoms including, 
rectal urgency, soiling and range of symptoms precluded the use of current designs as a quick and easy 
screening tool in women of reproductive age in clinical practice. The prospective framework assisted to 
answer the research question on what affected the disclosure of AI, and tested the research hypothesis. 
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The research recruited women afflicted by AI to help inform the development and validation of a 
screening tool (bowel screening questionnaire, BSQ). 
The initial steps included a review of the literature, identification of current screening tools utilised in 
women of reproductive age; to identify commonalities, and differences in type, frequency, scales utilised 
in the assessment of AI. The intent of stage two of the study was to develop a quick, easy to understand 
objective tool to identify a history of AI in this population of women and no quality of life questions 
were included.
Initial items included solid, liquid stool, flatus and rectal urgency. The literature identified the variable 
nature of AI and the research team questioned the use of a timeframe, as this may have precluded 
identification of symptoms; as such, no period was included. 
The research setting was in a disadvantaged area with low levels of secondary school completion. 
Therefore, the content of the initial questionnaire was assessed for the years of education required to 
understand the content by undertaking a Simple Measure of Gobbledygook (SMOG) test. The SMOG test 
of the BSQ achieved grade 5 (age 8 to 9 years of age) readability(31, 32). Questionnaire items subsequently 
reviewed for readability and relevance by researcher (JM) supervisors (VC, EM). The initial version 
of the pre-test BSQ (Appendix 3B) and copies of two clinical bowel screening tools used frequently in 
hospital settings; the St Marks fecal incontinence score, (Vaizey score; described in section 2.5.1) and 
Cleveland Clinic incontinence score (Wexner score). The inclusion of the Vaizey score and Wexner 
score in the current study was to compare the readability, and validity in the assessment of symptoms 
with the BSQ. The Vaizey score was derived from the Wexner score and whilst similarities existed 
between the tools, the Wexner score is a non-validated tool that is reported by clinicians as being easier 
to implement(29). The Wexner scoring system cross tabulated a lower symptom frequency to a total score 
between zero (no incontinence) to twenty (incontinence), however it was limited with the exclusion of 
rectal urgency(33). 
Items generated for the initial questionnaires resulted from a review of literature and opinion from 
purposive sampling of 35 participants, which included health professionals, involved in the care of 
pregnant and postnatal women, and women symptomatic of AI (Fig. 2.1). 
The sequential research design promoted identification of barriers to disclosing AI and importantly 
answered the research question “what factors impact on disclosing AI in women of reproductive age 
with AI(30). The research framework included three sections; firstly test and re-test questionnaire stage, 
secondly test questionnaire phase and thirdly qualitative interviews. Respective chapters (section 2.7, 
chapter 5) provided detailed discussion on the qualitative findings.
2.6.2 Research sample
Recruitment for each stage of the research included flyers and patient information sheets (Appendices 
1A, 1B, 2 & 3A). The primary researcher (JT) emailed information to all health professionals who 
provided care of antenatal and postnatal women for the test and re-test phase, whilst speciality midwives 
working within a continence team recruited women for the test and re-test questionnaire phase. 
The antenatal triaging midwives in the maternity unit at the tertiary centre assisted with recruitment 
of pregnant women in their first trimester appointment for the pilot testing of the questionnaire and 
qualitative interviews. 
2.6.2.1 Questionnaire design: test and re-test phase 
There appeared to be no standardised number of persons required in the development of tools. Based on 
previous literature reporting questionnaire development for women, it appeared advantageous to achieve 
a broad scope of persons and 10 or more persons required for test and re-test phases of the questionnaire 
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development(26, 30, 34). All health professionals (n = 30) received a generic email in the maternity unit, 
professionals who responded and completed all the phases were included in the analysis (Fig. 2.1). 
Women attending a CNS appointment in the maternity unit outpatient setting were invited to participate 
in the questionnaire development by the CNS midwife. Women who were of reproductive age, and had 
a history of AI and completed all phases of the study were included. The number of women recruited for 
the initial stage was lower than study expectations (n = 10). As there were no changes to the questionnaire 
at test and re-test phase the research team decided 10 woman would suffice with a further 10 women 
recruited for a pre-pilot test the questionnaire.
2.6.2.2 Test questionnaire phase: pilot test antenatal setting
Invitation to participate in the research was offered to women who attended a first trimester antenatal 
appointment at the antenatal clinic, within the hospital maternity unit. Recruitment then occurred at the 
antenatal appointment by a midwife. The previous year’s birth rate (2013) estimated the sample size of 
350 pregnant women using a power of 80% and α = 0.05. 
2.6.2.3 Qualitative interviews
Participation in qualitative interviews was available for women who took part in the pilot test phase 
(section 2.6.2.2) of the research. The recruiting midwife provided women with members of the research 
team to contact for further information about the study. This allowed the potential participant time to 
reflect on their willingness to participate(35-37). Qualitative interviews by nature seek to derive a deeper 
understanding of the issue at hand and thus recruiting a purposeful sample provided a group of women 
with a history of previous birth and AI  and opportunity to discuss issues(3, 5). There was no set recruitment 
target for qualitative interviews as recruitment continued until there was saturation of data where no new 
themes occurred(5, 37).  
2.6.3 Inclusion/exclusion criteria 
2.6.3.1 Questionnaire design: test and re-test phase 
Health professionals
Eligibility for inclusion in the test and re-test phase (section 2.6.2.1) included only health professionals 
who provided antenatal and postnatal care of women and included consultants and registrars from 
the disciplines of Obstetrics and Gynaecology and Colorectal, shared care, antenatal, postnatal and 
domiciliary Midwives. 
Symptomatic women
Women attending a CNS appointment in an outpatient setting of the maternity unit and of reproductive 
age with a history of AI and previous birth were included. The decision to include only multiparous 
women allowed for the recruitment of a homogenous group who may have been predisposed to PFD in 
a previous birth and increased the risk of AI.
Health professionals and symptomatic women were excluded if they had not completed a consent form, 
had incomplete questionnaires and or failed to return questionnaires.
2.6.3.2 Test questionnaire phase: pilot test antenatal setting
Women were included in the pilot test phase (section 2.6.2.2) if they were pregnant, had a previous 
birth and completed a consent form, and returned all completed questionnaires. Exclusions occurred if 
women were nulliparous.
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2.6.3.3 Qualitative interviews
Eligibility for qualitative interviews were as stated for the test and re-test phase and pilot test. Women 
were only included if they had completed the BSQ during a first trimester antenatal appointment.
2.6.4 Data collection
2.6.4.1 Questionnaire design: test and re-test phase 
Health professionals
This research incorporated a specifically designed questionnaire to gain an understanding of the 
relevance of items, readability, and clarity of the tool. This was a large tertiary setting and logistics of 
face-to-face feedback from health professionals was not practical. The BSQ and copies of the Vaizey 
score and Wexner score (Tables 1.4 & 1.5) which allowed for detailed comments were emailed to 
health professionals with a subsequent re-test at a 2 to 3 week interval (Appendix 3B )(38). Completed 
questionnaires returned to the researcher by internal hospital mail or email.
Symptomatic women
Women recruited by the CNS midwives completed their initial questionnaire and copies of the Vaizey 
score and Wexner score at a subsequent time within the CNS appointment.  A subsequent re-test of all 
study material posted by mail and followed with a phone call from the CNS midwife at 2 to 3 weeks.
All questionnaires were de-identified and allocated a number by the researcher. Data collection and 
coding entered into a secure database only accessible by the primary researcher (JT).  
Two cycles of test and re-test phases over two to three week intervals reviewed responses and changes 
made to the BSQ. Following no further amendments the pre-pilot test BSQ was completed by a further 
group of symptomatic women (n = 10).
2.6.4.2 Test questionnaire phase
The antenatal midwives in the tertiary centre implemented the pilot version of the questionnaire 
(BSQ; Appendix 4). The questionnaire collected socio-demographic, obstetric history, health-seeking 
behaviours whilst the bowel section assessed simple binary (yes or no) questions related to AI. The 
women completed the Vaizey score and Wexner score at the same point in time. Coding undertaken on 
each questionnaire with a number anonymising responses.
2.6.4.3 Qualitative interviews
Open-ended interviews, which were tape recorded and transcribed verbatim-facilitated data collection. 
A semi-formal interview guide with general statements assisted with the interview process and data 
collection (Appendix 5). Tape recording interviews allowed the researcher and woman to immerse in the 
discussion(5). Interviews where undertaken at a length, time and place convenient for the woman which 
allowed her time to discuss her story and provided a deeper understanding of information not previously 
uncovered(5, 37, 39). Women completed all three bowel-screening tools (BSQ, Vaizey score and Wexner 
score) prior to the interview. Journaling a method utilised in qualitative research provided meaningful 
information to the findings through noting verbal and nonverbal cues often missed(5, 39). Participants were 
aware the researcher transcribed all texts. 
2.6.5 Specific ethical considerations
Participants provided a written consent prior to commencing the research (Appendicies 1A & 3A) 
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following the provision of research study information (Appendicies 1A & 2). Each form of documentation 
was anonymised using a coded sequence; this information was accessed by the primary researcher (JT) 
and password protected. Qualitative transcribed texts were assigned a corresponding numerical code and 
participants were assigned a pseudonym, and there was no reference to participants within the thesis.
Ethical consideration addressed above in ethics (2.4).
2.6.6 Data analysis
2.6.6.1 Test and re-test questionnaire phase and test questionnaire phase
Descriptive statistics were utilised to describe the frequency of  AI and its relationship between 
symptomatic and asymptomatic groups. Comparison of means for continuous data between two 
groups utilised the independent sample’s t-test. Statistical analysis was undertaken on quantitative data 
using SPPS version 24 (Chicago Illinois) Measures of central tendency (mean, median, and mode) 
and variability (standard deviation, variance). Convergent validity of the initial questionnaire (BSQ) 
compared to the two bowel-screening tools (Vaizey score and Wexner score) used in clinical practice 
areas.
2.6.6.2 Qualitative interviews
Van Manen’s thematic analysis was utilised in the research(5). Data collection, analysis and interpretation 
was simultaneous so analysis begins at the first interview (Fig. 2.2)(5). Van Manen’s procedural 
framework required the researcher to stay in touch with the research questions and aims. The backwards 
and forwards process of the hermeneutic circle within the research process assisted in the reflection and 
uncovering the essence of women’s experiences of AI(5). The repetitious reading and writing of data 
from journaling, audio and transcribed texts further developed meaning. The sententious, highlighting 
and line by line analysis approach (thematic analysis) uncovered themes and sub themes(5). Specific data 
analysis considerations for qualitative interviews discussed in Chapter 5 (section 2.7).
2.7 UNDERSTANDING WHAT IMPACTS ON DISCLOSING ANAL INCONTINENCE FOR 
WOMEN WHEN COMPARING BOWEL SCREENING TOOLS: A PHENOMENOLOGICAL 
STUDY (STAGE 3)
2.7.1 Rationale for theoretical framework
Interpretive phenomenology was adopted as a framework for this research(5). This type of research 
was beneficial as it allowed research into an area not well understood(3, 5). Seeking to derive a deeper 
understanding of human beliefs, values and cultural experiences often omitted in quantitative research(5, 
39-41). To have excluded these experiences would have affected the true meaning of the phenomenon 
for both participants and researcher(41). Interpretative phenomenology recognised the researcher as an 
active participant in the research process, and as someone who holds their own beliefs, values and 
experiences(8, 41). The relationship of the person and their world (beliefs and values), which is referred 
to as co-constitution, continues to change through daily interactions(8, 41, 42). Interpretive phenomenology 
required the researcher not to put aside preconceived ideas but to make prior assumptions known 
throughout the research process to assist with reflection on women’s experiences(41). The overarching 
research was the development of a screening tool to identify AI in women of reproductive age. The 
research question stated factors might affect the disclosure of AI when utilising screening tools. The 
stated assumption within this research enhanced the research validity(8). 
Van Manen’s hermeneutical approach was consistent with the philosophical underpinning of interpretive 
phenomenology(5, 40). Van Manen framework both reflexive and reflective in nature  and as new 
information had been derived the researchers assumptions questioned, reformulated and new meaning 
derived(5, 40). This allowed for both descriptive and interpretive aspects of the experience identify the 
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inhibitors and enablers in disclosure and answered the research question. This methodology added flesh 
to the bones of the development of the final version of the BSQ and answered the research question 
“would identification of what impacted on disclosure assist in the development and validation of a 
tool to identify AI in women of reproductive age?” Research methods such as open-ended interviews 
enabled the contextual characteristics of the research issue to be illuminated(3, 5, 39).
2.7.2 Research sample
Purposeful sampling a common method used in interpretative research provided a group of women with 
a history of AI to recount an in-depth description of their experiences disclosing AI using screening 
tools(36). Recruitment occurred through flyers and information sheets (Appendices 1A & 2) and verbal 
recruitment by triaging midwives at the pilot test questionnaire phase (Appendix 4). 
Research interviews were undertaken at a place and time that was convenient for the woman. Prior to 
the interview, women completed three bowel assessment tools including pre-test BSQ, the Vaizey score 
and Wexner score. 
Sample size within this type of research  are often small due to the volume of information generated by 
Figure 2.2. Van Manen procedural framework. Adapted from: Van Manen M. Researching the lived 
experience human science for an action sensitive pedagogy. USA: The state University of New York, 
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the participants(43). The review of research literature identified no previous studies to guide recruitment 
numbers. However, qualitative research, which identified AI in women on reproductive age, contained 
less than ten participants(44, 45). We aimed to derive deeper understanding of what affected disclosure 
therefore recruitment continued until no new themes were evident and saturation of data occurred.
2.7.2.1 Inclusion/exclusion criteria 
Women were included if they had completed the test questionnaire phase and contacted the researcher 
to participate. Nulliparous and asymptomatic were not included. 
2.7.3. Data collection 
Van Manen’s six procedural stepped framework underpinned the research. The procedural framework 
guided data collection, analysis and interpretation (Fig. 2.2). Van Manen described these actions as 
interconnecting, as such they are not lineal steps but seen as an ongoing cyclic process informing each 
stage(5). For the purpose of thesis format, data collection section will detail the first two procedural 
actions and the final four procedural actions described in data analysis.
2.7.3.1 Van Manens’ procedural framework: turning to the phenomenon of interest
An important step in the research process was acknowledging an area of interest, making known any 
prior beliefs and then immersing oneself into the experience(5). The researcher’s current clinical practice 
included women of reproductive age with PFD and AI. This area provided a strong interest for the 
current research and led to the development of the research questions. As the researcher acknowledging 
and bringing to the foreground preconceived ideas that disclosure of AI may be limited by screening 
tools in current clinical practice, allowed for those beliefs to be challenged, refined and develop a deeper 
understanding of women’s experiences(46). Stating preconceived ideas at the commencement of the 
research enhanced confirmability of the research(8, 39). Confirmability including credibility, dependability 
and transferability were important aspects to judge rigor in qualitative research(39).
2.7.3.2 Investigating the experience as we live it rather than how it is conceptualised 
The second procedural action investigated the ‘lived experience’ through semi-structured open-ended 
interviews, verbatim-transcribed text and journaling utilised to explore and develop an understanding of 
women’s experiences of disclosing AI(3-5, 39). This type of research required the researcher to be an active 
participant immersing in the interview process, semi structured interviews facilitated the process(47). 
The credibility of the research enhanced though the recruitment process where women approached the 
researcher to participate in the research. Semi structured interviews were undertaken where women felt 
comfortable to disclose their stories and validity of the research enhanced through the reflexive and 
reflective process of the hermeneutic circle (Fig. 2.2).
Interview process
Audio taping interviews enabled the researcher and women to immerse themselves within the 
conversations, and to record the realm of emotions and depth of the women’s individual experiences(5, 
39). Recording interviews enhanced the accuracy and trustworthiness of data collected(8). A semi-formal 
interview guide assisted interview progress (Appendix 5) and guided questions by asking the woman to 
describe what it was like living with AI and to share what factors influenced or inhibited the disclosure 
of AI when using the three screening tools. 
The style of the interview encouraged rapport and empathy through a conversational nature, with 
interviews, which typically lasted between 30 to 50 minutes. Journaling by the researcher provided 
further depth to information in the interview and included non-verbal body language and written 
information provided on screening tools by participants (Appendix 6)(5). In the interviews, copies of the 
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screening tools (BSQ, Vaizey score and Wexner score) made available to women to assist in clarification 
and allowed women to describe the enablers and inhibitors in disclosure.
2.7.3.3 Specific ethical considerations
General ethical consideration addressed above in ethics (2.4).
Participants were required to provide written consent prior to commencing the research (Appendix 1A) 
following the provision of research study information (Appendices 1A & 2).
Prior to consenting for interviews, all women were aware that the researcher would transcribe all digital 
recordings. Sixteen women consented for interviews.
Women were aware that confidentiality maintained through the de-identified texts and research 
information stored on a secure password protected universal serial bus. Women distressed by the research 
were aware referral to appropriate services or withdraw from the research without penalty. 
2.7.4 Data analysis
Data analysis and interpretation occur simultaneously with data collection, commencing at the first 
interview(5).  The remaining four procedural actions of Van Manen framework are outlined as follows; 
hermeneutical reflection on themes, describing the phenomenon through writing and re-writing, 
maintaining an orientation to the phenomenon and balancing the research context by considering the 
parts and whole.
2.7.4.1 Hermeneutical reflection on essential themes
Transcribed texts, audio recordings and journaling provided a depth of information in qualitative 
research(8). Cues from verbal and nonverbal body language added further meaning to what was uncovered. 
The backwards and forwards process of the hermeneutic circle (Fig. 2.2) within the research process 
assisted in the reflection and uncovering the essence of women’s experiences. The repetitious listening, 
reading and writing of data further developed meaning through the identification of keywords, phrases 
and commonalities(5). Isolation of themes stemmed from this process. Themes are complex and often 
interconnected in order to derive meaning an excel spreadsheet recorded all phrases and concepts. Van 
Manen utilised three approaches in thematic analysis. The first approach, sententious approach looked at 
the overall understanding of the text(5). This required multiple reading of the text, as interpretation would 
vary between readers; however, the researcher continually revisited the findings asking the question do 
the findings represent women’s experiences in disclosing AI? Initial interpretations were refined as the 
researcher immersed themselves within the literature elucidating and overall meaning which described 
the text. 
The second approach, highlighting approach focused on selective reading of the text to isolate phrases, 
statements and repetitious words which stood out to describe the experience(5). Audio and journal 
entries provided the verbal and nonverbal cues missing from the transcribed text (Fig. 2.2). Statements 
compared between interviews for commonalities.
The line-by-line approach was the final step in Van Manen thematic analysis and identified key word 
and concepts from the highlighting phase(5). At the initial interview, emerging concepts and subthemes 
became evident. However, through reading, writing and further interviews commonalities were identified 
with main concepts and sub-themes. 
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2.7.4.2 Describing the phenomenon through writing and re-writing
The Hermeneutical process was a cyclical process and required attention to reading and writing multiple 
times to redefine and clarify meaning. The findings reviewed by the researcher’s supervisor (VC & AW) 
to establish trustworthiness of data. The fourth procedural action included not only an overall reading 
of the text but a meticulous line by line approach which derived the core meaning of the experience. 
Journaling identified the researcher’s preconceived beliefs, followed the documentation of the research 
process, and provided rigor for the qualitative research.
2.7.4.3 Maintaining an orientation to the phenomenon of interest
Van Manen fifth procedural action maintaining an orientation to the phenomenon of interest guided the 
researcher in reflection and remaining true to the research question(5). Journaling provided information 
of thoughts, feelings throughout the research and questions the relevance of the research question and 
credibility of information collected(5).
2.7.4.4 Balancing the context of the phenomenon by considering the parts and whole
The sixth procedural action in Van Manes hermeneutical framework considered the parts and wholes of 
the phenomenon(5). The cyclic nature of data collection, analysis and interpretation considered the parts 
in context with the whole of the experience. Thematic analysis uncovered words, phrases and concepts 
and described the multiple meanings of the whole experience. The individual interviews and experiences 
considered in relation to each other to gain a deeper understanding of the overall research question.
2.8 SCREENING WOMEN OF REPRODUCTIVE AGE WITH A NEWLY DEVELOPED 
SCREENING TOOL TO IDENTIFY AI (STAGES 4 & 5)
2.8.1 Rationale for theoretical framework
Findings from stage three of the research suggested revision to the BSQ format would enhance its 
useability. The addition of both historical (greater than four weeks) and recent history (within the last 
four weeks) would capture the variable nature of AI. Repeating the research in a first trimester antenatal 
population would identify if the BSQ produced similar findings to stage four. Additionally, the hormonal 
influences on the pelvic floor in pregnancy and childbirth have been associated with an increased risk 
of AI. Undertaking research in women of reproductive age in a similar demographical area population 
would identify if the BSQ produced similar prevalence rates of AI (stage 5).
2.8.2 Research sample
Antenatal setting
Recruitment for the research included flyers and patient information sheets (Appendices 2 & 5A). The 
triaging midwives at the tertiary centre assisted with recruitment of pregnant women. Invitation to 
participate in the research was open to women attending their first antenatal booking at a large tertiary 
centre. Recruitment occurred at the first trimester antenatal booking by the antenatal midwife. The 
previous year’s birth rate 3333 (2013) estimated the sample size of 350 pregnant women using a power 
of 80% and α = 0.05. Antenatal midwives provided with education from the researcher (JT) on research 
and bowel screening tool.
Community setting
Recruitment for each stage of the research included flyers and patient information sheets (Appendices 2 
& 5A). Doctors and researcher (JT) recruited women of reproductive age in a large general practitioner 
community health centre in the northern suburbs of South Australia (Adelaide Unicare, The University 
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of Adelaide). The community sample size based on the sample utilised in the antenatal setting for the 
BSQ in sections 2.6, 2.7 and 2.8. 
2.8.2.1 Inclusion/exclusion criteria
Antenatal setting
Women were included if they were pregnant and had a previous birth. Exclusions occurred if women 
were nulliparous. Participants were only included if they had completed a consent (Appendix 5A) form 
and returned completed questionnaires (Appendix 7).
Community setting
Women were included if they were of reproductive age (15 to 50 years) and had a previous birth and not 
pregnant. Exclusions occurred if women were nulliparous. Participants were only included if they had 
completed a consent form (Appendix 5A) and returned completed questionnaires (Appendix 7).
2.8.3 Data collection 
Antenatal setting
The antenatal midwives in the tertiary centre implemented the final version of the questionnaire (BSQ) 
(Appendix 7). The questionnaire sort to elicit demographic and obstetric history, whilst the bowel section 
asked five simple questions related to AI. Coding of each questionnaire with a number anonymising 
responses. Reliance on participant recall increases the risk of inaccurate reporting therefore extraction 
of data from the case-notes by the same researcher (JT), with a 15% sample also extracted by another 
researcher (JD) to evaluate for repeatability and reproducibility. 
Community setting
Women attending a community health centre for their general practitioner appointment completed the 
BSQ (Appendix 7) Data collection; coding and anonymising responses completed as outlined above in 
the antenatal setting (2.8.3). Additional data obstetric, demographic characteristics and body mass index 
(BMI) were identified and assessed probable causation for AI. Participants recalled their weight and 
height to calculate BMI.
2.8.4 Specific ethical considerations
Ethical consideration addressed above in ethics (2.4).
2.8.5 Data analysis
Descriptive statistics were utilised to describe the frequency of AI and its relationship between 
symptomatic and asymptomatic groups.  Comparison of means for continuous data between two groups 
utilised the independent sample’s t-test. Statistical analysis was undertaken on quantitative data using 
SPPS version 25 (Chicago Illinois) and SAS 9.4 (SAS Institute Inc., Cary, NC, USA). Measures of 
central tendency (mean) and variability (standard deviation, variance), ordinal logistics generalized 
estimating equation (GEE) models for historical and current reporting of AI. Odds ratio (ORs), 95% 
confidence intervals (CIs) and P values. The associations between a history and current AI were analysed 
in relation to ethnicity, delivery mode, perineal outcome, age, BMI, gravida and parity using binary 
logistic regressions and results reported as odds ratios (OR) with confidence intervals (95% CI) and P 
values.
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Do women of reproductive age presenting with pelvic floor dysfunction 
have undisclosed anal incontinence: a retrospective cohort study
ABSTRACT
Background: Indirect and direct trauma following vaginal birth can negatively impact on the pelvic 
floor function increasing the risk of anal incontinence. It is often difficult for women to openly disclose 
that they have anal incontinence and there are limited data collection tools available for the identification 
of these women in a clinical setting. 
Aim: This study aims to describe the prevalence of undisclosed anal incontinence in antenatal and 
postnatal women with pelvic floor dysfunction. 
Methods: Retrospective cohort study of 230 antenatal and postnatal women referred to a Continence 
Nursing Service in a large tertiary hospital in South Australia, Australia, with pelvic floor dysfunction. 
A criteria list was utilised to access the primary reason for referral, anal incontinence assessments and 
attendance to an appointment.
Results: Anal incontinence was identified in 26% of women (n = 59). Anal incontinence was the 
primary reason for referral amongst 8 women, with the remaining 51 women identified as having anal 
incontinence following clinical screening via phone consultation. Eighty six percent of women stated 
they had not previously disclosed anal incontinence to health professionals. Overall, 71% of symptomatic 
women (n = 28 antenatal and n = 14 postnatal women) attended appointments to a service specialising 
in pelvic floor dysfunction.
Conclusion: Women presenting with urinary incontinence or other markers of pelvic floor dysfunction 
should be actively screened for anal incontinence, as the prevalence of this condition is high amongst 
childbearing women.
Keywords: Anal incontinence, women, reproductive age, clinical screening.
 
 
Summary of relevance 
Problem Anal incontinence is underdiagnosed in pregnant and postnatal women. 
What is known Direct and indirect trauma to nerves, muscles and pelvic floor structures 
for two-thirds of first time mothers following vaginal birth contributes to 
pelvic floor trauma and pelvic floor dysfunction on the pelvic floor 
resulting in increased risk of anal incontinence. Disclosure of 
incontinence is difficult for women experiencing this problem and there is 
no routine screening in most clinical settings for this condition. 
What this paper adds Routine clinical screening for anal incontinence identified a significant 
amount of symptomatic women. Once identified women are willing to 
attend clinical appointments for assessment and management of this 
condition, indicating that appropriate measures to encourage disclosure of 
this problem can lead to improved care of these women. 
 3.1. INTRODUCTION
An intact perineum following vaginal childbirth is not a true indicator that a pelvic floor is undamaged(1). 
There is growing evidence that direct and indirect trauma to nerves, muscles and pelvic floor structures 
occur in 66% of first time mothers following vaginal birth contributes to pelvic floor dysfunction(2-5). 
Pelvic floor dysfunction symptoms include bladder prolapse, vaginal prolapse, rectal prolapse and 
urinary and faecal incontinence(6, 7). The aetiology of pelvic floor dysfunction is multi-factorial and 
includes genetic background, nutrition, hormonal changes to the pelvic floor in pregnancy and medical 
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co-morbidities(8). However, mechanical and neural trauma can follow vaginal birth and are major risk 
factors pelvic floor dysfunction(4, 7, 8). Pelvic floor dysfunction symptoms are interrelated and the risk of 
worsening symptoms are compounded through subsequent childbirth and ageing(5, 6). 
Obstetric anal sphincter injury (OASIS) and neural damage are risk factors for anal incontinence (AI)(6, 
9-11). AI is defined as the accidental loss of solid or liquid stool and flatus(12). The prevalence of OASIS is 
reported between 0.6% and 9% of women, however ultrasound findings suggest this is underreported, 
with 20% to 41% of women presenting with missed or occult sphincter damage on endo-anal ultrasound(6, 
13, 14). In women with a documented OASIS, the prevalence of AI is variable and reported between 7% 
and 74% of women(14-16). Disclosure of AI to health professionals is often complex for women as it is a 
debilitating condition which negatively impacts on the physical and psychological wellbeing of young 
women’s lives and results in underreporting of this complaint(17). Research identifies routine clinical 
screening could identify women who have not previously disclosed AI, but current evidence suggests 
there is no universal, routine screening for AI in pregnant and postnatal women(1, 10, 16, 18, 19). 
The early identification of AI can result in the improvement of short and long-term health outcomes 
for those afflicted(1, 18, 20, 21). Once identified, then appropriate clinical approaches can be introduced and 
reduce the deterioration of this condition over time and providing women with options of care to improve 
their quality of life(20, 22, 23). However, there appears to be no routine clinical screening for AI in this 
group of women. We have retrospectively examined whether pregnant and postnatal women referred 
to a Continence Nursing Service (CNS) for any pelvic floor dysfunction (PFD) had a complication 
of AI using a validated screening tool, the St Marks faecal incontinence score (Vaizey score)(24). The 
purpose of this analysis was to determine whether AI was unidentified at the time of referral by health 
professionals, which may explain why it is underreporting in at risk women. Additionally we assessed 
how many symptomatic women who were offered further assessment at a service, which specialised in 
bowel control attended appointments.
3.2. METHODS
Ethics approval was received through two Human Research Ethics Committees; University of Adelaide 
Human Research Ethics Committee and the Adelaide Health Service Human Research Ethics Committee.
This retrospective cohort study was completed during May 2014 to May 2015 and involved a review of 
288 case-notes for women referred to the Continence Nursing Service (CNS) at a Level 2 tertiary centre 
in Adelaide, Australia, during January 2011 to December 2013. The CNS specialises in behavioural 
management of pelvic floor dysfunction (PFD) and routinely screens women with the St Marks Vaizey 
incontinence score for AI. Women (n = 230) were eligible for review if the referral was for antenatal and 
postnatal women (<6 weeks postpartum; Fig.3.1). Women of non-reproductive age (n = 22), and non-
contactable phone consults (n = 36), were excluded.
A systematic data collection tool specifically designed for the research extracted data from case notes 
(Appendix 1). Data collected within this research included: demographics, obstetric history, primary 
reason for referral, assessment of AI and attendance to CNS appointment. Data extraction from the 
case-notes by the same researcher (JT), with a 10% sample also extracted by another researcher (JD) to 
evaluate for repeatability and reproducibility.
Indication for primary referral was identified from the generic hospital referral within case-notes. Health 
care providers do not routinely question women about continence status and referrals are often generated 
as a result of women initiating a concern. A primary health care provider at antenatal or postnatal contact 
completed referrals. Referrals were actioned by CNS within 1-3 days of receipt. Referrals were grouped 
as urinary incontinence (UI), AI, UI and AI; other complaints. Other complaints included constipation, 
obstructed defecation, pelvic floor laxity and haemorrhoids. Demographic details were included to 
describe the profile of the women. Age, previous pregnancies and births were collected to identify 
correlation to AI.
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AI was defined as the involuntary loss of liquid, solid stool and flatus(12). AI symptoms were identified by 
the CNS during initial phone consultation, utilising a validated assessment tool, the Vaizey score(24). The 
Vaizey score consists of two scoring systems with a five point scale which evaluates type and frequency 
of solid/liquid stool loss, flatus incontinence and impact on quality of life(24, 25). Additionally, the Vaizey 
addresses rectal urgency (no = 0; yes = 4) and use of pad or constipating medications (no = 0; yes = 2). 
The scoring system denotes continence (0/24) or incontinence (>0/24). The Vaizey score assesses AI 
symptoms over the past month; but given the variable history of AI in pregnancy and postnatal periods, 
it is common practice for all CNS staff to omit the month timeframe(10, 18). If symptomatic, women were 
also asked whether they wished to be referred to a service which specialised in pelvic floor dysfunction 
(Fig. 3.1).
3.2.1 Statistical methods
Ten percent of data collection utilising the systematic data collection tool assessed for inter-rater 
agreement reliability between the researchers (JT) and assisting researcher (JD). The Kappa measure 
of agreement was utilised to estimate the proportion of agreement between researcher’s findings. The 
Kappa Measure of Agreement value was 1.00, with a significance of P<0.0005 and represents good 
agreement
Descriptive statistics were utilised to describe the frequency of AI and its relationship to UI. The 
independent sample’s t-test compared means of continuous data between two groups. Categorical 
background data compared utilising chi- square test. Mean or median scores where appropriate were 
derived for age, parity, Vaizey score. Statistical analysis utilised Statistical software package IBM SPSS 
version 20.0 (SPPS Inc. Chicago. Illinois. USA).
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3.3 RESULTS
A total of 288 referrals were made to the CNS specialising in pelvic floor dysfunction (Fig. 3.2). Women 
were excluded if they were of non-reproductive age (n = 22) or not contactable by phone (n=36) leaving 
230 women for analysis. Women were referred to the CNS by antenatal and postnatal midwives (82%, 
n = 188), obstetric and colorectal doctors (11%, n = 26) and other health providers (physiotherapists, 
mental health nurses) (7%, n = 16). Referrals included antenatal (53%, n = 122) and postnatal (47 %, n = 
108) women. Antenatal referrals (69%) were predominately within the late 1st or early 2nd trimester. The 
range of pregnancies and births for antenatal women were reported between 1and 15 respectively with 
a mean of 3.6 pregnancies and 1.8 births. Postnatal women reported between 1 and 8 pregnancies and 
births with a mean of 2.7 pregnancies and 1.9 births. Women were predominantly Caucasian, married 
and/or in a defacto relationship. Within the cohort, the median number of previous pregnancies was 3.2 
(Table 3.1). The mean age of the women was 28 years, and the mean number of births was 1.9.
The primary reason documented on the initial referral for the phone contact group (n = 230) included 
subgroups UI; 67.9% (n = 156), AI; 1.7% (n = 4), AI/UI; 1.7% (n = 4) and other complaints 28.9% (n = 
66; Table 3.1). It was difficult to further define the type of UI as stress, urge or both, given the inaccuracy 
of reported case-note data and referrals.
Following the phone consultation, disparity existed between the initial reason for referral and what 
women identified as the primary problem where UI was confirmed in 52.1% of women (n = 120), AI 
identified in 8.3% of women (n = 19), AI/UI identified in 17.4% of women (n = 40) and other complaints 
reported in 22.2% of women  (n = 51; Fig. 3.2).
The incidence of pelvic floor dysfunction was higher in women (n = 120) with UI symptoms (Table 
3.2). AI was reported by 26% of women (n = 59) of which dual incontinence was reported by 17.4% of 
women (n = 40). Women with AI and AI/UI were more likely to be pregnant with a third pregnancy (SD 
2.4– 2.5) with parity >2.1 (SD 1.4-1.6). However, these parameters were not statistically significant. 
Women with both AI/UI had a higher mean Vaizey of 5.5 (SD 3.7) whereas women with AI alone had a 
mean Vaizey score of 3.4 (SD 3.1). There was a significant difference (t-test P = 0.001) between Vaizey 
scores for AI/UI relative to women who reported AI as a sole complaint.
AI symptoms consisted of non-specified AI (n = 9), rectal urgency (n = 6), flatus incontinence (n = 23) 
and flatus and urgency noted often as dual complaints (n = 21). Fourteen percent (n = 8) of women were 
primarily referred with a history of AI and 86% of women (n = 51) had not disclosed a history of AI, and 
were identified following clinical screening.
Figure 3.2 (left). Reason for 
referral to CNS service pre- 
and post phone screening (n = 
230). Abbreviations: †AI, anal 
incontinence; ‡AI/UI, anal and 
urinary incontinence; *UI, urinary 
incontinence; ^Other, complaints 
consisted of constipation, 
haemorrhoids and pelvic floor 
laxity.
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Table 3.2. Patient characteristics according to type of incontinence identified following phone 
consultation (n = 230). Abbreviations: AI, anal incontinence; UI, urinary incontinence, other complaints 
consisted of constipation, haemorrhoids and pelvic floor laxity.
Table 3.1. Demographic details of contactable study participants (n = 230). Abbreviations: †AI, 
anal incontinence; ‡AI/UI, anal and urinary incontinence; *UI, urinary incontinence; ^Other, complaints 
consisted of constipation, haemorrhoids and pelvic floor laxity. ˇSD, standard deviation.
Table 3.1. Demographic details of study 
participants (n=230). Abbreviations: †AI, 
anal incontinence; ‡ AI/UI, anal and urinary 
incontinence; *UI, urinary incontinence; ^ 
Other, complaints consisted of constipation, 
haemorrhoids and pelvic floor laxity. ˇSD 
standard deviation 
 
Criteria  Number of contactable 
participants 
Number (n) 230 
Mean age in years (SD)ˇ 28 (5.9) 
Ethnicity  
Caucasian, n (%) 192 (83.5) 
Other 38 (16.5) 
Marital status, n (%)  
Married/de facto 223 (97) 
Other 7 (3) 
Employed, n (%) 93 (40.4) 
Pregnancy, mean (SD) 3.2 (2.3) 
Births, mean (SD) 1.9 (1.3) 
Referral, n (%)  
Antenatal 122 (53) 
Postnatal 108 (47) 
Vaizey score, mean (SD) 1.2 (2.8) 
Indication for referral, n (%)  
AI† 4 (1.7) 
AI/UI‡ 4 (1.7) 
UI* 156 (67.9) 























Table 3.2.  Patient characteristics according to type of incontinence identified following phone consultation 
(n=230). Abbreviations: AI, anal incontinence; UI, urinary incontinence, other complaints consisted of 
constipation, haemorrhoids and pelvic floor laxity 
 
 Criteria AI† AI/UI‡ UI* Other^ P value 
Number (n) 19 40 120 51   
Mean age (SD)ˇ 30(6.1) 29 (6.1) 28(6.3) 27.5 (4.1)  0.661 
Ethnicity, n (%) 
Caucasian 16 (8.3) 32 (16.7) 104 (54.2) 40 (20.8)  0.572 
Other 3 (7.9) 8 (21.1) 16 (42.1) 11 (28.9)  0.572 
Marital Status, n (%) 
Married/defacto  16 (7.2) 39 (17.5) 117 (52.5) 51 (22.9)   0.860 
Other 3 ( 42.9) 1 (14.3) 3 (42.9) 0 (0)  0.860 
Employed, n (%) 9 (9.7) 15 (16.1) 45 (48.4) 24 (25.8)  0.220 
Referral, n (%)  
Antenatal 12 (6.5) 24 (19.7) 58 (47.5) 28 (23.3) 0.893 
Postnatal 7 (9.8) 16 (14.8) 62 (57.4) 23 (20.3) 0.893 
Pregnancy, mean (SD) 3.5 (2.5) 3.8 (2.4) 3.1 (2.4) 2.9 (1.8)  0.730 
Births, mean (SD) 2.1 (1.6) 2.2 (1.4) 1.8 (1.4) 1.8 (1.1)  0.678 
Vaizey score, mean (SD) 3.4 (3.1) 5.5 (3.7) 
  
 0.001 
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All women with a history of AI were offered and accepted appointments to a service specialising in 
bowel control. Overall 71% of symptomatic women (n = 42) attended appointments.
3.4 DISCUSSION
The current data indicates that utilising a bowel-screening tool identified AI in this cohort of women. 
Symptoms of AI were highly prevalent in antenatal and postnatal women who were primarily referred 
to the CNS clinic for UI. The presence of the dual complaint of AI and UI are consistent with recent 
research which indicates there is a relationship between AI and other pelvic floor complaints(26). Flatus 
and rectal urgency were often noted as the dual complaints. The identification of these symptoms is 
imperative as research suggests these symptoms identify pelvic floor dysfunction and are indicative 
of worsening continence status across the lifespan(27, 28). Subsequent births and ageing are associated 
with an increased risk of AI and worsening symptoms, and this is supported by research that identified 
AI was more prevalent in older women who had two or more deliveries(29). The communication of a 
history of AI for subsequent pregnancies is vital for reducing further impact on an already compromised 
pelvic floor and further supports current research findings of the importance of using a screening tool to 
identify AI in pregnant women(1, 26). 
Our data indicated that an enquiry for AI by specialist health care providers for women who present 
with other symptoms of pelvic floor dysfunction, identified AI in 26% of women utilising a symptom 
severity tool. In addition, there is evidence in the literature that direct enquiry of AI symptoms can 
elicit a response about continence status from sufferers, yet this questioning often does not occur and 
indicates a screening tool is required(30). Development and utilisation of a routine screening tool for the 
identification of AI in reproductive age women will assist clinicians in improving the identification of 
AI and expediting access to health care services(31, 32).
Women with AI often do not seek help for their condition and conceal its existence for multiple reasons, 
which include stigma; belief that AI is normal sequelae of childbirth, and an acceptance of learning to live 
with a chronic condition(20, 22, 23, 31, 33). Additionally, a study by Tucker and colleagues identified women 
were determined to maintain their role in society and in-order to cope and remain socially acceptable 
they often kept AI hidden(17). Health professionals associated with obstetrics and gynaecology are best 
placed to enquire about continence status in reproductive aged women. Thus, referrals for women within 
this study were from a range of health care providers involved in ante and postnatal care. However, there 
was disparity between the identified concern at initial referral and the identified condition following 
phone consultation using the St Marks Vaizey score where AI was subsequently identified in 26% of 
women. The disparity of results may be explained by non-disclosure of symptoms at initial contact, 
however the data reported that utilising a screening tool identified AI and this raises the question of 
whether we are adequately screening reproductive aged women for pelvic floor dysfunction.
Attendance at a service which specialised in pelvic floor dysfunction was accepted by all symptomatic 
women (n = 59) with an overall attendance rate of 71% to specialists services. These findings provide 
evidence that women will disclose AI when questioned using an appropriate tool and most will accept 
further services to improve their health outcomes.
3.4.1 Strengths and limitations
Strengths of this retrospective cohort study are that this research identified that the utilisation of the 
St Marks Vaizey screening tool identified AI in women, which was unidentified at initial referral. This 
study is unique as it reports the findings from a health service which currently utilises a standardised 
bowel screening tool for AI in this cohort with pelvic floor dysfunction. A positive acceptance and 
attendance to appointments provides evidence that routine screening is advantageous for this group of 
women. Considerable research exists which identifies AI in late pregnancy and the postnatal period , the 
findings of this research provide information in an area where few studies have examined AI in early 
gestation and in the early postnatal period of 6 weeks. 
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The overall small study population limits the potential to establish statistically significant differences 
between groups, where clinically significant differences may exist. Selection bias may have existed in 
this cohort as women are not routinely questioned about pelvic floor dysfunction by health care providers 
and only women who identified with symptoms were referred. Women referred to the CNS had some 
form of pelvic floor dysfunction and therefore may be at an increased risk of AI. Non-disclosure of 
symptoms by women may account for disparity in reporting of AI at initial contact with health providers. 
Original data entry was completed by multiple health professionals which potentially increases the risk 
of errors in data selection, collection and entry into the database. Additionally the continence status of 
women within the non-contactable group could not be assessed or compared.
3.5 CONCLUSIONS
Indirect and direct trauma to the pelvic floor structures and nerve pathways following vaginal delivery 
negatively affects pelvic floor function in reproductive aged women increasing the risk of a lifelong 
condition of AI. It is evident from this research that routine clinical screening for AI utilising the St 
Mark’s Vaizey score successfully identified AI in antenatal and postnatal women. This indicates the 
prevalence of this condition is high amongst reproductive aged women with urinary incontinence or 
other pelvic floor dysfunction. Furthermore, this study indicates it would be advantageous to use a 
screening tool for AI in all reproductive aged women presenting to health professionals for maternal, 
obstetric and gynaecological care.
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Anal incontinence (AI) is the accidental loss of faeces and gas with associated physical, social and 
financial implications(1). A woman’s risk of incontinence, is associated with trauma to the pelvic floor 
during pregnancy and childbirth(2, 3). Symptoms are variably reported with rates of AI varying from 8% 
to 65% in late pregnancy and from 3% to 39% in the postpartum period(4-7). Subsequent pregnancies 
and childbirth can further compromise the pelvic floor, compounding symptoms for women across 
their lifespan(8, 9). The obstetric literature identifies risk factors for pelvic floor dysfunction (PFD), and 
obstetric anal sphincter injury (OASIS) and its relationship to incontinence following childbirth, but 
does not suggest or provide evidence to support routine screening for AI in pregnant and postnatal 
women(3).  Some clinicians do undertake routine screening in the population at risk for AI, particularly 
when working in clinics specialising in PFD(10-12). 
Many tools utilised are developed for the general population and are not specific for pregnant or postnatal 
women (Table 4.1)(13). There are similarities between the screening tools in the  items measured to assess 
AI with scoring systems that include incontinence to solid and liquid stool, flatus incontinence, rectal 
urgency with a frequency scale range of symptoms and the inclusion of quality of life questions(14, 15). 
However, clinically derived screening tools are limited with a lack of standardised definitions, and 
variations in the symptoms assessed(13, 15).
Development and validation of a tool to identify anal incontinence 
in women of reproductive age: mixed method research
ABSTRACT
Objective: Anal incontinence is associated with direct or indirect mechanical and neuromuscular 
trauma to the pelvic floor during pregnancy and childbirth. Subsequent pregnancies and childbirth 
worsen symptoms. Health professionals specializing in the care of pregnant and postnatal women 
rarely screen all women for anal incontinence and there is no evidence of specific screening tools 
developed for routine use in this group of women. This mixed method research aimed to design and 
validate a tool to be utilized in routine clinical practice.
Methods: Test and re-test phase included 45 health professionals and women of reproductive age. 
The specifically designed bowel screening questionnaire BSQ) was utilized with the St Marks fecal 
incontinence score (Vaizey score) and the Cleveland score (Wexner score) in 358 prospectively 
recruited antenatal parous women attending their first antenatal screening. Qualitative interviews 
reinforced the strengths and limitation of all three screening tools. 
Results: The reliability of the bowel-screening questionnaire identified internal consistency at 
all stages in development with a Cronbach alpha coefficient reported P >0.919 (excellent internal 
consistency). In the pilot test, 99% of participants recruited completed the BSQ, 33% completed the 
Vaizey score and 36% completed the Wexner score. Qualitative interviews provided evidence for low 
completion rates for the latter two tools, which included variable reporting of symptoms, and difficulty 
in understanding clinical terms. A history of AI was reported in 191 (53%) of the total population 
utilizing the BSQ. Symptomatic women reported AI in the BSQ (100%) compared to lower reporting 
with the Vaizey score (62%) and Wexner score (68%). The predominant symptoms identified were 
rectal urgency (n = 40; 21%) and flatus incontinence (n = 48; 25%). 
Conclusion: The newly bowel screening tool is a reliable and valid tool, which identified a high 
prevalence of anal incontinence in women of reproductive age. Predominant symptoms included the 
inability to hold on (rectal urgency) and gas or wind. The variability of symptoms not captured in 
current clinical tools was the main concern for most women.
Keywords: Anal incontinence, pregnant, screening.
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The tools preferred by clinicians for assessing AI are often the Cleveland Clinic score described by 
Wexner and the St Marks score described by Vaizey(16). Whilst many clinicians favour the Wexner score, 
it does not measure rectal urgency(5, 14, 17-25). The Vaizey score unlike the Wexner score is validated and 
defines AI as including rectal urgency over a four-week timeframe. 
Previous research(26) has demonstrated that urgency and incontinence to flatus are predominant symptoms 
in women of reproductive age and likely to be indicative of damage to the external anal sphincter during 
vaginal birth and a precursor for worsening function in subsequent births(27-30). The ability to screenfor 
these symptoms is therefore important.
There is no doubt that language and clinical terminology in questionnaires, limits the disclosure of this 
serious affliction(31, 32). The health literacy of a woman can affect her ability to understand the importance 
of disclosing AI, further impacting on her  ability to access care and can also influence her understanding 
of  written information(32, 33). Lack of understanding may be further compounded within tertiary birthing 
centres that care for a high number of multicultural diverse and socially disadvantaged women(34, 35).  
This current research has been undertaken in a socially disadvantaged population in the outer northern 
suburbs of Adelaide, South Australia which has high levels of unemployment (22%), low levels of 
completion of secondary education (40%), high levels of sole female parenting (22%) and a reliance 
on public housing (27%)(35). Negative social determinants of health disadvantage this population, 
contributing to poor health seeking behaviour and impairing access to services through lack of education 
and poor health literacy. These factors suggest that the available screening tools may not be effective in 
screening for AI(32, 36).
This study aimed to develop and validate a bowel-screening tool for women of reproductive age. To the 
best of the authors’ knowledge, there is no validated questionnaire routinely utilised in clinical practice 
to solely screen for AI within this population of interest. 
Table 4.1. Comparison of symptom severity scores used in women of reproductive age. Pelvic 
floor inventory questionnaire (PFIQ-7) (includes colorectal anal impact questionnaire 7 CRADI-7), 
Pelvic floor distress inventory (PFDI-20) (includes Colorectal Anal distress inventory CRADI-8), 
Wexner score (Cleveland clinic score), Rapid assessment faecal incontinence score (RAFIS), Modified 
Miller score (Rothenberg score), St Marks faecal incontinence score (Vaizey score), Manchester 
Health Questionnaire (MHQ), International consultant on incontinence questionnaire- bowel (ICIQ-B), 
Faecal incontinence severity index (FISI), FIQoL, Danish anal sphincter rupture questionnaire (ASR), 


























APFQ 70 (12 Bowel)      × Not specified 
ASR 33 (12 FI)     × × Not specified 
FIQoL 29 × × × × × QoL Not specified 
FISI 4    ×  Mucous 4 
ICIQ-B 21      Staining 12 
MHQ 31 (12 Bowel )      Passive soiling Not specified 
Vaizey score 8      QoL 4 
Modified Miller  4    ×  × Not specified 
Parks score 4    × × × Not specified 
Pescatori scale 3    ×  Mucous 1 
RAFIS 6 Not stated Not stated Not stated Not stated Not stated Only leakage frequency  4 
Wexner score  5    ×  QoL Not specified 
PFDI-20  20 (8 Bowel)      × 12 
PFIQ-7 21 (7 Bowel) × × × × × QoL 12 
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4.2 MATERIALS AND METHODS
The Human Research Ethics Committees; University of Adelaide Human Research Ethics Committee 
and the Adelaide Health Service Human Research Ethics Committee (HREC/14/TQEHLMHMH/58) 
approved this research.  The study site was a large tertiary hospital in the northern suburbs of South 
Australia and the study was performed between December 2014 and May 2017.  All questionnaires and 
qualitative texts were de-identified and information stored on a secure password protected Universal 
Serial Bus.
4.2.1 Ethical considerations
The informed consent of the women who participated was assured through participant information forms 
and verbal discussion with the researcher. Anonymity and confidentiality were assured by assigning a 
code to individual data and then the removal of all information that could link a woman to the information. 
Information was stored in accordance with university regulations. Participants were aware to contact 
the research team if they had any concerns or they wanted to withdraw from the research at any point 
without impact on their care.
4.2.2 Questionnaire development
The development of screening tools or health questionnaires require aspects of validity, reliability and 
responsiveness to be addressed(37, 38). Development of the BSQ required a pool of items which focused on 
symptoms rather than a traditional disease based approach(14). By undertaking a review of the literature 
to determine and assess what tools were utilised for bowel screening in women of reproductive age, 
the commonalities and differences noted within tools addressed aspects of the content validity(14). The 
primary researcher (JT) and supervisors (VC, EM), reviewed a pool of items for inclusion in the tool. No 
timeframe was included in the questionnaire as research identified the variable nature of AI in pregnant 
and postnatal women(18, 39). As the aim of the screening tool was to identify AI, no questions on pad use 
or quality of life (QoL) were included when an initial version of the BSQ was developed. The team 
were mindful of the demographic area the research was conducted in, and rewording of symptoms for a 
readability age of 8 to 9 years was undertaken. The wording of items and use of simple language, which 
identify AI, was an important consideration as previous research reported that the Wexner score as a 
preferred tool over other screening tools due to its simplicity(14). Furthermore, incontinence and urgency 
are frequent terms utilised in screening tools however, they may not be understood by the general 
population as related research identifies discordance between tools due to lack of comprehension(31, 40). 
Revision of items included changing the wording of “stool” to “poo”, “flatus to wind” or “gas”, and 
“defer”, to “cannot hold on” or “need to rush”. After the test to re-test phase “soiled and/or stained your 
underwear” were included. 
Participants
The BSQ was tested and piloted with women and health professionals. Participants were only included 
if they had completed a consent form and returned completed questionnaires. 
Women of reproductive age, who had a history of AI, were recruited in an outpatient setting by the 
continence nurse midwives. Initial recruitment was problematic due to disclosure of AI, however, as 
there were no changes to the BSQ following the first test phase, the research group concluded that 10 
women at the re-test phase, and 10 women to pilot-test the BSQ was acceptable.
An email from the researcher invited health professionals including obstetricians and gynaecologists, 
colorectal surgeons, shared care general practitioners, antenatal, postnatal and domiciliary midwives to 
participate in the test to re-test phase. The response rate for the health professionals included 25 who 
completed the BSQ, a further five health professionals were excluded for no response (Fig. 4.1). 
Chapter 4 Development and validation of a bowel screening tool
76
The test and re-test phase occurred at two to three week intervals. This process allowed for clarification 
of the BSQ content, questionnaire wording, relevance, page layout, response categories, consistency, 
and order of questions and time to complete. Participants completed two additional tools (Vaizey and 
Wexner scores) to assess convergent validity. There were no further changes at the second test phase. A 
final pilot-test and re-test occurred at a two to three week interval phase in 10 women of reproductive 
age, who were symptomatic of AI. No further changes were required and the final version of the BSQ 
for utilisation in an antenatal population included additional demographic questions and reasons for 
disclosure and nondisclosure of AI.
4.2.3 Testing the questionnaire - antenatal women
The sample size was derived from the previous year’s birth rate of 3333 births at the relevant health 
service(41). A power of 80% and alpha value = 0.05, was used to calculate the sample size and this was 
estimated at 350 women. Three hundred and fifty eight parous women with at least one previous birth, 
attending their first antenatal booking within a large tertiary hospital, completed the BSQ, Vaizey score 
and Wexner score. Education about the research tool prior to recruitment phase was given to the triaging 
midwives in the antenatal clinic. 






Questionnaire development and research 
team (JT, VC, EM) 
No Revisions 
Email to health professionals (n = 30) 
Recruitment of women with a history of AI by Continence Nurse (n = 20) 
BSQ implementation, St Marks Vaizey and Wexner score  
              Recruitment of parous pregnant women, 1st trimester, n = 358 
Antenatal visit between Jan 2015 - Dec 2016 
 
Re-test stage 1 (2 to 3 weeks) 
Health professionals n = 25 
Symptomatic Women n = 10 
Test phase stage 1 
Health professionals n = 30 
Symptomatic women n = 10 
 
Pilot test 
Symptomatic women n = 10 
Review bowel screening 
tools and literature 
Difficulty recruiting symptomatic 
women due to stigma. Decision 
made to work with 10 women. 
Five health professionals excluded 
(no response) 
 
No Further revisions 
Phase 3 Qualitative interviews, n = 16  
Jan 2015 - May 2017 
Derive meaning barriers in disclosing AI with screening tools 
Modified BSQ - staining/soiling format 
 
Figure 4.1: Development of screening tool flow sheet 
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4.2.4 Qualitative interviews
Limited information exists on the disparity in reporting between bowel screening tools in this population 
of women. Therefore, Interpretive Phenomenology was adopted as a framework for qualitative interviews 
with guided semi-structured open-ended interviews, verbatim-transcribed text and journaling to explore 
and develop an understanding of women’s experiences of disclosing AI(42-44). This research has been 
reported elsewhere(45). 
4.3 DATA ANALYSIS
Descriptive statistics were utilised to describe the frequency of AI and its relationship between 
symptomatic and asymptomatic groups.  Comparison of means for continuous data between two groups 
utilised the independent sample t-test. Statistical analysis was undertaken on quantitative data using 
SPPS version 24 (Chicago Illinois). Measures of central tendency (mean, median, and mode) and 
variability (standard deviation ant interquartile range) were presented. Convergent validity of the initial 
questionnaire (BSQ) compared to the two bowel-screening tools (Vaizey and Wexner scores) used in 
clinical practice areas. Qualitative data utilised Van Manen thematic analysis(43).
4.4 RESULTS
4.4.1 Questionnaire development
Table 4.2 describes the characteristics of the respondents in the test and re-test phase of the questionnaire 
development. This included 25 health professionals and 20 women with a history of AI who were 
predominately Caucasian and non-pregnant, but with a history of OASIS.
Table 4.2. Questionnaire development stage - information from health professionals and women
 
Health professionals (n = 25)   Women (n = 20)  
Professional group, n (%)   Ethnicity, n (%)  
Midwives 12 (48)  Caucasian 14 (70) 
Colorectal 2 (8)  Asian 2 (10) 
O&G 11 (44)  Middle Eastern  4 (20) 
Senior  24 (96)  Pregnant, n (%) 7 (35) 
Junior 1 (4)  1st trimester 4 (20) 
Identify gender, n (%)    2nd trimester 3 (15) 
Male 4 (84)  History AI, n (%) 20 (100) 
Female 21 (16)  Gravida, mean (SD) 2.55 (2.01) 
     Parity, mean (SD) 1.65 (1.18) 
     History OASIS, n (%)  
     no 5 (25) 
     3A 5 (25) 
     3B 1 (5) 
     3C 7 (35) 
   4th  2 (10) 
 
 
Table 4.2: Questionnaire development stage of health professionals and women information. 
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4.4.1.1 Validity of the BSQ 
The initial review of screening tools at a two to three week interval addressed the content, internal 
validity and feasibility of the BSQ.  There was a consensus from all respondents that all questions were 
relevant including content, clarity, flow, simplicity and language. Two minor changes were introduced 
following the first test phase. In the demographic section, changes included altering the wording of 
“delivery” to “birth”. In the symptom section, the additions of soiling and staining resulting in five 
bowel questions with a yes or no response. At the final phase, no further changes were required and a 
pilot test was undertaken (Fig. 4.1). There was an acceptable reliability correlation (Cronbach’s Alpha = 
0.9) between the BSQ and two bowel-screening tools (Vaziey score and Wexner score) in the test, and 
retest and pilot test phases.
4.4.1.2 Reliability of the BSQ
Cronbach’s Alpha and logistic regression assessed the degree of concordance of the BSQ. The 
reproducibility and reliability of the BSQ conducted at two and three-week intervals identified good 
internal consistency of the BSQ at all stages in development with an adequate Cronbach alpha coefficient 
reported P > 0.919. There was not a significant difference in mean BSQ between the test and re-test 
groups (P value = 0.557).
4.4.2 Testing the questionnaire - antenatal women
Comparison between screening tools and demographic characteristics are presented in Table 4.3 and 
4.4. Completion rates for the BSQ (n = 356; 99%) were higher than the Vaizey score (n = 118; 33%) and 
Wexner score (n = 129; 36%). A history of AI was reported in 191 (53%) of the total population utilising 
the BSQ. Symptomatic women reported AI within the BSQ (100%) and a lower reporting with the 
Vaizey score (62%) and Wexner score (68%). There was agreement between the screening tools where 
AI symptoms compared two instruments at each point of time, examined with a Cohen Kappa’s statistic. 
The Wexner score excluded rectal urgency, unlike the Vaizey score and BSQ.There was agreement 
for reported symptoms of flatus incontinence and a combination of two or more symptoms between 
the BSQ and the two screening tools. There was a negative agreement for liquid stool and solid stool 
between the Vaizey score and Wexner score. 
Soiling was reported in a combination of symptoms in the BSQ (n = 3) and the written addition by a 
participant to the Wexner score (n = 1). 
4.4.2.1 Demographic data
The demographic data for the symptomatic population was consistent with the overall population of 
women accessing the local hospital (Table 4.4). There was a statistically significant association between 
AI in the symptomatic and non-symptomatic women according to ethnicity and parity.
Using a binary logistic regression model, there was a statistically significant association between 
reporting of AI and ethnicity (global P value = 0.006). Asian women were less likely to report AI relative 
to Caucasian women (OR = 0.17, 95%, CI: 0.10, 0.24, P value = 0.0234). The prevalence of AI was 
higher in women who had had one previous birth to women with two or more births (57% vs 40%) 
(OR=1.33, CI: 1.21, 1.44, P value = 0.0011) relative to women with two or more previous births (OR 
=1.20, CI: 1.12, 1.32, P value = 0.034 global P value = 0.0243). There was no statistical differences 
between the symptomatic and asymptomatic AI groups of women’s age (global P = 0.0044). For each 
year increase in age, the odds of a woman having AI increased 36 % (OR = 1.36, 95% CI: 1.24-1.50).
Ten percent of symptomatic women (n = 20) had previously revealed symptoms to a health care provider 
(Table 4.5). Reasons for nondisclosure-included variability of symptoms (48%), acceptance as a normal 
consequence of birth (21%), “too embarrassed” to enquire with a health professional (3%), not stated 
Chapter 4 Development and validation of a bowel screening tool
79
Table 4.3. Anal incontinence identified with screening tools in pregnant women (n = 191). 
Symbols: # >2 symptoms ‡BSQ, bowel screening tool; ˄Vaizey score - St Marks faecal incontinence 


























Table 4.3. Anal incontinence identified with screening tools in pregnant women (n=191) # >2 symptoms ‡BSQ- 




BSQ‡ n (%) (SD) 191 (100) (±0.0)   
Flatus 48 (25)  
Urge 40 (21)  
Solid  0  
Liquid 0  
>2 symptoms # n 103 (54)  
Flatus and urgency 59  
Liquid and solid  0  
Liquid and flatus 30  
Flatus, urgency and soiling 3  
All symptoms 11  
Vaizey Score˄ n (%) (SD)  118 (62) (±0.49)  
Flatus 36 (30)  
Urge 3 (3)  
Solid  2 (2)  
Liquid 3 (3)  
Form ticked but no symptoms 37 (31)  
>2 symptoms # 37(31)  
Flatus and urgency 10  
Liquid and solid  1  
Liquid and flatus 15  
Flatus, urgency and soiling 0  
All symptoms 11  
Wexner score† n (%) (SD) 129 (68) (±0.47)   
Flatus 49 (38)  
Urge 0†  
Solid  1 (0.5)  
Liquid 2 (1.5)  
Form ticked but no symptoms 35 (27)   
>2 symptoms # 42 (33)  
Flatus and urgency   
Liquid and solid  0  
Liquid and flatus 18  
Flatus, urgency and soiling 1†  
All symptoms 23†  
 Cohen Kappa’s statistic  95% Confidence Interval (CI) 
BSQ and Vaizey score 0.36 0.30 – 0.43 
Flatus 0.35 0.087 – 0.276 
Urgency 0.79 0.002 – 0.034 
2 or more symptoms 0.31 0.055 – 0.248 
BSQ and Wexner score 0.37 0.31 – 0.42 
Flatus  0.32 0.139 – 0.363 
2 or more symptoms 0.34 0.055 – 0.248 
Vaizey and Wexner score 0.77 0.69 – 0.84 
Flatus 0.664 0.014 – 0.072 
Liquid -0.004 0.992 – 1.003 
Solid -0.006 0.987 – 1.002 
2 or more symptoms 0.565 0.039 – 0.131 
(17%) and previously disclosed (11%). Suggestions given to improve assessment of AI included health 
professional direct enquiry (59%), with a screening tool (12%) that is easy to comprehend by women 
(5%), better information given at antenatal and postnatal visits (10%) and not stated (14%).
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Table 4.4. Demographic details of the overall group of women, test questionnaire phase. The 
comparison of proportions calculator available from https://www.medcal.org/calc/comparison_of_
proportions was utilized  for the following analyses: Chi-square P value,  Fischer’s Exact Test P value, 
Independent T test. Percentages are identified as row percentage. Symbols: *Significant P value; 
#OASIS (obstetric anal sphincter injury); ^RMLE (Right medio lateral episiotomy).
Table 4.4 Demographic details overall group of women test questionnaire phase. Analysis Comparison of 
proportions calculator at https://www.medcal.org/calc/comparison of proportions, *Chi-square P value. Fischer’s 
Exact Test P value. Independent T test. Row percentage #OASIS (obstetric anal sphincter injury) ^RMLE (Right 
medio lateral episiotomy) 
 
 
Number (n 358) Symptomatic Not Symptomatic P value 
Anal incontinence, n (%) 191 (54) 167 (46) 0.132 
Mean age in years (SD) 29.18 (±5.1) 29.26 (±5.1) 0.874 
Marital status, n (%)   0.229 
Married/de facto 166 (55) 138 (45)  
Other 25 (46) 29 (54)  
Employed, n (%) 96 (55) 80 (45) 0.656 
Ethnicity, n (%)   0.006* 
Caucasian 165 (58) 117 (42) 0.008* 
Asian 14 (34) 27 (66) 0.194 
Middle Eastern 4 (40) 6 (60) 0.490 
African 3 (27) 8(73) 0.185 
Aboriginal 2 (25) 6 (75) 0.237 
Other 3 (50) 3 (50) 1.000 
Parity, n (%)   0.243 
1 birth 121 (57) 92 (43) 0.011* 
2 birth 47 (52) 43 (48) 0.570 
>2 births 23 (42) 32 (58) 0.161 
Perineal outcome 
Intact 74 (52) 68 (48) 0.368 
OASIS# 15 (62) 7 (38) 0.060* 
RMLE^ 43 (49) 44 (51) 0.853 
Small tear 25 (50) 25 (50) 0.625 
1st degree tear 25 (52) 23 (48) 0.832 
2nd degree tear 24 (48) 26 (52) 0.392 
Mode of birth, n 
Normal vaginal 99 (53) 89 (47) 0.782 
Instrumental* 28 (53) 32 (47) 0.934 
Caesarean section 40 (56) 32 (44) 0.675 
Combination all modes 24 (53) 21 (47) 0.998 














Table 4.5. Reasons for previous non-disclosure of anal incontinence in pregnant women (n=191) 
 
Previously Disclosed AI, n (%)   
Yes 20 (10.4) 
No 159 (83.3) 
Not stated 12 (6.3) 
Reason for non-disclosure, n (%)  
Variable symptoms  92 (48) 
Acceptance as normal post birth 41 (21) 
Embarrassed /waited to be asked by health professional 6 (3) 
No reason given 32 (17) 
Disclosed previously 20 (11) 
What would make disclosure easier?  
Initiated by health professionals 112 (59) 
Questionnaire/screening tool 23 (12) 
Applicable comprehension 10 (5) 
Information given pre/post birth 19(10) 
Not stated  20 (14) 
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4.4.3 Qualitative interviews
Sixteen women participated in qualitative interviews. The findings are reported elsewhere and provide 
a deeper understanding of inhibitors and enablers to disclose AI when utilising three screening tools(45). 
Three key areas were identified to inhibit disclosure: firstly, the social expectations surrounding birth and 
continence, and the stigma associated with AI; secondly, the need to allow safe disclosure of symptoms; 
and lastly, the ability to understand questions in relation to screening tools. The latter is vital as the key 
outcomes suggest that disclosure is inhibited by clinical terminology and the inability of the screening 
tools to adequately capture variability of symptoms, including rectal urgency and staining.
Women unanimously described the BSQ as the preferred tool, describing the language and tool design 
easy to understand, promoting completion and disclosure of AI.  
4.5 DISCUSSION
4.5.1 Principal findings
The findings suggest that there was a logical, systematic approach to the BSQ development through 
generation and review of the pool of items by health professionals and women, testing phases, amendments 
and utilising two standard scoring systems to compare convergent validity. Successful completion of the 
BSQ in development stages demonstrated the BSQ was easy to complete and understand. Feedback 
assisted in changes to wording from “delivery” to “birth” and the addition of the symptoms of soiling 
and staining. 
Childbirth increases the risk of PFD and AI however; clinicians involved in the care of women of 
reproductive age have neglected routine screening. The positive completion and feedback in development 
of the BSQ from health professionals in these disciplines may signal a change in attitude towards the 
relationship between AI and childbirth(10, 14). 
A key feature of this study was the focus on the development of a screening tool and use of appropriate 
language. It was apparent that women required simple language to articulate their symptoms. The 
qualitative findings from this study have been described in detail elsewhere(45). These findings consistent 
with those of Bartlett(31) who suggested that simple language and reducing embarrassment would enhance 
understanding and reduce discordance between screening tools. 
4.5.2 Interpretation of results 
The variability in completion of the BSQ (99%), Vaizey score (33%) and Wexner score (36%) suggests 
that higher completion rates of the BSQ may have been a result of improved comprehension of the BSQ. 
Whilst the kappa statistics utilised to examine agreement showed moderate agreement between all tools, 
there was substantial agreement between the clinically derived Vaizey score and Wexner score, which 
reflected similar completion rates in this study. Both tools contained similar wording and scales, and 
suggests that clinicians developed the tools.  Variability within these tools existed with higher reporting 
of symptoms in the Wexner score than the Vaizey score. This was consistent with the qualitative findings, 
which provided evidence that the language in the Wexner score was easier to understand and influenced 
reporting when compared to the Vaizey score(45). Discordance  between clinical screening tools is 
common with studies such as Bartlett et al.(31)  suggesting comprehension was a factor for differences in 
reporting between clinical derived screening tools. 
Conversely, the initial development and refinement of the BSQ with women participants may have 
enhanced the reporting of symptoms. The active engagement identified roadblocks for disclosing 
symptoms described as relevant for women. It appeared that health professionals often place greater 
significance on incontinence to solid stool rather than liquid incontinence, flatus incontinence and 
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urgency(14, 28, 29, 46).  This undervalues the impact of these symptoms on a person’s quality of life and 
the fact that these symptoms are precursors for worsening function with ageing(14, 28, 29, 46). Cotterill’s(40, 
47) research supported the current findings, outlining the importance of developing clinical screening 
tools with women, in an effort to illuminate areas of concern relevant to the care and management of 
women, which often is missed or undervalued by clinicians. Interpretation from qualitative interviews 
provided further clarification that not only the wording but also the omission of symptoms in clinical 
screening tools (Vaizey score and Wexner score) negatively affected comprehension and were considered 
roadblocks to disclosing AI(45).  Notably women suggested that the use of screening tools that were easy 
to understand, and included “not being able to hold on ” or “need to rush “(rectal urgency), soiling, along 
with both historical reporting of AI, and a current history in the past four weeks with a frequency scale, 
would improve disclosure and allow accurate reporting from screening tools. 
This research is unique as it developed and validated a specifically designed screening tool that was 
able to identify AI in 53% of women in the first trimester of pregnancy. This is unlike previous research, 
which utilised a range of clinical screening tools, which generally focused on late pregnancy, postpartum 
and few studies in the first trimester of pregnancy(2, 5, 10, 17-19, 39, 48-60). These studies have included the 
Vaizey score, Wexner score and non-validated questionnaires with variable reporting of AI and FI in 
early pregnancy (26.8% to 40.8%), late pregnancy (1.3% to 40.8%) and the postnatal period (3% to 
39%(4-7, 10, 19). The higher rates of reporting of AI within these studies occurred when rectal urgency 
was included and with screening tools that utilised non-medicalised terminology, which is consistent 
with our findings(60). Van Brummen(60) utilised a specifically designed self-reported defecation distress 
inventory (DDI) at 12 weeks of pregnancy and attributed the increased reporting of AI compared to 
other studies, as a result of utilizing a self-reported questionnaire. This is consistent with findings in this 
study where women self-completed all three tools with similar rates for flatus incontinence compared 
to the DDI (34.6%). Capturing rectal urgency was problematic for the DDI, the Vaizey score and the 
Wexner score, which reported much lower rates of urgency compared to the BSQ (21%). Flatus and 
rectal urgency may be the only reported symptom a woman disclosed, and should not be overlooked as 
these symptoms suggest pelvic floor trauma and in particular, damage to the anal sphincter muscles(61, 
62). Accurate assessment of symptoms with tools like the BSQ in the first trimester of pregnancy may 
improve management of this group of women and prevent further compounding injury, and worsening 
symptoms of AI in the short and long-term.
Passive soiling is variably reported, and may indicate damage to the anal sphincter, particularly the 
internal anal sphincter with a significant impact on quality of life in women of reproductive age(40, 56, 63). 
Neither the Wexner nor the Vaizey score include passive soiling and this may be a limitation in their 
usefulness in screening in this population. The BSQ reported higher rates of soiling (1.5%) compared 
to other research which identified soiling (0.5%) in women with no history of PFD, however they did 
cite “difficulty wiping clean” in 21% of their population(56).  Persson et al.(56) utilised the Danish anal 
sphincter rupture questionnaire (ASR), and the wording of this tool is easy to comprehend and identified 
difficulties with cleaning, and hence the risk of soiling. The response rate to the ASR was low and 
only 51% of questionnaires were analysed which may bias the findings.  Passive soiling as a potential 
precursor for worsening bowel function is important to detect both in research and screening, but also in 
managing pregnant women and this underlies the need for screening tools like the BSQ, which are easy 
to use and comprehend.
Whilst the intent of this research study was to develop and validate the BSQ to identify AI in a first 
trimester population of women,  the research  identified causal relationships between  AI and age, 
ethnicity, parity, episiotomy (RMLE) and obstetric anal sphincter injury (OASIS) consistent with 
previous research studies(3, 12, 59, 64). 
Importantly, the current findings reported a higher prevalence of AI in women who reported a previously 
intact perineum, women who had had a previous caesarean section and vaginal birth and in Caucasian 
women. These results add to the recent body of evidence that pregnancy, labour and birth contributes 
to weakening the pelvic floor and disruption of nerves in women who birth vaginally or by caesarean 
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section(3, 4, 7, 53, 64-67). Compression and traction to pelvic floor muscles and nerves accounting for transient 
AI has been reported with subsequent injury and ageing(10, 24). This was consistent in the current findings, 
which identified for every year of ageing women had a 36% increased risk of AI.
Many studies undertaken in Western societies have reported that Asian ethnicity is linked to increased 
rates of OASIS, PFD and risk of AI following childbirth due to shorter perineum larger babies and 
instrumental deliveries(68, 69). However, the current findings suggested Asian women were less likely to 
report AI compared to Caucasian women.  The relationship of perineal trauma and ethnicity remains 
unclear and raises concerns about the relevance of findings from studies undertaken in Western societies. 
These studies may not be representative of Asian cultures and there may be additional factors impacting on 
perineal trauma other than perineal length(70, 71). There is evidence that the cultural and social expectations 
and language barriers may influence the risk of PFD and trauma and also influence disclosure(71-73). These 
latter issues are vitally important and therefore needs consideration when screening women for AI. 
4.5.3 Strengths and limitations
To the best of the author’s knowledge, this is the first bowel-screening tool developed and utilised by 
pregnant women in the first trimester to identify AI. The strength of the study was the development and 
validation of a reliable, quick and easy to use tool containing five questions. In addition, comparison 
of the BSQ and two bowel-screening tools enhanced the validation and strength of this study. During 
the questionnaire development the sample, population did identify minor changes to the tool enhancing 
the validity of the BSQ. The BSQ contained no timeframe but reliance on participant’s memory may 
have contributed to recall bias and limitations. Future research could include a sample testing of case 
notes to compare reporting of symptoms by participants. The pilot test included only a small group of 
symptomatic women but the reliability of this phase was adequate. The sample size and purposeful 
recruiting of participants may have been a potential bias and limitation of the findings. 
Women suggested the inclusion of a frequency scale for all symptoms and noting both current and 
historical AI would be useful. These additions would strengthen the current tool in future research. The 
responsiveness of a questionnaire may alter over time and current findings may alter in the future or with 
use by a different population. Caution must be considered when taking into account these limitations and 
when generalising findings or utilising the BSQ in another study population with differing demographic 
characteristics.
4.6 CONCLUSIONS
This study identified the BSQ as a reliable and valid tool able to identify AI in 53% of parous women 
attending a first trimester antenatal appointment. Predominant AI symptoms were the inability to “hold 
on” (rectal urgency) and incontinence of flatus which are known precursors for worsening function. The 
variable reporting of these symptoms resulted in their omission in previous screening tools and resulted 
in their inability to screen for both past and present symptoms. The importance in establishing a pre-
existing history in the context of current symptoms would assist with improved care and management 
and further research is required to ascertain if changes in the BSQ format will improve historical and 
current disclosure of AI in antenatal and community settings.
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Understanding what impacts on disclosing anal incontinence for women 
when comparing bowels screening tools: a phenomenological study
ABSTRACT
Background: There is limited research defining the true prevalence of anal incontinence (AI) in women 
of childbearing age. Understanding the limitations of the current assessment tools in the identification 
of AI is paramount for identifying the prevalence of AI and improving the care and management for 
women of childbearing age. The aim of this research was to explore and develop an understanding of 
women’s experiences in disclosing AI when completing a new bowel-screening questionnaire when 
compared to two established AI tools.
Methods: A phenomenological qualitative research study was undertaken in a maternity setting in a 
large tertiary hospital. Parous women in the first trimester of a subsequent pregnancy were recruited to 
complete a specifically designed screening tool (BSQ), St Marks Faecal incontinence score (Vaizey) and 
Cleveland (Wexner) score. Qualitative semi-structured interviews were utilised to identify experiences 
in disclosing AI.
Results: Women (n = 16, 22-42 years) with a history of anal incontinence either following the first 
birth (n = 12) or the second (n = 4) provided differing responses between the three assessment tools. 
All women answered the BSQ while the Vaizey and Wexner scores were more difficult to complete 
due to clinical language and participants level of comprehension. Women identified three major themes 
that were barriers for disclosing incontinence, which included social expectations, trusted space and 
confusion.
Conclusion: There are barriers for disclosing AI in the pregnant and post-natal population, which can be 
improved with the use of an easy assessment tool. The BSQ may facilitate discussion on AI between the 
patient and health professional leading to earlier identification and improvement in short and long-term 
health outcomes. 
Keywords: anal, incontinence, women, reproductive, screening, tools
5.1 BACKGROUND
Anal incontinence (AI) has a detrimental impact on quality of life. The cause of AI is multifactorial 
including direct/indirect trauma to muscle and nerves of the pelvic floor following vaginal births(1-4). 
Compounding injury to the pelvic floor with subsequent birthing increases the risk of worsening 
symptoms of AI for women in both the short and long term(2, 5). Evidence exists to support the use 
of bowel screening tools in the identification of AI within the pregnant and postnatal population(6-8). 
Screening tools are adopted for research but limited in clinical practice as research identifies specialities 
involved in obstetrics and gynaecology rarely screen women for AI(9). Importantly, there is no tool, 
routinely used to screen this at risk group, and the true prevalence of AI in women of reproductive age 
remains unknown. 
Clinically derived bowel screening tools have been utilised in research to report AI in women in the 
late stages of pregnancy (8%–65%), following birth (16%–49%), gynaecology outpatients (16%–28%), 
and in the general population (4.4%)(6, 10). The wide variations in reporting may be a consequence of the 
definitions utilised to identify AI, the sample size, population studied, selective disclosure, the length and 
language comprehension of the questionnaire, how the tool was administered(8, 11-14). Understanding the 
limitations of the current assessment tools in the identification of AI assists in defining true prevalence 
and improving the care and management for women of reproductive age. 
Minimal research has explored the reasons for discordance between different screening tools from the 
afflicted person’s perspective. Research undertaken by Bartlett et al.(11) identified disagreement between 
two bowel screening tools, the Self-Administered Faecal Incontinence Questionnaire (SAFIQ) and the 
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Cleveland Clinic Florida Faecal Incontinence Score (CCF-FI). Bartlett et al.(11) cited terminology and 
embarrassment were barriers to disclosure and suggested direct enquiry by a health professional utilising 
an AI questionnaire, in language that was easily understood could improve disclosure. Qualitative research 
by Tucker et al.(15) identified that women with a history of obstetric anal sphincter injury experienced 
barriers for disclosing AI and concur with these findings. Concurrent research identified active screening 
with assessment tools increased reporting of AI(8). These findings instigated the development of a Bowel 
Screening Questionnaire (BSQ). The design and pilot testing of the BSQ included qualitative interviews 
with a group of symptomatic women. The aim of the qualitative research was to explore and develop an 
understanding of women’s experiences in disclosing AI when completing the BSQ and two established 
bowel assessment tools. 
5.2 METHODS
Ethical approval was provided through the University of Adelaide Human Research Ethics Committee 
and the Human Research Ethics Committee (HREC/14/TQEHLMHMH/58). Research was undertaken 
between January 2015 and May 2017 and forms part of a larger research project. The research aimed 
to develop and validate the BSQ to identify AI in antenatal women attending a large tertiary hospital 
within a low socio-economic demographic area in South Australia. The antenatal triaging midwives 
invited parous women in their first trimester of a subsequent pregnancy with a previous history of AI to 
participate in the qualitative research. Nulliparous and asymptomatic women were not included. 
Confidentiality was maintained for women who consented to the research. All texts were de-identified 
and information stored on a secure password protected universal serial bus. Women were aware that 
if the research caused any distress they could be referred to appropriate services or withdraw from 
the research without penalty. The main author (JT) undertook interviews. The consolidated criteria for 
reporting qualitative research (COREQ) guidelines were adhered to for the research.
Interpretive phenomenology was adopted as a framework for this research(16). A qualitative research 
method utilising semi-structured open-ended interviews, verbatim-transcribed text and journaling was 
used to explore and develop an understanding of women’s experiences of disclosing AI. Interviews were 
audio taped which enabled the researcher and women to immerse themselves within the conversations, 
and to record the realm of emotions and depth of the women’s individual experiences. Recruitment 
continued until no new themes were evident and saturation of data occurred at 16 women. 
Research interviews were undertaken at a place and time that was convenient for the woman. Prior to the 
interview, women completed three bowel assessment tools including BSQ specifically developed by our 
team for the improved identification of AI. It was compared to the St Mark’s faecal incontinence score 
(Vaizey score) and Cleveland score (Wexner score)(17, 18).  The Vaizey and Wexner scores were included 
as they are frequently cited in research for this cohort(9, 19). 
The Vaizey score is a validated tool and consists of two scoring systems with a five-point scale, which 
evaluates type and frequency of solid/liquid stool loss, flatus incontinence and impact on quality of 
life(18). The Vaizey score is based on the Wexner score (non-validated score), the former including 
constipation and rectal urgency(19). The scoring system assesses symptoms over the last month and 
ranges from 0 (continent) to 24 (total incontinence). Both the Vaizey and Wexner scores are utilised in 
clinical studies and surgical therapies(19). The development of the BSQ occurred in consultation with 
health professionals and women with a history of AI. After review of questions, frequency scales and 
symptoms from establish tools for AI; the BSQ consisted of a symptom scale similar to the Vaizey 
and Wexner scores. The BSQ included six items prefaced with the statement “have you ever lost by 
accident?” included additional symptoms of staining, soiling, and request for referral (Table 5.1). A 
frequency scale measured symptoms and utilised a scale 0 (never) to four (daily) not unlike the Vaizey 
and Wexner scores. Previous research identified the variable nature of AI impacting on young women’s 
quality of life as such no timeframe was included(15, 20, 21). 
Interviews began by asking the woman to describe what it was like living with AI and to share what 
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BSQ Qualitative interviews Never Rarely Sometimes Weekly Daily 
Answer the questions by placing a tick in the column  0 1 2 3 4 
Have you ever lost by accident?      
Solid poo (stool)      
Liquid poo (stool)      
Wind (gas)      
Stained your underwear      
Soiled your underwear      
Do you need to rush to the toilet?      
Total score out of 24 (>0 consider referral)      
Would you like to be referred to a specialist Doctor? 
(Circle response) 
Yes  No   
Table 5.2. Themes, sub-themes and meanings.
Table 5.3. Themes, sub-themes and women’s statements.
Theme Sub theme Meaning 
Social 
expectation 
Birthing process Normal consequence, worse in subsequent delivery. 
Keeping it hidden Self-preservation, avoiding shame, waiting to be asked. 
Trusted space Finding a voice Safe environment to tell, Being safe, knowing someone understands, listen too, sensitive questions, help me understand the words. 
Confusion Understanding Embarrassing words, defining words, capture variability. 
 
Table 5.2. Themes, sub themes and meanings. 
 




“That’s what happens after a baby… I thought it didn’t matter” 
“ It gets worse in your next pregnancy” 
Keeping it hidden 
“Health professionals don’t ask and I feel horrible that I pass gas all the time” 
“ I would tell if someone asked me”  
“ ask me in words I understand” 
Trusted space Finding a voice 
“ use words that don’t make me feel any more disgusted in myself than I already 
do” 
“I need to feel safe to tell…” 
“How can I tell you I poo myself when I don’t know what the word stool is?” 
Confusion Understanding 
“ Telling a woman is easier… she’s been there and birthed” 
“Health professionals need to be sensitive when asking….I feel dirty and 
disgusted in myself already” 
“I don’t understand incontinence or urge…. What do they mean?” 
…what’s a plug?” 
“ I don’t get symptoms all the time” 
“ If you ask ….I would tell to get help” 
 
Table 5.3. Themes, sub themes and women’s statements 
Theme Sub theme Meaning 
Social 
expectation 
Birthing process Normal consequence, worse in subsequent delivery. 
Keeping it hidden Self-preservation, avoiding shame, waiting to be asked. 
Trusted space Finding a voice Safe environment to tell, Being safe, knowing someone understands, listen too, sensitive questions, help me understand the words. 
Confusion Understanding Embarrassing words, defining words, capture variability. 
 
Table 5.2. Themes, sub themes and meanings. 
 




“That’s what happens after a baby… I thought it didn’t matter” 
“ It gets worse in your next pregnancy” 
Keeping it hidden 
“Health professionals don’t ask and I feel horrible that I pass gas all the time” 
“ I would tell if someone asked me”  
“ ask me in words I understand” 
Trusted space Finding a voice 
“ use words that don’t make me feel any more disgusted in myself than I already 
do” 
“I need to feel afe o tell…” 
“How can I tell you I poo myself when I don’t know what the word stool is?” 
Confusion Understanding 
“ Telling a woman is easier… she’s been there and birthed” 
“Health professionals need to be sensitive when asking….I feel dirty and 
disgusted in myself already” 
“I don’t understand incontinence or urge…. What do they mean?” 
…what’s a plug?” 
“ I don’t get symptoms all the time” 
“ If you ask ….I would tell to get help” 
 
Table 5.3. Themes, sub themes and women’s statements 
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factors influenced or inhibited the disclosure of AI when using the three assessment tools. Initially 
there was uneasiness with the interview process through limited depth to responses and nonverbal body 
language. The style of the interview encouraged rapport and empathy through a conversational nature, 
with interviews typically lasting between 30 to 50 minutes. Women were able to seek assistance or 
clarification from the researcher in the completion of the tools.
5.2.1 Data Analysis
Transcribed verbatim texts, audio recordings and journal entries were analysed utilising Van Manen’s 
thematic analysis(16). The backwards and forwards process of the hermeneutic circle within the research 
process assisted in the reflection and uncovering the essence of women’s experiences. The repetitious 
reading and writing of data further developed meaning. Thematic analysis uncovered significant 
statements and led to the development of three themes and four sub-themes (Tables 5.2 and 5.3).
5.3 RESULTS
Participating women (n = 16) were aged between 22 to 42 years and had a history of AI. All women 
identified English as first language; and were either Caucasian (n = 13, 81%) or Aboriginal (n = 3, 19%). 
Participants were predominately (75%) presenting in a second pregnancy, with 25% of women in their 
third pregnancy. Mode of birth included normal vaginal delivery (n = 13, 81%), forceps (n = 2, 13%) 
and caesarean section (n = 1, 6%).
Women who were symptomatic of AI following their principal birth accounted for 12 women (75%) with 
four women (25%) in their second pregnancy. Twelve women (75%) described a history of obstetric anal 
sphincter injury. Nine (75%) of these women reported the onset of AI following sphincter injury (Table 
5.4). 
Table 5.4. Demographic details of participants. Abbreviations: OASIS, Obstetric Anal Sphincter 





















Table 5.4.  Demographic details of participants. OASIS: Obstetric anal sphincter injury; BMI: body mass index; 
AI: anal incontinence 
Participants, n = 16 
Mean age in years (range) (SD) (St error) 30.8 (22-42) (5.94) (1.49) 
Ethnicity, n (%) 
Caucasian 13 (81) 
Aboriginal TSI 3 (19) 
Parity, n (%) 
2nd 12 (75) 
3rd 4 (25) 
Gestation weeks, mean (range) (SD) 22 (20-28) (3.5) 
English 1st language, n (%) 16 (100) 
BMI mean (range) (SD) 29 (21-42) (6.56) 
Mode of delivery, n (%) 
Normal vaginal  13 (81%) 
Forceps 2 (13%) 
Caesarean section 1 (6%) 
History OASIS, n (%) 12 (75%) 
Onset of AI post OASIS 9 (75%) 
AI, n (%) 
Following 1st birth 12(75%) 
Following 2nd pregnancy 4(25%) 
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5.3.1 Initial interpretation of the screening tools
All women who participated in the qualitative interviews completed and provided a detailed account 
of disclosing AI using the assessment tools, the Vaizey score, Wexner score and BSQ. Women were 
unaware the BSQ had been newly designed to assess AI. Women identified a disparity in reporting 
between the three assessments tools, the BSQ easily completed and the Vaizey and Wexner were more 
difficult to complete due to clinical language and comprehension. The Vaizey and Wexner scores required 
the assistance of the researcher to understand aspects of the tools.
The Vaizey score was reported to be the most difficult to understand due to the clinical language, 
including incontinence, stool, plug and defecation. The variability of liquid, solid stool and flatus were 
assessed by a scoring system from zero to four for each symptom. However, women were critical that 
the Vaizey score reported symptoms in the last month. Additionally, the absence of a scale to identify the 
frequency of rectal urgency considered by women to underrepresent the variability of their symptoms.
Whilst the Wexner score included clinical language, women described the wording of this tool easier to 
understand and the preferred option to the Vaizey score. The Wexner score provided a frequency scale 
for symptoms with no timeframe. However, women detailed the exclusion of rectal urgency as a major 
limitation of the Wexner score as it was a predominant symptom for women.
The BSQ was the unanimously preferred tool, with women describing the language and tool design 
easy to understand when disclosing AI. A statement “have you lost by accident?” prefaced the BSQ and 
identified solid/liquid stools, flatus, urgency and staining and included a frequency scale 0 (never) to 
four (daily). Women stated a defined frequency scale for symptoms was preferred. Whilst the strengths 
and limitations of all tools were identified, women further described important additions in all tools. A 
frequency scale that identified a past and current history of solid/liquid stool, flatus, rectal urgency and 
staining was required. 
5.3.2 Deeper interpretation in disclosing AI 
The disclosure of AI was reported as complex for most women. Understanding what the tool actually 
intended to ask influenced full disclosure. Women identified three major themes that described how they 
responded to disclosing AI with the three assessment tools. The themes included social expectations, 
trusted space and confusion (Tables 5.2 & 5.3).
5.3.2.1 Social expectations
Social expectations were an overarching theme and included two sub themes keeping it hidden and the 
birthing process. Women within this research identified how this influenced the completion of the bowel 
assessment tools.
Keeping it hidden
Keeping it hidden detailed how the social stigma surrounding AI limited disclosure. Young women 
identified the daily struggle of anxiety and despair in an attempt to maintain their dignity in society and 
coping with the consequences of the need to rush to the toilet and accidental loss of gas. They limited 
activities of daily living. 
“I feel anxious, the sound and smell is always on your mind, you don’t go out…I feel dirty” (Participant 
13).
“It took a while for me to feel confident to tell someone, I was really embarrassed …..the urgency was 
bad but I had to tell someone eventually” (Participant 3).
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Birthing process
All women commented on the negative impact of vaginal delivery on pelvic floor function, resulting 
a weakened pelvic floor and continence issues. There was resignation that the birth process and size 
of babies would have a negative impact on their pelvic floor, and as such, there was no reason to 
disclose symptoms. However, the concern for worsening AI was a reality with further birthing. Women 
stated that symptoms were often variable but worse in pregnancy. They were often not aware as to the 
clinical significance and under reported symptoms. Women described these concerns with the following 
statements,
“Women aren’t aware of the importance of AI… it’s not seen as a problem because that comes with 
birthing” (Participant 1).
“It happens to all women…doesn’t it? So it’s not a problem, so why tell anyone” (Participant 8).
 “I don’t get symptoms all the time, sometimes you get worse in pregnancy…. I worry for it (AI) will get 
worse in next pregnancy and birth. You don’t really want to be in nappies!” (Participant 16).
5.3.2.2 Trusted space
Participants outlined several key factors to improve disclosure. There was the need to be in a safe 
environment with those who identified with their situation enabling women to feel comfortable in 
finding a voice. There was a real sense of yearning for health professionals to ask questions related to 
continence, active screening by the health professional improved disclosure. Women recounted how the 
bowel assessment tools would help this process but the tool needed to be sensitive and use everyday 
words. 
“It’s never easy to tell…not in a busy place, it needs to be private and I need to trust the health 
professional. I cannot tell you if I do not understand what you are asking me…the words are confusing. 
The health professional helped me tell by asking questions differently…I don’t understand incontinence” 
(Participant 6).
“Health professionals need to ask especially for those of us who are from different cultural backgrounds….
because I won’t tell otherwise” (Participant 13).
“I get embarrassed about my symptoms mostly urgency. I think health professionals need to ask about 
AI. Sometimes it’s easier telling a woman, she understands because she’s had a baby” (Participant 14).
5.3.2.3 Confusion
The theme confusion identified the disparity in reporting symptoms were largely a consequence of 
not understanding the questions. Women described the difficulty in understanding definitions, clinical 
language and inability of the tools to capture their symptoms of AI. 
The women within this research study described the important role of the health professional in 
completing the screening tool and disclosing AI. The interpretation of questions by the women often 
resulted in confusion where women would respond with no symptoms if they did not understand the 
language or meaning.
“What does incontinence mean? The words are technical; I do not know what they mean… So even if I 
do have urgency or staining I say I have no symptoms” (Participant 8).
 “My symptoms are all over the place especially when I’m pregnant….the tools don’t see that? Simple 
words are needed…. tricky words like continence and defer need changing… who understands that?” 
(Participant 1).
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“I need someone to help me understand the words; I don’t know incontinence, urgency, and plug. I get 
staining but is that liquid poo or is that different…I am very confused. I think it’s good to sit with the 
professional and discuss the questions (assessment tools), it’s hard otherwise to understand the words” 
(Participant 14).
5.4 DISCUSSION
Disclosure of AI when utilising screening tools is reliant on multiple factors. Social expectations, role 
of the health professional, and how a screening tool is developed is pivotal in enabling or inhibiting 
disclosure of AI. 
Social expectations were the overarching theme, which identified AI as a taboo health and wellbeing 
issue in many cultural settings. How we are socialised, will influence what illnesses we consider socially 
acceptable and either inhibit or promote health-seeking behaviour. The inability to conform to societal 
norms and the mere thought of discussing bodily functions often results in personal disgust and shame 
affecting disclosure(15, 22-24). The physical and psychological impact of AI following obstetric anal 
sphincter injury is detailed by Tucker et al.(15) who identified the self-imposed social isolation, negative 
health-seeking behaviours and non-disclosure of AI(15). These findings concur with our research findings, 
which identified the emotional complexity surrounding AI, stigma, embarrassment and personal disgust 
limited disclosure to health professionals and full disclosure by clinical screening tools. Embarrassment 
is reported as another key factor in the underreporting of AI within assessment tools(11).
Health seeking behaviour and disclosure relies on those afflicted with AI to have an understanding or 
knowledge of the problem(25). Women within this research identified AI was a normal consequence 
of birthing and therefore described no reason to seek help or disclose AI. Importantly, whilst it was 
acknowledged there were concerns about worsening function in subsequent births disclosure was 
compounded as a result of pending social stigma. Additional research supported these findings, 
acknowledging nondisclosure was the result of the duality of the consequences of birthing and 
embarrassment associated with AI(6, 15, 23).
The role of the health professional in the initiation of questioning was pivotal in enabling or inhibiting 
disclosure of AI. Tucker et al.(15) concur with these findings further citing lack of enquiry by professionals 
was often viewed by women, as the clinician having limited knowledge or fear of client dissatisfaction in 
the assessment of continence status. Women from the current research identified with these conclusions 
noting a safe environment or, a trusted space and preference for female health professional facilitated 
the disclosure of AI. The partiality for female health professionals in genital and anal examinations is 
identified in the literature to facilitate patient centred communication, increased empathy and resultant 
reduction in embarrassment in reporting symptoms(15, 23, 26). Whilst there is mixed debate as to the 
effectiveness of self-reported questionnaires and assessment tools versus clinician assisted discussion, 
the benefits of sensitive discussion with the latter have been shown to promote disclosure of AI(7, 11, 23). 
Whilst this was evident within our findings, women identified a disparity in disclosure between the 
three assessments tools was a major limitation which focused on the design of the tool, and in particular 
language and comprehension. 
Traditionally bowel screening and assessment tools objectively review type and frequency of AI from 
a clinicians point of view(19). The limitations of clinically derived screening tools have been outlined 
previously(11, 14). The confusion with terminology and the inability of the screening tools to capture 
symptoms was evident within our study. This is a concern for women as the underreporting of AI further 
marginalises them from adequate clinical care and management in current and subsequent pregnancies, 
potentially worsening quality of life(9, 15). 
In order to disclose AI, clinical assessment tools needed to be easy to understand. A higher reading and 
comprehension level of health tools often results in misunderstanding(27). Leonard reported there is a need 
to evaluate whether health literature is at an appropriate level for the intended population(27). Findings 
from the current research identified women’s confusion with terms such as continence, defecation, stool 
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and plug in utilising the Vaizey and Wexner scores. This may have been a result of the study population, 
who were recruited from a tertiary setting within a low socioeconomic demographical area. Confusion 
often resulted in no symptoms identified in reporting across two of the clinically derived assessment 
tools the Vaizey and Wexner scores. Preferred terms for incontinence included accidental leakage and 
is previously supported by Sung et al.(28) who identified AI did not reflect the patients perspective. 
Additionally research by Cotterill et al.(14) identified the importance of the patient’s perspective in the 
development of clinical tools and identified key areas not previously addressed. Women in the current 
research study identified the BSQ as the preferred assessment tool; because it did not contain any of 
the confusing terminology and each statement was prefaced with “have you ever lost by accident”. The 
acceptability of the BSQ may be due to the fact it was developed in consultation with women with a 
history of AI.
The current research identified the disclosure of symptoms often relied on the variability and impact 
of symptoms on quality of life with less frequent symptoms resulting in underreporting. Research 
undertaken by Bartlett et al.(11) supported these findings. The inability of the Vaizey and Wexner scores 
to capture the frequency of rectal urgency was cited as a limitation for this group of women. Previous 
research identified the shortcomings of assessment tools that do not incorporate the frequency of rectal 
urgency(19, 29). Rectal urgency is associated with external anal sphincter injury and precursor of worsening 
symptoms across the lifespan. The ability of screening tools to identify the frequency of rectal urgency 
is important in the management of women of reproductive age.
Staining was an additional symptom women in our research identified. The symptom was variable but 
did result in considerable bother. Sung et al.(28) utilising qualitative research identified mucous loss as a 
consistent finding that required acknowledgement and  inclusion in future frameworks on AI.
Women described the importance of a frequency scale from zero (no symptoms) to four (daily symptoms) 
to describe the variability of all symptoms. However, they noted limitations of the assessment tools, 
as they did not effectively identify the variability of symptoms across a longer period, in particular 
rectal urgency. These findings are consistent with previous research and promote the development of a 
screening tool which identifies a history of AI and current symptoms over the past 4 weeks(9).
5.4.1 Strengths and Limitations
Qualitative research findings are often limited in generalisability to a larger population. However, 
findings from this research may be applicable to research which aims to develop tools to identify AI in 
this population. The research method facilitated open disclosure and increased the richness of women’s 
stories but also allowed potential bias. Research bias was reduced through the invitation for women to 
take part by triaging antenatal midwives. The nature of the research question and the researcher’s role as 
a health professional may have influenced full disclosure. Despite this, the research methods facilitated 
open disclosure. The absence of a defined timeframe for the BSQ may be seen as a further limitation 
if utilised as a standalone tool. However, the aim of the BSQ was to be utilised in clinical practice to 
screen for AI and promote discussion of symptoms. Findings of the research-identified women wanted 
both historical and current symptoms identified by assessment tools and provides further information 
for future tool development.
5.5 CONCLUSIONS
Findings of this research identify factors, which enabled and inhibited disclosure of AI utilising three 
bowel assessment tools. Women in this research identified the construction and development of screening 
and assessment tools should consider the appropriate language, comprehension of the tool, account for 
the variable nature of AI, the frequency of rectal urgency and staining. The BSQ was the preferred 
screening tools, as it was easy to understand and quick to utilise. However, women described the need 
for tools to include both historical and current symptom for AI. Whilst the findings are important for 
the development of screening tools there is an urgent need by clinicians to understand the social stigma 
surrounding AI and the importance of using sensitive language in a safe environment to facilitate 
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disclosure. Utilising screening tools like the BSQ in the pregnant and postnatal population   will assist 
with disclosure and the early detection of AI that improves a woman’s short and long-term management 
and health outcomes. 
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Many different bowel-screening tools are utilised in research and in clinical practice areas(1-4). These 
clinically derived tools objectively screen for anal incontinence (AI), or for fecal incontinence (FI), 
excluding rectal urgency(5, 6). Clinically derived tools were created with little consumer participation in 
their development and subsequently there is a higher weighting for incontinence to solid stool ccompared 
to other types of leakage(7-9). This unfortunately excludes or underrates some symptoms which women rate 
as important including soiling, urgency and flatus incontinence and thus contributes to  under-reporting 
of symptoms(8, 10). There is no evidence within these tools of a shared clinical terminology between 
clinicians and consumers, which may limit the ability of women to understand the questionnaires and 
disclose clinically relevant incontinence(11, 12).
As part of a larger research project (reported in chapter 4), which included the development and 
validation of the bowel-screening questionnaire (BSQ) for the routine clinical screening of AI in women 
of reproductive age, qualitative interviews assessed the reliability and validity of the tool from the 
consumer perspective(13). The research identified significant discordance between two frequently used 
clinical tools utilised in screening women of reproductive age and the BSQ(13). Women preferred the BSQ 
as it was easier to understand and included terminology that women understood such as, “poo” (stool), 
“can’t hold on” (rectal urgency), “wind or gas” (flatus incontinence), “staining and soiling”. To enhance 
the validity and reliability of the BSQ the suggested changes included having both historical (greater 
than four weeks) and current reporting (within the past 4 weeks) of AI as no tool currently addressed 
these concerns. Additionally, screening tools should include a frequency scale for all symptoms and 
provide equal weighting for symptom bother. The aim of this prospective study was to utilise a revised 
version of the BSQ to identify the historical and current reporting of AI in two groups of women: 
1) pregnant in their first trimester attending an antenatal clinic and 2) non-pregnant reproductive age 
women attending a community health centre.
6.2 MATERIALS AND METHODS
Two Human Research Ethics Committees (HREC), the University of Adelaide Human Research 
Ethics Committee and the Adelaide Health Service Human Research Ethics Committee (HREC/14/
TQEHLMHMH/58) approved the research.  The research was undertaken at two sites. The first site was 
an antenatal setting in a large tertiary centre in the northern suburbs of Adelaide, South Australia between 
July 2017 and April 2018. The second site was a community setting in a large general practitioner 
led health care centre (Adelaide Unicare, University of Adelaide) within the same demographic area 
between November 2017 and March 2018. A revised format of the bowel-screening questionnaire (BSQ) 
(Appendix 7) was used within both settings.
Chapter 2 (materials and methods) outlines the methods (2.8; 2.8.1), design (2.8.1), study inclusion and 
exclusions (2.8.2.1), ethical considerations (2.8.3), data collection (2.8.4.; 2.8.5) for this stage of the 
research.
6.2.1 Data analysis
Statistical analysis was undertaken on quantitative data using SPPS version 25 (Chicago Illinois) and SAS 
9.4 (SAS Institute Inc., Cary, NC, USA). The following descriptive statistics were presented including 
measures of central tendency (mean, median) and variability (standard deviation (SD), interquartile 
range (IQR) for continuous variables, and frequencies and percentages for categorical variables). Ordinal 
logistic generalized estimating equations (GEE) models were performed for historical (greater than four 
weeks) and current (within the last four weeks) reporting of AI. Presentation of odds ratio (ORs), 95% 
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confidence intervals (CIs) and P values.
6.3 RESULTS
6.3.1 Antenatal setting
Three hundred and fifty four women in the first trimester of pregnancy completed the BSQ. Rates 
of completion for historical reporting (100%) were higher than the current history (70%). Caucasian 
ethnicity was identified as the sole significant difference between antenatal women with and without AI 
in relation to the demographics and obstetric details described in tables 6.2 to 6.4. 
6.3.1.1 Demographic and obstetric details
For women who completed the BSQ, the characteristics of the symptomatic and asymptomatic groups 
reported were similar including age (mean ± SD: 30 ± 4.96 vs 30± 5.13 yrs.), gravidity (3.3 ± 1.68 vs 
3.4 ± 1.69), parity (1.7 ± 1.11 vs 1.7± 1.13) and body mass index (BMI; 27.10 ± 6.94 vs 27.82 ± 6.99; 
Table 6.2). There was a broader range of BMI in the symptomatic group (15 to 54) when compared 
with the asymptomatic group (20 to 45). Amongst the total antenatal study population, women were 
predominantly Caucasian (72.9%, P < 0.001), with a history of a normal vaginal delivery (70.6%) and 
intact perineum (58.2%). 
The prevalence of AI in the 1st trimester of pregnancy was 68% of women (n = 242; Table 6.2). Most 
of the symptomatic group women were Caucasian (75.2%), then Asian (16.1%), and African (3.7%). 
Symptomatic women had one previous birth (58%), two previous births (26%), or two or more (16%) 
births. Mode of birth included normal vaginal delivery (70.7%), instrumental delivery (12.8%), and 
caesarean section (12.9%) and a combination of all modes (3.6%). Forceps delivery (OR = 1.09, 95% 
CI: 0.48, 2.46, P value = 0.8402), LSCS (OR = 1.12, 95% CI: 0.56, 2.24, P value = 0.7396) and a 
combination of LSCS and instrumental deliveries (OR = 1.39, 95% CI: 0.14, 13.35, P value = 0.7750) 
showed a trend towards increased risk of AI, but without significance. 
More symptomatic women were reported as having an intact perineum (56.2%) compared with those 
who reported having had an episiotomy (RMLE; 25.2 %), a 2nd degree tear (7.4%), or a 1st degree tear 
(3.7%), and a combination of perineal outcomes (2.5%). Five percent of women were reported to have 
an OASIS. There was no significant contributing factors to AI within this population, although there 
was a trend for an increased risk. Predictors which were associated with increased risk of AI including 
OASIS (OR = 5.79, 95% CI: 0.74, 45.10, P value = 0.0935) or RMLE (OR = 1.06, 95% CI: 0.63, 1.79 
P value = 0.839) and second-degree tears (OR = 1.42, 95% CI: 0.55, 3.68, P value = 0.4708; Table 6.3). 
There was a higher rate of reporting of AI in women who sustained OASIS in the symptomatic (n = 
12) group when compared to asymptomatic women (n = 1). Additionally, RMLE rates were higher in 
women with AI (n = 61) compared to asymptomatic women (n = 27).
A statistically significant association was identified between historical AI and ethnicity (Global P value 
= 0.0268). Women of African ethnicity (81%) were less likely to have AI when compared to Asian 
ethnicity (OR = 0.19, 95% CI: 0.07, 0.53, P value = 0.0014). Additionally, African women were less 
likely to have AI when compared with Caucasian women (OR = 0.23, 95 % CI: 0.10-0.55, P value = 
0.0010). Women who identified as Asian and Caucasian reported more AI compared to most other ethnic 
groups. Asian women (OR = 1.25, 3.00, 95% CI: 0.33, 23.49) were more likely than any other ethnicity 
to have AI. No statistical association existed between a historical reporting of AI and age, BMI, gravida 
and parity (Table 6.3). However a yearly increase in age increased the odds of women having AI by 1% 
(OR = 1.01, 95% CI: 0.96, 1.1.05, P Value = 0.7263), and a reduction in BMI by one unit reduced the 
risk of AI by 1% (OR = 0.99, 95% CI: 0.96, 1.02, P value = 0.4078).
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Figure 6.1. Historical and current reporting of AI in antenatal symptomatic women (n = 288). 
Historical (greater than 4 weeks), current (within the last 4 weeks).
 
Figure 6.1: Historical and current reporting AI in antenatal symptomatic women (n=288). Historical (greater 
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Table 6.2. Demographic and obstetric details for symptomatic versus asymptomatic antenatal 
population (n = 354). Compiled using the comparison of proportions calculator available from https://
www.medcal.org/calc/comparison_of_proportions. The following analyses were undertaken: Chi-
square P value, Fischer’s Exact Test P value, Independent T test. Symbols: +Missing data in current 
reporting; ‡Instrumental (forceps and ventouse birth); #OASIS (3rd or 4th degree tear); ˄RMLE (right 
medio lateral episiotomy); *P value determined by independent student T test.
1st trimester of pregnancy Symptomatic Not Symptomatic P value 
Number (%) 242 (68) 112 (32) <0.001* 
Anal incontinence,  
n (Mean ± SD) 242 (0.68 ± 0.465) 0(0)  
AI last month, n (Mean ± SD)+ 46 (0.12 ± 0.179) 0(0) 0.0001* 
Age (Mean ± SD) (Range) 30±5.13 (20-50) 30 ± 4.96 (20-45) 0.726 
BMI,(Mean ± SD) (Range) 27.1 ± 6.99 (15-54) 27.82 ± 6.94 (20-45) 0.409 
Gravida (Mean ± SD) (Range) 3.3 (1.69) (2-11) 3.4 (1.68) (2-11) 0.522 
Parity (Mean ± SD) (Range) 1.7 (1.13) (1-7) 1.7 (1.1) (1-7) 0.506 
Parity, n (%)     
1 birth 140 (58)  56 (50) 0.206 
2 births 62 (26) 32 (29) 0.699 
>2 births 39 (16) 24 (21) 0.194 
Ethnicity, n (%)   <0.010* 
Caucasian 182 (75.2) 76 (68) 0.001* 
Asian 39 (16.1) 13 (11.6) 0.266 
Middle Eastern 2 (0.8) 2 (1.8) 1.000 
African 9 (3.7) 16 (14.3) 0.187 
Aboriginal 4 (1.7) 2 (1.8) 0.471 
Other 6 (2.5) 3 (2.7) 0.362 
Mode of birth, n (%)    
Normal vaginal 171 (70.7) 79 (70.5) 0.994 
Instrumental‡ 31 (12.8)  16 (14.3) 0.704 
Caesarean section 31 (12.9)  13 (11.6) 0.740 
Combination, all modes 9 (3.6)  4 (3.6) 0.555 
Perineum, n (%)    
Intact 136 (56.2)  70 (62.5) 0.264 
OASIS# 12 (5.0)  1 (0.9) 0.059 
RMLE^ 61 (25.2)  27 (24.1) 0.824 
1st degree 9 (3.7) 6 (5.3) 0.478 
2nd degree 18 (7.4)  6 (5.4) 0.420 
Combination (no OASIS) 6 (2.5) 2 (1.8) 0.579 
 
Table 6.2 Demographic and obstetric details for symptomatic versus asymptomatic antenatal population (n = 
354) Missing data AI current. Comparison of proportions calculator at https://www.medcal.org/calc/comparison 
of proportions. Chi-square P value. Fischer’s Exact Test P value. Independent T test.  ‡Instrumental (forceps and 
ventouse birth).#OASIS(3rd or 4th degree tear)˄RMLE (Right mediolateral episiotomy) P value determined 
independent student T test. 
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Table 6.3. Demographic predictors and history of AI in antenatal women. Fischer’s Exact Test P 
values as binary logistics model did not converge. Symbols: *Statistically significant P value <0.05; 




































Table 6.3 Demographic predictors and history of AI in antenatal women. Fischer’s Exact Test P values as 
binary logistics model did not converge. * Statistical significance P value <0.05.** RMLE (episiotomy), 
#OASIS(obstetric anal sphincter injury 
Outcome Predictor Comparison Odds Ratio  (95%, CI)** 
Comparison 
P value 
AI Ethnicity Aboriginal vs African 3.56 (0.54, 23.39) 0.1869 
  Aboriginal vs Asian 0.67 (0.11, 4.07) 0.6606 
  Aboriginal vs Caucasian 0.84 (0.15, 4.66) 0.8372 
  Aboriginal vs Middle Eastern 2.00 (0.15, 26.73) 0.6003 
  Aboriginal vs Other 1.00 (0.11, 8.95) 1.0000 
  African vs Asian 0.19 (0.07, 0.53) 0.0014* 
  African vs Caucasian 0.23 (0.10, 0.55) 0.0010* 
  African vs Middle Eastern 0.56 (0.07, 4.70) 0.5953 
  African vs Other 0.28 (0.06, 1.41) 0.1222 
  Asian vs Caucasian 1.25 (0.63, 2.48) 0.5175 
  Asian vs Middle Eastern 3.00 (0.38, 23.49) 0.2954 
  Asian vs Other 1.50 (0.33, 6.87) 0.6014 
  Caucasian vs Middle Eastern 2.39 (0.33, 17.31) 0.3869 
  Caucasian vs Other 1.20 (0.29, 4.91) 0.8025 
  Middle Eastern vs Other 0.50 (0.05, 5.51) 0.5714 
AI Age  1.01 (0.96, 1.05) 0.7263 
 BMI  0.99 (0.96, 1.02) 0.4078 
 Gravida  0.96 (0.84, 1.09) 0.5216 
 Parity  0.87 (0.72, 1.04) 0.1239 
 All modes   0.5545 
 Combination LSCS/NVD  0.46 (0.09, 2.30) 0.3411 
 Combination LSCS/Instrument  1.39 (0.14, 13.55) 0.7750 
 LSCS  1.12 (0.56, 2.24) 0.7396 
 Ventouse  0.65 (0.24, 1.75) 0.3894 
 NVD  1.00 (0.61, 1.64) 0.9994 
 Forceps  1.09 (0.48, 2.46) 0.8402 
 Perineum    
 Intact  0.77 (0.49, 1.22) 0.2641 
 RMLE**  1.06 (0.63, 1.79) 0.8239 
 OASIS#  5.79 (0.74, 45.10) 0.0935 
 1st degree  0.68 (0.24, 1.97) 0.4791 
 2nd degree  1.42 (0.55, 3.68) 0.4708 
 Combination RMLE  2.34  (0.27, 20.28) 0.4398 
 Combination no RMLE  0.46 (0.03, 7.46) 0.5868 
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Table 6.4. Comparing individual AI symptoms between the historical (greater than 4 weeks) and 
current period (within the last 4 weeks) for symptomatic antenatal women (n = 354). Fischer’s 
Exact Test P values as ordinal logistic model did not converge. Symbols: *Significant P value <0.05; 
†Missing data; **Symptoms are a combination. The table summary is greater than 100% as women 
identified more than one symptom. 
Antenatal women, n = 354 Historical Current† P value, Odds Ratio (95% CI) 
AI reported, n (%) 242(68) 46(12.9)  
Solid 28 (8.0) 0(0.0) 0.3927 
Never 214 (88.4) 242 (100)  
Rare 9 (3.7) 0(0)  
Sometimes 7 (2.9) 0(0)  
Weekly 8 (3.3) 0(0)  
Daily 4 (1.7) 0(0)  
Liquid 65(18.3) 2(0.6) 0.0032*  8.15 (2.02, 32.82)  
Never 177 (73.1) 240(99.2)  
Rare 53 (21.9) 2(0.8)  
Sometimes 12 (5.0) 0(0)  
Weekly 0(0) 0(0)  
Daily 0(0) 0(0)  
Wind or gas 179 (50.6) 28 (7.9) 0.0067* 2.03 (1.22, 3.39) 
Never 63 (21.9) 214 (88.4)  
Rare 69 (28.5) 10 (4.1)  
Sometimes 80 (36.8) 13 (5.3)  
Weekly 10 (4.1) 3 (1.2)  
Daily 20 (8.7) 2 (0.8)  
Stain 48(13.5) 0(0.0) 0.0034*     
Never 194 (80.2) 242 (100)  
Rare 33(13.6) 0(0)  
Sometimes 14(5.8) 0(0)  
Weekly 1(0.4) 0(0)  
Daily 0(0) 0(0)  
Soiling 22 (6.2) 0 (0.0) 0.2184 
Never 220 (90.9) 242 (100)  
Rare  18( 7.4) 0(0)  
Sometimes 2(0.8) 0(0)  
Weekly 0(0) 0(0)  
Daily 2(0.8)   
Cannot hold on (urge) 155(43.7) 20(5.9) 0.0006* 2.61 (1.51, 4.51) 
Never 87 (36.0) 222 (91.7)  
Rare 45(18.6) 9(3.7)  
Sometimes 83 (34.3) 8(3.3)  
Weekly 10 (4.1) 2(0.8)  
Daily 17(7.0) 1 (0.4)  
Combined symptoms**   <0.0001*13.44 (5.74, 31.48) 
1 94(38.8) 39(16.5)  
2 84(34.7) 5(2.1)  
3 or more   66 (26.4) 1(0.4)  
 
Table 6.4. Comparing individual AI symptoms between the historical (greater than 4 weeks) and current period 
(within the last 4 weeks) for symptomatic antenatal women  (n=354). Fischer’s Exact Test P values as ordinal 
logistic model did not converge.* significant P value <0.05 †missing data **Symptoms are combination. Table 
summary greater than 100% as women identified more than one symptom 
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Table 6.5. Demographic and obstetric details for community women (n = 350). Compiled using 
the comparison of proportions calculator available from https://www.medcal.org/calc/comparison_of_
proportions. The following analyses were undertaken: Chi-square P value, Fischer’s Exact Test P value, 
Independent T test, Wilcoxon Rank Sum Test. Symbols: #OASIS (3rd or 4th degree tear); ˄RMLE (right 





































Table 6.5. Binary logistic regressions for demographic and obstetric details for community women (n = 350). Comparison of 
proportions calculator at https://www.medcal.org/calc/comparison of proportions*Chi-square P value. Fischer’s Exact Test P 
value. Independent T test. Wilcoxon Rank Sum Test. # OASIS(3rd or 4th degree tear)˄RMLE (Right mediolateral 
episiotomy), ¥All modes combination vaginal birth, instrumental, caesarean with subsequent births. 
Community women Symptomatic Not Symptomatic P value 
Number (%) 179 (51.1) 171 (48.9)  
Anal  incontinence, n (Mean ± SD) 179 (0.51 ± 0.50) 171 (0.34 ± 0.47) 0.709 
AI last month, n (Mean ± SD)  121 (0.34 ± 0.49)  0.000* 
Age (Mean ± SD) (Range) 33.8 ± 6.73 (20-50) 32.73 ± 6.76 (18-50) 0.0013* 
BMI (Mean ± SD) (Range) 26.05 ± 6.42 (17-47) 25.76±5.94 (18-40) 0.701 
Gravida (Mean ± SD) (Range) 2.67 ± 1.37 (1-7) 2.59±1.34 (1-7) 0.230 
Parity (Mean ± SD) (Range) 2.28 ± 1.14 (1-7) 2.23±1.16 (1-7) 0.506 
1 birth 42 (23.5) 49 (28.7) 0.449 
2 births 80 (44.7) 74 (43.3) 0.612 
3 births 34 (19.0) 30 (17.5) 0.792 
>3 births 23 (12.8) 18 (10.6) 0.408 
Ethnicity, n (%)   0.032* 
Caucasian 165 (92.1) 143 (83.7) 0.162 
Asian 7 (3.9) 12 (7.0) 0.286 
Middle Eastern 1 (0.5) 0 (0.0) 0.327 
African 4 (2.3) 10 (5.8) 0.164 
Aboriginal 1(0.5) 6 (3.5) 0.150 
Other 1 (0.5) 0 (0.0) 0.327 
Mode of birth, n (%)         
Normal vaginal delivery 89 (49.7) 101 (59.1) 0.079 
Forceps 9 (5.0) 6 (3.5) 0.485 
Ventouse 4 (2.2)  4 (2.3) 0.947 
Caesarean Section 43 (24.0) 35 (20.4) 0.424 
Combination, all modes 34 (19.1) 25 (14.6) 0.613 
Perineum, n (%)    
Intact 76 (42.5) 69 (40.3) 0.571 
OASIS# 9 (5.0) 4 (2.3) 0.259 
RMLE˄ 38 (21.2) 41 (24.0) 0.539 
1st Degree tear 17 (9.5) 23 (13.5) 0.247 
2nd Degree tear 6 (3.4) 7 (4.1) 0.714 
Combination no RMLE (no OASIS) 7 (3.9) 3 (1.8) 0.226 
Combination RMLE (no OASIS) 26 (14.5) 24 (14.0) 0.896 
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Table 6.6. Binary logistic regression model results of AI (historical) versus various predictors in 
the community setting. Modelling the probability that AI = Yes. Symbols: †RMLE (right medio lateral 
episiotomy); ^OASIS (obstetric anal sphincter injury); #Combormle (combination of perineal outcomes 
but no RMLE); ##Combonorml (combination of perineal outcomes with RMLE); ††LSCS (caesarean 
section); ×Combo (combination of birth mode in subsequent births); *Statistically significant P value = 
<0.05.
Outcome Predictor Comparison Odds Ratio (95% CI) Global P value* 
AI Ethnicity binary Caucasian vs Other 2.31 (1.17, 4.55) 0.0159* 
AI Forceps Yes vs No 1.46 (0.51, 4.18) 0.4853 
AI Lscs†† Yes vs No 1.23 (0.74, 2.04) 0.4248 
AI Ventouse Yes vs No 0.95 (0.23, 3.88) 0.9478 
AI Nvd Yes vs No 0.69 (0.45, 1.05) 0.0799 
AI Combo× Yes vs No 1.35 (0.42, 4.34) 0.6133 
AI Allmode Yes vs No 2.21 (0.67, 7.32) 0.1941 
AI Intact Yes vs No 1.09 (0.71, 1.67) 0.6892 
AI Rmle† Yes vs No 0.85 (0.52, 1.41) 0.5390 
AI Oasis^ Yes vs No 2.21 (0.67, 7.32) 0.1941 
AI Second Yes vs No 0.81 (0.27, 2.47) 0.7143 
AI First Yes vs No 0.68 (0.35, 1.31) 0.2474 
AI Combormle# Yes vs No 1.04 (0.57, 1.90) 0.8958 
AI Combonorml## Yes vs No 2.28 (0.58, 8.96) 0.2383 
AI Age  1.05 (1.02, 1.09)  0.0013* 
AI BMI  1.02 (0.98, 1.05) 0.3534 
AI Gravida  1.10 (0.94, 1.29) 0.2307 
AI Parity  1.08 (0.90, 1.29) 0.4315 
 
Table 6.6. Binary logistic regression model results of AI (historical) versus various predictors in the community 
setting. Modelling the probability that AI = Yes. †RMLE (Right medio lateral episiotomy)^OASIS(obstetric anal 
sphincter injury)# Combormle(combination of perineal outcomes but no RMLE)## Combonormle( combination 
of perineal outcomes with RMLE.).††LSCS (Caesareans section)×comb (combination of birth mode in 
subsequent births).* Statistical significance P value= <0.05 
6.3.1.2 Main antenatal outcomes
The prevalence of AI was higher in the past (68%) comp red to screening that occurred in the four 
weeks prior to completing the questionnaire (current period) (12.9%) (Table 6.4). The historical 
reporting of symptoms included solid stool (8%), liquid stool (18.3%), flatus or gas (50.6%), staining 
(13.5%), soiling (6.2%) and rectal urgency (43.7%).  Rates of reported symptoms that were lower in the 
last four weeks of screening included; liquid stool (0.6%), flatus (7.9%) and rectal urgency (5.9%) and 
no symptoms reported for solid stool, staining or soiling.  Women with a history of AI reported either 
one symptom (38.8%), combination of two symptoms (34.7%) or reported three or more symptoms 
(26.4%). Reporting was lower in the last four weeks (current history) with 16.5% of women reporting 
one symptom, 2.1% two symptoms and three or more symptoms reported in 0.4% of women (Table 6.4 
and Fig 6.1).
The difference in the rates of reporting of the symptoms, liquid stool, flatus, staining, and rectal urgency 
between historical and current periods was statistically significant (Table 6.4). In the first trimester, 
women were 8.2 times less likely to report liquid stool (OR = 8.15, 95% CI 2.02, 32.82, P value = 
0.0003), and 2 times less likely to report incontinence of flatus (OR = 2.03, 95% CI 1.22, 3.39, P value 
= 0.007). Women were 2.6 times more likely to report a history of rectal urgency in the past (OR = 
2.61, 95% CI 1.51, 4.51, P value = 0.0006) compared to current reporting. The historical reporting of a 
combination of symptoms was greater when compared to current reporting (OR = 13.44, 95% CI 5.74, 
31.48, P value = <0.0001).
6.3.2 Women of reproductive age in the community setting
Three hundred and fifty non-pregnant women completed the BSQ for both historical and current 
reporting of AI. The prevalence of AI was higher historically with 179 (51.1%) of 354 women reporting 
a history of symptoms compared to 121 of 354 (34.5%) women reporting current symptoms in the last 
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four weeks. Age and ethnicity were the only demographic factors significantly associated with different 
rates of reporting with and without AI in relation to the demographics and obstetric details described in 
tables 6.5 to 6.6.
6.3.2.1. Demographic and obstetric details of community women
Symptomatic women were older (33.8 ± 6.73, P value = 0.0013) and had a higher body mass index 
(BMI; 26.05 ± 6.42, P = 0.071) compared with asymptomatic women (32.7 years (± 6.76) and BMI 
25.76 (± 5.94); Table 6.5).  An increase by one unit in BMI increased a woman’s risk of AI by 2% (OR 
= 1.02, 95% CI: 0.98, 1.05, P value = 0.3534). Women reported a range of symptoms across all BMI’s 
and whilst clinically significant this was not statistically significant. Normal BMI was associated with 
increased reporting of all symptoms whereas, women who were obese reported higher incidence of 
flatus and rectal urgency (Fig. 6.2). 
Regarding ethnicity, 88% of the women in the community group identified as Caucasian, 5.4% as Asian, 
4% as African, 2% as Aboriginal, 0.3% as Middle Eastern and 0.3% identified as other ethnicity. Most 
women reported their previous mode of birth as vaginal (54%), with an intact perineum (41%). More 
women reported two previous births (44%) than one previous birth (26%), three previous births (18%) 
or four or more births (11.6%; Table 6.5 & 6.6). No women identified as being currently pregnant. 
The associations between AI were analysed in relation to ethnicity, delivery mode, perineal outcome, 
age, BMI, previous pregnancies and parity (Table 6.6).  There were no associations between AI and 
mode of birth and perineal outcomes. Women with a history of forceps delivery (OR = 1.46, 95% 
CI: 0.51, 4.18, P value = 0.4853), LSCS (OR = 1.23, 95%CI= 0.74, 2.04, P value = 0.4248), or prior 
recognised obstetric sphincter injury (OR = 2.21, 95% CI = 0.67, 7.32, P value = 0.1941) did not have 
significant increased risk of AI (Table 6.6). 
A yearly increase in age increased the odds of women having AI by 5% (P = 0.0013, OR = 1.05, 95% 
CI: 1.02, 1.09, P value = 0.0013). A statistically significant association between AI and ethnicity was 
identified with Caucasian women being two times more likely to report AI compared with women who 
identified as non-Caucasian (OR = 2.3, 95% CI: 1.2, 4.6, P value = 0.0159). 
6.3.2.2. Main outcomes for women of reproductive age in the community
Women reported a prior history of either one symptom (27.4%), two symptoms (13.7%) or three or more 
symptoms (10%). When reporting their current symptoms, 26% of women reported only one symptom, 
compared with 6% with two symptoms and lower rates of 2.5% for three or more symptoms (Table 6.7). 
There was increased reporting for bowel symptoms between the two reporting times with women having 
more bowel symptoms in times past relative to the current period.  
Predominant symptoms included flatus and rectal urgency. A previous history of symptoms included 
incontinence to flatus incontinence (41.1%), rectal urgency (21.4%), incontinence to liquid stool (14.9%), 
staining (8.9%), soiling (4%) and incontinence to solid stool (2.3%) compared to lower reporting of 
these symptoms within the current period. Current rates of incontinence reported tor flatus reported in 
26.8%, rectal urgency in 12.2%, incontinence to liquid stool in 4%, staining in 2.3%, soiling in 0.3% ad 
incontinence to solid stool in 1.4% (Table 6.7). 
In the last four weeks, women were less likely to report soiling compared to a previous history of soiling 
(OR = 10.10, 95% CI: 1.51, 67.53, P value = 0.0171)). Women were more likely to report incontinence 
to liquid stool (P value <0.001), incontinence to flatus (P value = 0.0175), staining (P value = 0.0008), 
rectal urgency (P value <0.0455) and combination of symptoms (P value <0.0001) compared to the past. 
Solid stool loss was not significantly different across the two reported timeframes (Table 6.7).
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6.3.2.3. Comparison of symptomatic women of reproductive age in the antenatal population and 
community population
There were more symptomatic women in the antenatal population (n = 242) compared with the community 
population (n = 179). Antenatal women were younger (30 years ± 5.13), had more pregnancies (3.3 ± 
1.69) and less births (1.7 ± 1.13) compared with symptomatic women in the community (33.8 years ± 
6.73, pregnancies 2.67 ± 1.37 and births 2.28 ± 1.14). BMI was higher (27.1 ± 6.99) with a greater range 
(15-54) in antenatal women compared with women in the (BMI 26.05 ± 6.42; 17- 47; Table 6.9).
Whilst both groups reported a predominance of Caucasian women with AI, there was a higher number 
of Caucasian (n = 182) and Asian (n = 39) women in the antenatal group (P value <0.0001). More 
antenatal women had one previous birth (n = 140) compared with community women who were more 
likely to report two births (n = 80) or more previous births. Antenatal women with AI reported a higher 
incidence of NVD (P value <0.0001), forceps delivery (P value = 0.1501), intact perineum (P value 
= 0.0053), OASIS (P value = 0.9743), second-degree tears (P value = 0.0738) and RMLE (P value = 
0.3414) compared with symptomatic community women. There was a significant association between 
AI and LSCS (P value =0.0030), combination RMLE (P value = 0.0001) and first-degree tears (P value 
=0.0149) in women within the community (Table 6.8). 
There was a higher historical reporting of all symptoms for antenatal women compared with women 
withim the community (68% vs 51.1%). Antenatal women more likely to report a history of solid stool 
(P value = 0.013), liquid stool (P value = 0.0003), flatus incontinence (P value =0.0001), rectal urgency 
(P value = 0.0001), soiling (P value= 0.60) and staining (P value = 0.001) compared with community 
women (Table 6.9A). Symptoms reported within the last four weeks were higher for community women 
when compared with antenatal women (34.3% vs 12.9%). The rates of solid stool (P value = 0.0025), 
liquid stool (P value = 0.004), flatus incontinence (P value =0.0001), rectal urgency (P value = 0.0001), 
soiling (P value = 0.42) and staining (P value = 0.001) (Table 6.9B). Flatus incontinence and rectal 
urgency were predominant symptoms across both periods for each subgroup of women (Tables 6.9A & 
B).
6.3.3 Combined study populations and relationship to anal incontinence
Seven hundred and four women were included in the study. The overall prevalence of AI in the combined 
study groups was 58.9% (Table 6.10). Current reporting of AI reduced to 23% for the combined 
antenatal and community group. The obstetric and demographic characteristics between symptomatic 
and asymptomatic groups were similar for age (mean (SD) = 31.8 ± 6.1 vs 31.5 ± 6.1; P value = 0.069), 
gravida (3.0 ± 1.6 vs 3.1 ± 1.6; P value = 0.139), parity (2.0 ± 1.2 vs 2.0 ± 1.2; P value = 0.174) and BMI 
(26.7 ± 6.8 vs 26.6 ± 6.5; P value = 0.56; Table 6.10).  
Women reporting AI were more likely to be Caucasian (82.4% vs 80.3%; P value = 0.0995) or Asian 
(10.9% vs 10.0%; P value = 0.366), with one previous birth (43.2% vs 40.9 %; P value = 0.120) compared 
with the overall population. No associations were observed in relation to mode of birth. The mode of 
birth varied and included vaginal delivery (62% vs 62.4%; P value = 0.60), LSCS (17.6% vs 17.3; P 
value = 0.821) and forceps delivery (7.1% vs 6.4%; P value = 0.333). The perineal outcomes were 
similar between groups with symptomatic women reporting a predominance of intact perineum (50.3% 
vs 51.1%; P value = 0.74), RMLE (23.5% vs 23.7%; P value = 0.875) and a combination of perineal 
outcomes with RMLE (7.4% vs 8.0%; P value = 0.488). Women with AI identified as having a first-
degree perineal tear (6.2% vs 7.8%; P value = 0.0507) and second-degree tear (5.7% vs 5.3%; P value = 
0.519), OASIS (5.0% vs 3.6%; P value = 0.033) and a combination of perineal outcomes with no RMLE 
and OASIS (1.9% vs 1.7%; P value = 0.623).
Women who reported a history of AI were more likely to report having sustained an OASIS (OR= 0.34, 
95% CI: 0.13, 0.92, P value = 0.0334) or second-degree tear (OR = 0.80, 95% CI: 0.40, 1.59, P value = 
0.5194)) compared with no OASIS or second-degree tear. Women had a 2% increased risk of having AI 
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Table 6.7. Comparison of historical and current AI in community women (n = 350). Fischer’s Exact 
Test P values as ordinal logistic model did not converge. Symbols: *Significant P value <0.05; †Missing 
data; **Symptoms are a combination. Table summary is greater than 100% as women identified more 
than one symptom.  Percentage is calculated out of a total of n = 350.
Community women, 
n = 350 Historical Current P value, Odds Ratio (95% CI) 
AI reported, n (%) 179 (51.1) 121 (34.3)  
Solid 8 (2.3) 5 (1.4) 0.7957, 1.08 (0.62, 1.87) 
Never 171 (95.5) 174 (97.2)  
Rare 8 (4.5) 5 (1.4)  
Sometimes 0(0) 0(0)  
Weekly 0(0) 0(0)  
Daily 0(0) 0(0)  
Liquid 52(14.9) 14(4.0) <.0001*, 3.37 (2.02, 5.63) 
Never 127 (71.0) 165 (92.2)  
Rare 52 (29.1) 14 (4.0)  
Sometimes 0(0) 0(0)  
Weekly 0(0) 0(0)  
Daily 0(0) 0(0)  
Wind or gas 114(41.1) 94(26.8) 0.0175*, 1.56 (1.08, 2.25) 
Never 35 (19.6) 85 (48.0)  
Rare 144 (80.5) 94 (52.0)  
Sometimes 0(0) 0(0)  
Weekly 0(0) 0(0)  
Daily 0(0) 0(0)  
Stain 31(8.9) 8(2.3) 0.0008*, 2.93 (1.56, 5.52) 
Never 194 ( 80.2) 171 (95.5)  
Rare 31 (13.6) 8 (4.5)  
Sometimes 0(0) 0(0)  
Weekly 0(0) 0(0)  
Daily 0 (0) 0(0)  
Soiling 14 (4.0) 1 (0.3) 0.0171*, 10.10 (1.51, 67.53) 
Never 165 (92.2) 178 (99.4)  
Rare  14 (47.8) 1 (0.6)  
Sometimes 0(0) 0(0)  
Weekly 0(0) 0(0)  
Daily 0(0) 0(0)  
Cannot hold on 
(urge) 75 (21.4) 43 (12.2) 0.0455*, 1.34 (1.01, 1.78) 
Never 104 (58.1) 136 (76.0)  
Rare 75 (41.9) 43 (24.0)  
Sometimes 0 (0) 0 (0)  
Weekly 0 (0) 0 (0)  
Daily 0 (0) 0 (0)  
Combined 
symptoms**     <.0001*, 3.11(2.12, 4.57) 
1 96 (27.4) 91 (26.0)  
2 48 (13.7) 21 (6.0)  
3 or more  35 (10) 9 (2.5)  
 
Table 6.7. Comparison of historical and current AI in community women (n=350). **Symptoms are 
combination. Table summary greater than 100% as women identified more than one symptom. ® Percentage of 




with each yearly increase in age (OR = 1.02, 95% CI: 1.00, 1.05, P value = 0.0690). Women were more 
likely to report AI if they had one previous birth (OR = 0.78, 95% CI: 0.58, 1.07, P value = 0.1205), and 
were Caucasian (OR = 0.73, 95% CI: 0.50, 1.06, P value = 0.0995) or Asian (OR = 0.79, 95% CI: 0.47, 
1.32, P value = 0.3669). None of these associations reached significance however sustaining a forceps 
delivery (OR = 0.73, 95% CI: 0.39, 1.38, P value = 0.333), or LSCS (OR = 0.96, 95 % CI: 0.64, 1.42, P 
value = 0.8213) also increased the risk of AI but was not significantly.
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Table 6.8.  Comparison of symptomatic community (n = 179) and antenatal women (n = 
242). The following analyses were undertaken: Chi-square, Fisher’s Exact Test, Independent t-test, 
Wilcoxon Rank Sum Test. *Significant P value 0.05.
Women reproductive age Community group, n = 179 Antenatal group, n = 242 P value 
Age (Mean ± SD)(Range) 33.8 ± 6.73 (20-50) 30 ± 5.13 (20-50) <0.0001* 
BMI,(Mean ± SD)(Range) 26.05 ± 6.42 (17-47) 27.1 ± 6.99 (15-54) 0.0011* 
Gravida (Mean ± SD) (Range) 2.67 ± 1.37 (1-7) 3.3 (1.69) (2-11) <0.0001* 
Parity (Mean ± SD) (Range) 2.28 ± 1.14 (1-7) 1.7 (1.13) (1-7) <0.0001* 
Parity, n%   <0.0001* 
1 Birth 42 (23.5) 140 (58.1)  
2 Births 80 (44.7) 62 (25.7)  
3 Births 34 (19.0) 21 (8.7)  
>3 Births 23 (12.9) 18 (7.5)  
Ethnicity, n (%)   0.0001* 
Caucasian 165 (92.2) 182 (75.2)  
Asian 7 (3.9) 39 (16.1)  
African 4 (2.2) 9 (3.7)  
Aboriginal 1 (0.6) 4 (1.7)  
Middle Eastern 1 (0.6) 2 (0.8)  
Other 1 (0.6) 6 (2.5)  
Mode of birth, n (%)        <0.0001* 
NVD 89 (49.7) 171 (70.5) <0.0001* 
Forceps 9 (5.0) 21 (8.7) 0.1501 
LSCS 43 (24.0) 31 (12.9) 0.0030* 
Ventouse 4 (2.2) 10 (4.1) 0.4111 
Combination  LSCS 7 (3.9) 3 (1.2) 0.1050 
Combination all modes 9 (5.0) 3 (1.2) 0.0341* 
Perineum, n %   <0.0001* 
Intact 76 (42.5) 136 (56.1) 0.0053* 
RMLE 38 (21.2) 61 (25.2) 0.3414 
Combination RMLE 26 (14.5) 5 (2.1) <0.0001* 
OASIS 9 (5.0) 12 (5.0) 0.9743 
Second degree tear 6 (3.5) 18 (7.4) 0.0738 
First degree tear 17 (9.0) 9 (3.7) 0.0149* 
Combination no RMLE or OASIS 7 (3.9) 1 (0.4) 0.121 
 
Table 6.8.  Comparison of symptomatic community (n= 179) and antenatal women (n=242).* P value 0.05. Chi-
square. Fisher’s Exact Test, Independent t-test. Wilcoxon Rank Sum Test. 6.4. DISCUSSION
6.4.1 Principal findings
AI is very common in women of reproductive age affecting 58.9% of women in this study. A main 
strength of this study was the identification of both a history and current symptoms of AI at one point 
in screening in women attending either an antenatal clinic or community health centre. The variable 
reporting of AI symptoms was evident with higher reporting in the historical period within all subgroups 
of the study compared to the current reporting. 
Flatus and rectal urgency are important precursor for worsening incontinence and were commonly 
reported symptoms both at the time of screening and in the past. Women of reproductive age are at 
risk of worsening symptoms because of subsequent pregnancies, births and ageing(14-16). The ability 
to identify both a previous history of symptoms and current symptoms early in pregnancy assists in 
the improved management and prevention of worsening pelvic floor dysfunction and incontinence in 
subsequent births and across the lifespan. The BSQ is the first questionnaire to capture both historical 
and current AI symptoms and opens the way for a more accurate way of identifying women with 
incontinence symptoms.
Chapter 6 A new screening tool to identify anal incontinence
118
Table 6.9A. Reporting of historical AI symptoms (greater than 4 weeks) in community women 
(n = 179) and antenatal women (n = 242). The following analyses were undertaken: Chi-Square, 
Fisher’s Exact Test P value, Wilcoxon Rank Sum Test. *Significant P value <0.05.
Historical reporting AI Antenatal Community 
P value, Odds 
Ratio (95% 
CI) 
AI reported, n (%) 242 (68) 179 (51.1)  
Solid 28 (8.0) 8 (2.3) 0.0025* 
Never 214 (88.4) 171 (95.5)  
Rare 9 (3.7) 8 (4.5)  
Sometimes 7 (2.9) 0 (0)  
Weekly 8 (3.3) 0 (0)  
Daily 4 (1.7) 0 (0)  
Liquid 65 (18.3) 52 (14.9) 0.0040*  
Never 177 (73.1) 127 (71.0)  
Rare 53 (21.9) 52 (29.1)  
Sometimes 12 (5.0) 0 (0)  
Weekly 0 (0) 0 (0)  
Daily 0 (0) 0 (0)  
Wind or gas 179 (50.6) 114 (41.1) <0.0001* 
Never 63 (21.9) 35 (19.6)  
Rare 69 (28.5) 144 (80.5)  
Sometimes 80 (36.8) 0 (0)  
Weekly 10 (4.1) 0 (0)  
Daily 20 (8.7) 0 (0)  
Stain 48 (13.5) 31 (8.9) 0.0010*     
Never 194 (80.2) 194 (80.2)  
Rare 33 (13.6) 31(13.6)  
Sometimes 14 (5.8) 0 (0)  
Weekly 1 (0.4) 0 (0)  
Daily 0 (0) 0 (0)  
Soiling 22 (6.2) 14 (4.0) 0.6058 
Never 220 (90.9) 165 (92.2)  
Rare  18 (7.4) 14 (47.8)  
Sometimes 2 (0.8) 0 (0)  
Weekly 0 (0) 0 (0)  
Daily 2 (0.8) 0 (0)  
Cannot hold on (urge) 155 (43.7) 75 (21.4) <0.0001* 
Never 87 (36.0) 104 (58.1)  
Rare 45 (18.6) 75 (41.9)  
Sometimes 83 (34.3) 0 (0)  
Weekly 10 (4.1) 0 (0)  
Daily 17 (7.0) 0 (0)  
Combined symptoms    <0.0052 
1 94 (38.8) 96 (27.4)  
2 84 (34.7) 48 (13.7)  
3 or more   66 (26.4) 35 (10)  
 
Table 6.9A. Reporting of AI symptoms historical (greater than 4 weeks) in community women (n=179) and 
antenatal women (n=242) * Chi-Square P value <0.05. Fisher’s Exact Test P value. Wilcoxon Rank Sum Test 
The reporting of AI within the literature ranges between 2% and 50% of the population, a result of 
variations in how incontinence was defined, the type of study, study size, population studied and disclosure 
by participants(1, 17-25). The higher rates of reporting of AI within these studies occurred when rectal 
urgency and flatus incontinence were included, which was consistent with our research outcomes(18, 20, 26-
29). Pares et al.(27) cross sectional study of 228 nulliparous women utilised the Wexner score and identified 
40.8% of  women in early and late pregnancy having at least one episode of AI. Additionally, screening 
tools that utilise language, which is easy to understand, or that use non- medicalised terminology, not 
unlike the BSQ, also reported higher rates of AI(26, 29, 30). Brown et al.(31) concurred with these findings and 
suggested disclosure is enhanced through the type of screening tool (self-report versus clinician) and the 
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Table 6.9B. Reporting AI symptoms in the current period (within last 4 weeks) in symptomatic 
community women (n = 121) and antenatal women (n = 46). The following analyses were 
undertaken: Chi-Square, Fisher’s Exact Test P value. *Significant P value <0.05; †Missing data.
History of AI Antenatal
† 
N = 242 
Community 
N = 179 
P value, Odds 
Ratio (95% CI) 
Current AI reported, n (%) 46 (12.9) 121 (34.3)  
Solid 0 (0.0) 5 (1.4)  
Never 242 (100) 174 (97.2)  
Rare 0 (0) 4 (1.4)  
Sometimes 0 (0) 0 (0)  
Weekly 0 (0) 0 (0)  
Daily 0 (0) 0 (0)  
Liquid 2(0.6) 14 (4.0) 0.0003* 
Never 240 (99.2) 165 (92.2)  
Rare 2 (0.6) 14 (4.0)  
Sometimes 0 (0) 0 (0)  
Weekly 0 (0) 0 (0)  
Daily 0 (0) 0 (0)  
Wind or gas 28 (7.9) 94 (26.8) <0.0001* 
Never 214 (88.4) 85 (48.0)  
Rare 10 (4.1) 94 (52.0)  
Sometimes 13 (5.3) 0 (0)  
Weekly 3 (1.2) 0 (0)  
Daily 2 (0.8) 0 (0)  
Stain 0(0.0) 8 (2.3) 0.0010* 
Never 242 (100) 171 (95.5)  
Rare 0 (0) 8 (4.5)  
Sometimes 0 (0) 0 (0)  
Weekly 0 (0) 0 (0)  
Daily 0 (0) 0 (0)  
Soiling 0 (0.0) 1 (0.3) 0.4252 
Never 242 (100) 178 (99.4)  
Rare  0 (0) 1 (0.6)  
Sometimes 0 (0) 0 (0)  
Weekly 0 (0) 0 (0)  
Daily  0 (0)  
Cannot hold on (urge) 20(5.9) 43 (12.2) <0.0001* 
Never 222 (91.7) 136 (76.0)  
Rare 9 (3.7) 43 (24.0)  
Sometimes 8 (3.3) 0 (0)  
Weekly 2 (0.8) 0 (0)  
Daily 1 (0.4) 0 (0)  
Combined symptoms**    <0.0001* 
1 39 (16.5) 91 (26.0)  
2 5 (2.1) 21 (6.0)  
3 or more  1 (0.4) 9 (2.5)  
 
Table 6.9B. Reporting AI symptoms current period (within last 4 weeks) in community women (n=179) and 
antenatal women (n=242) * Chi-Square P value <0.05. Fisher’s Exact Test P value. †Missing data 
use of terminology. This study involved 5817 women over the age of 45 years in the United States, and 
included an online questionnaire adapted from a validated bowel screening tools the Faecal Incontinence 
Severity Index (FISI) and the Wexner score. Whilst the self-reporting format of the questionnaire 
enhanced reporting with 97% of women noting a history of AI in the last 12 months, there were issues 
surrounding terminology with 31% of women never having heard the term faecal incontinence(31). The 
strength of the BSQ was in the design and development of the questionnaire, which included consumer 
participation, where it was apparent women preferred non-clinical terminology, which included “poo”, 
“gas or wind”, “cannot hold”, and “staining”. This enhanced disclosure and described symptoms women 
associated with anal incontinence(13). This was consistent with other studies, which have shown women 
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Table 6.10. Total research population of women of reproductive age (n = 704). Binary logistic 
regression, anal incontinence versus predictor. *Significant P value <0.05.
Women of reproductive age Total group,  n = 704 
Anal incontinence 
group, n = 421 P value 
Odds Ratio 
(95% CI) 
Age (Mean ± SD) (Range) 31.5 ± 6.1 (18 to 50) 31.8 ± 6.1 (20–50) 0.0690 1.02 (1.00, 1.05) 
BMI (Mean ± SD) (Range) 26.6 ± 6.5 (15 to 54) 26.7 ± 6.8 (15–54) 0.5622 1.01 (0.98,1.03) 
Gravida (Mean ± SD) 
(Range) 
3.0 ± 1.6 
(1,11) 3.1 ± 1.6 (1,11) 0.1329 1.08 (0.98,1.19) 
Parity (Mean ± SD) (Range) 2.0 ± 1.2(1,7) 2.0 ± 1.2 (1,7) 0.1742 0.92 (0.81,1.04) 
Parity, n%     
1Birth 288 (40.9) 182 (43.2) 0.1205 0.78 (0.58,1.07) 
2 Births 247 (35.0) 142 (33.7) 0.3699 1.15 (0.84,1.58) 
3 Births 94 (13.4) 55 (13.0) 0.7934 1.06 (0.68, 1.65) 
>3 Births 74 (10.5) 41 (0.23) 0.4216 1.22 (0.75,1.98) 
Ethnicity, n (%)     
Caucasian 566 (80.3) 347 (82.4) 0.0995 0.73 (0.50,1.06) 
Asian 71 (10.0) 46 (10.9) 0.3669 0.79 (0.47,1.32) 
African 39 (5.5) 13 (3.1) 0.0009* 3.18 (1.60,6.29) 
Aboriginal 13 (1.8) 5 (1.2) 0.1245 2.42 (0.78,7.48) 
Middle Eastern 5 (0.7) 3 (0.71) 0.9927 0.99 (0.16,5.97) 
Other 10 (1.4) 7 (1.7) 0.5112 0.63 (0.16,2.47) 
Mode of birth, n (%)          
NVD 439 (62.4) 260 (62.0) 0.6029 1.09 (0.80,1.48) 
Forceps 45 (6.4) 30 (7.1) 0.3333 0.73 (0.39,1.38) 
LSCS 122 (17.3) 74 (17.6) 0.8213 0.96 (0.64,1.42) 
Ventouse 25 (3.5) 14 (3.3) 0.6933 1.18 (0.53,2.63) 
Combination  LSCS 18 (2.6) 10 (2.4) 0.7101 1.20 (0.47,3.07) 
Combination all modes 54 (7.6) 32 (7.6) 0.2190 0.49 (0.16,1.53) 
Perineum, n %     
Intact 360 (51.1) 212 (50.3) 0.7470 0.95 (0.70, 1.29) 
RMLE 167 (23.7) 99 (23.5) 0.8754 1.03 (0.72, 1.47) 
Combination RMLE 56 (8.0) 31 (7.4) 0.4801 1.22 (0.70, 2.11) 
OASIS 26 (3.6) 21 (5.0) 0.0334* 0.34 (0.13,0.92) 
Second degree tear 37 (5.3) 24 (5.7) 0.5194 0.80 (0.40,1.59) 
First degree tear 55 (7.8) 26 (6.2) 0.0507 1.73 (1.00,3.01) 
Combination no RMLE or 
OASIS 12 (1.7) 8 (1.9) 0.6231 0.74 (0.22,2.48) 
 
Table 6.10: Total research population women of reproductive age (n=704) Binary logistic regression, anal 
incontinence versus predictor. * Significant P value <0.05 
preferred health literature appropriate to the literacy level for the intended population, and including 
terms, which were easy to understand and enhanced reporting of symptoms(30-33). 
Rectal urgency, the inability to defer defecation longer than 15 minutes, and flatus incontinence, were 
common symptoms reported in women of reproductive age and this is consistent with other research(20, 
26-28, 34). Passive soiling and staining are indicative of damage to the anal sphincter complex, particularly 
the internal anal sphincter. These symptoms have a significant impact on quality of life in women 
of reproductive age, yet few studies have assessed soiling and staining(1, 20, 23, 26, 27, 35-37). Other studies 
however, which included soiling, reported similar rates to findings from this current study(38, 39).
Screening women of reproductive age for AI is difficult due to the transient nature of symptoms. The 
BSQ identified the varied reporting of symptoms both in the past and at the current time of screening. 
Symptoms were reported less frequent in the current period; in particular, for the antenatal group 
of women suggesting early pregnancy may influence or alter the incidence of AI. It is known that 
pregnancy hormones increase the risk of constipation in the first and second trimester and reduce the 
risk of AI during this timeframe and may account  for the differences observed in the study outcomes(40, 
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41). Additionally, 29.9% of BSQ were not completed or partially completed for this timeframe; as a 
result, the lower response rates may have influenced the validity of the findings for the antenatal group. 
Prospective studies have identified the varied reporting of AI across different points of time with bowel 
screening tools, which were consistent with our study findings(21, 24, 26-28, 35). The inability of these tools to 
identify a pre-existing history of AI in addition to current symptoms limits their use as a quick and easy 
screening tool and may prevent early intervention in care and management, which would reduce the risk 
of worsening symptoms. Birth pathway planning generally begins in the first trimester of pregnancy 
and requires assessment of pre-existing and current history of incontinence symptoms. However, the 
transient nature of AI and inability of current clinical tools to screen effectively increases the risk for 
compounding injury and worsening incontinence. The BSQ is therefore a superior tool, which will assist 
in the early assessment of women of reproductive age. It will detect incontinence symptoms and enable 
women and clinicians caring for them to make decisions, which can help, preserve their continence over 
time and provide women with prions for care to improve their quality of life(42-44).  
6.4.2. Obstetric predictors and relationship to AI
Overall findings for the 704 women in our study suggested OASIS was the only significant risk factor 
for AI. Previous studies have confirmed our findings and identified the risk associated between AI 
and OASIS, with many women continuing to experience symptoms 12 months following birth(45-47). 
Increasing age is associated with an increased risk of AI and whilst the findings in our study were not 
significant , it was identified the risk of AI increased by 1% to 5% with every year of ageing and adds 
to the current literature(1, 48). The overall risk of AI in the study was associated with older age, increased 
BMI, ethnicity, forceps, first birth, LSCS, OASIS, second-degree tear and intact perineum’s and has 
been demonstrated in other studies(35, 49-52). 
There was a higher reporting of historical symptoms by antenatal women compared to women in the 
community. The differences may be a result of the compounding effects of risk factors including BMI, 
first birth, ethnicity, forceps delivery, normal vaginal delivery, RMLE, OASIS, second degree tear, 
intact perineum. Several studies have shown associations between increased BMI and AI and this was 
consistent with the antenatal findings in our study(35, 50, 52). Macarthur et al.(35) reported predominant 
symptoms of faecal incontinence (7.1%) and flatus incontinence (24%) in overweight women, and these 
are comparable to our findings.  My study was undertaken in a socially disadvantaged population, which 
increased the likelihood of obesity(53-56). Over half women, surveyed (53%) were overweight (BMI ≥ 
25) with 32% of women with a BMI of 30 or more (obese). Obese women are more likely to have 
obstetric complications including the risk of high blood pressure, gestational diabetes, larger babies, risk 
of instrumental delivery, perineal trauma and in particular, OASIS, which are all known risk factors for 
AI(53, 57, 58).
Asian ethnicity increased the risk of AI in the overall group of women and sub group of antenatal 
women. The shortened perineal length, body type and less pelvic organ mobility in labour for Asian 
women are described in studies as risk factors for perineal trauma and AI(28, 35, 49, 59-61).  Additional findings 
identified Caucasian women, were likely to have, AI compared to other ethnic groups excluding Asian 
women. The overall study population was predominately Caucasian and therefore the predominance of 
an ethnic group within a study may have influenced my findings and consistent with findings from other 
studies(62) . 
Studies have continually shown the relationship of forceps delivery, RMLE and OASIS and provided 
support for the findings within our study(63-65). Interventional modes of delivery increase the risk of 
perineal trauma where women with instrumental deliveries are more likely to sustain trauma and potential 
AI. My findings however suggested uncomplicated vaginal birth was associated with AI. This may be a 
consequence of a longer second stage increasing the risk of underlying indirect trauma or neuropathy(66-69). 
Studies identified the risk of perineal trauma increased with every hour in the second stage of labour 
and the risk increased further with the intervention of instrumental delivery(67). The relationship of AI to 
an intact perineum and previous LSCS were identified in the study and are consistent with our previous 
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research (chapter 4). Pregnancy, labour and birth are known risks, which contribute to weakening the 
pelvic floor and disruption of nerves in women who birth vaginally or by caesarean section and these 
findings are similar to other studies(23, 25, 66, 70-74).  Our current study did not assess length of second stage 
or differentiate between elective LSCS or emergency LSCS, which would influence reporting of AI.
Second-degree tears were associated with AI in the antenatal group of women and these findings are 
consistent with the current literature which  identified an increased trend where AI was doubled in 
women who sustained second degree tears (22.8%)(52). Further studies suggested in the absence of known 
OASIS, the cause of incontinence can be a result of undetected OASIS, or pudendal neuropathy and 
subclinical damage in the first birth may play a role for the development of AI(46, 52, 72). This concurred 
with the study findings where more women had only one previous birth and higher numbers of first and 
second-degree tears.
6.4.3 Strengths and limitations
This study is unique as it reported the findings of a specifically designed bowel-screening tool, which 
assessed both historical, and current reporting of anal incontinence at one time point.  There is currently 
no other screening tool which achieves this outcome. This was a major strength of the BSQ and an 
important aspect of risk assessment for women of reproductive age when presenting in a subsequent 
first trimester of pregnancy. Women may not present with symptoms due to the variable nature of AI 
and influence of pregnancy hormones on bowel function. The ability of the BSQ to assess the variable 
reporting and the prevalence of flatus incontinence, and rectal urgency, commonly reported symptoms 
and precursors for worsening function with age, was a further strength of the findings. Importantly the 
BSQ identified an additional precursor for worsening function; soiling a symptom not routinely included 
in assessing women of reproductive age. 
The prevalence of AI within the overall groups were high and comparable to studies, which utilised 
screening tools developed with consumer participation. The importance of consumer participation in 
symptom selection and use of common terms that were easily understood enhanced the reporting of 
symptoms within the BSQ. Although women who were health seeking or wanting to assist the research 
may have influenced the findings through the provision of affirmative answers and this may have been a 
limitation to the overall reporting. 
A further limitation may have resulted due to selection bias. A consequence of attending health 
professionals who may have encouraged recruitment of symptomatic women, which would have 
influenced a higher reporting of AI.  The accuracy of prevalence rates further influenced through 
response bias where the BSQ was utilised as a mixed mode questionnaire. Women could self-report 
but also seek assistance when required. Completion of the questionnaire in the presence of a health 
professional may have caused embarrassment and non-disclosure for antenatal women, and influenced 
the current reporting period, with 29.9% of BSQ not completed and limited the accuracy of the findings. 
The variability of symptoms have been shown to influence reporting where higher inaccuracies were 
associated with the severity of health concern and longer periods between reporting.  The current study 
relied on women to recall their birth history and continence symptoms and the period between births 
or variability of symptoms may have influenced reporting.  Additionally, women in the community 
self-assessed their weight and height and the provision of socially desirable responses in particular 
underreporting BMI may have influenced the accuracy and reliability of the findings. The study did 
address the issue of recall bias for antenatal women with the extraction of fifteen percent of data from 
the antenatal case-notes and a significant interrater agreement was identified.
Whilst clinically significant differences and associations between known risk factors for AI including 
parity, BMI, Asian ethnicity, forceps delivery, RMLE were established there were no statistical 
significance.  This may be a result of multiple predictors being responsible for causation of AI as 58.9% 
of women in the study had more than one previous birth and differing birth mode. The findings of 
the study reported a relationship between AI and LSCS, NVD, intact perineum’s, second-degree tears; 
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factors not identified as common predictors within the literature. The higher reporting of AI in women 
who reported LSCS provided evidence that multiple factors influence AI. Although the findings did not 
differentiate between women who had an emergency LSCS and elective LSCS, it could be concurred the 
impact of labour on the pelvic floor might have further influenced outcomes. The compounding effect 
of predicators, including family history and collagen weakness outlined in other studies influence pelvic 
floor function and risk of AI. The aim of this study was not to assess the relationship between AI and 
predictors but identify the prevalence of AI in women of reproductive age. However, assessment of a 
pre-existing history in the context of current reporting of symptoms not only improves detection but also 
allows for further investigation for causation. 
6.5 CONCLUSIONS
In conclusion, the findings of this this study suggests there is a high prevalence of anal incontinence in 
women of reproductive age and the reporting of incontinence symptoms is variable. The identification 
of symptoms, inparticular flatus incontinence, rectal urgency and soiling, precursors for worsening 
function has in the past been problematic a result of the transient nature and lack of routine screening 
with an appropriate tool that captured both past and current history of AI. Results from this study have 
shown the BSQ a specifically designed screening tool developed as part of the overall thesis is the 
first bowel-screening tool to identify a pre-existing history and or a current reporting of incontinence 
symptoms at one point of screening. The findings of this study demonstrate lower reporting of symptoms 
in women with a history of anal incontinence in their first trimester of pregnancy. The ability of the BSQ 
to detect past symptoms from current reporting makes it superior to other clinical tools as it therefore 
reports the true prevalence of anal incontinence. The correct identification of symptoms translates to 
earlier referrals and access to clinical care, which can ultimately improve the quality of life for women 
in both the short and long-term.
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Final discussion and recommendations
OVERVIEW
The preceding chapters of this thesis have addressed the following research questions:
1. What factors influence the disclosure of anal incontinence (AI) in women of reproductive age?
2. Would the identification of these issues assist in the development and validation of a bowel-screening 
tool to identify AI in this group of women?
Three research aims answered the research questions utilising a mixed methodological approach.  The 
quantitative research (chapters 3, 4 and 6) addressed the development and validation of the bowel 
screening tool (BSQ). The qualitative interviews (chapter 5) assisted in the development of the BSQ 
by deriving a deeper understanding on the inhibitors and enablers associated with disclosing anal 
incontinence (AI).
Research aims: 
The overarching aim of this study was to develop and validate an easy-to-use tool to identify AI in 
women of reproductive age. This stage was informed by two further research aims;
1. To determine whether routine screening was already undertaken in the pregnant and postnatal 
population to identify AI, and; 
2. To analyse the factors that affect the disclosure of symptoms of AI to health care providers. This 
would further inform the development and validation of a screening tool for AI.
The outcomes of the study have demonstrated that the newly developed bowel-screening tool is a valid 
and reliable tool for the identification of AI. Importantly, the research has shown that AI was evident 
in the first trimester of pregnancy with flatus incontinence, rectal urgency and soiling identified as 
predominant symptoms. These symptoms are suggestive of damage to the anal sphincter muscles and are 
known precursors for worsening symptoms with age(1). The research findings show the variable reporting 
of AI across different times. The strengths of the BSQ was that it recognised both historical and current 
reporting of incontinence (within the last four weeks), and that it captured the transient nature of AI, 
which was not identified with the clinical tools used in current practice. The thesis findings demonstrate 
a need to screen all women of reproductive age regardless of a history of birth trauma because there is a 
clear link between risk factors such as parity, Asian ethnicity, forceps delivery, episiotomy and obstetric 
anal sphincter injury (OASIS). Other factors such as age, body mass index (BMI), vaginal delivery and 
caesarean sections are also associated with AI. 
Research to date has largely focused on the causes of AI, and has identified multiple risk factors for pelvic 
floor dysfunction and resultant AI(2-6). At present, routine screening does not appear to be undertaken 
during the first trimester of pregnancy when initial planning and management of care is implemented. 
There is also a lack of evidence to suggest that specific screening tools have already been developed 
by and for pregnant or postnatal women(2, 7-15). The Wexner and Vaizey scores are two tools currently 
used by clinicians to identify incontinence. This thesis highlights that such clinical tools are limited in 
busy clinical settings because they contain jargon that is too difficult for women to understand, there 
is no standard definition of AI, and they use inconsistent frequency scales and scoring systems(16).  The 
inability of these tools to capture a previous history of AI during current screening of women presenting 
in pregnancy therefore under reports the true prevalence of AI and negatively impacts on the women’s 
wellbeing. The findings from this thesis demonstrated that the new BSQ, developed in partnership with 
women, identified a high prevalence of AI, captured the variability of reporting across different times, 
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and identified soiling as a symptom for inclusion.
7.1 INHIBITORS FOR DISCLOSING ANAL INCONTINENCE
This thesis aimed to identify factors that affected disclosure of AI to health care providers. The findings 
from the first stage of the study showed that 89.6% of women had not disclosed AI to another person. 
These findings are consistent with other studies that report rates of disclosure between 10% and 20%(17, 
18). These studies reported that women rarely sought care and were more likely disclose to a friend 
(51%) than a doctor (10% to 30%)(17, 19, 20). Health-seeking was identified as being complex and involved 
a person’s understanding that AI was a problem, and not a normal consequence of birthing(21, 22). 
Additionally, the motivation to ask for help was influenced by social beliefs, frequency of symptoms, and 
the receptiveness of health professionals(21, 22). This was consistent with the findings from the prospective 
and qualitative stages (chapters 4 and 5), which demonstrated that women often did not recognise AI 
was a problem, but considered it to be a normal consequence of pregnancy and childbirth. The increased 
frequency of symptoms was a main factor that promoted health-seeking(23-25). 
The inability to conform to societal norms and maintain continence status, or personal disgust and 
shame associated with discussing bodily functions, were identified in other studies as roadblocks 
to disclosure(24-27). Such findings are consistent with those from this thesis (chapters 4 and 5). The 
qualitative findings from this thesis demonstrated that the role of the health professional in screening 
for AI was pivotal; however, disclosure was complex for both the clinician and person afflicted because 
of the stigma surrounding incontinence. This is consistent with other qualitative research where lack of 
enquiry because of stigma or the undervaluing symptoms from the patients perspective influenced non- 
disclosure(24). 
The thesis findings demonstrated a gap within the care of pregnant and postnatal women; it is now 
evident that a screening tool has not yet been specifically developed for this group of women, and routine 
screening is rarely undertaken(28). Screening tools are utilised in speciality areas or research settings. 
These tools are often borrowed from other disciplines and are developed for the general population with 
no consumer participation(16, 29). The retrospective findings of this thesis demonstrated a disparity in the 
reporting of AI at primary referral, and following screening by the speciality service (chapter 3). This 
raises questions as to how health providers undertook screening at the initial point of contact. 
Importantly, this thesis has shown that clinical terminology and the inability of tools to capture the 
variability of symptoms, including rectal urgency and staining, inhibits disclosure with the current 
clinical screening tools. These findings are similar to to those from research undertaken by Bartlett(30) 
who stated that disclosure is enhanced when the screening tools capture the variability of all symptoms 
and included a public vocabulary. Brown(31) reported that the use of clinical terminology in the screening 
tool, such as the word “incontinence”, was shown to negatively impact the reporting of AI. The qualitative 
findings from this thesis identified that women were less likely to provide affirmative responses if they 
did not understand the question or the wording used in the clinical tools. 
7.2 THE WEAKNESS WITHIN CURRENT SCREENING TOOLS UTILISED FOR WOMEN 
OF REPRODUCTIVE AGE 
The development of the BSQ required a review of the screening tools presently used to assess bowel 
incontinence in women of reproductive age. This review identified that the current tools are limited as 
the questions are not standardised. Whilst the tools all describe the type of incontinence, they also differ 
in their ability to capture the frequency and severity of all of symptoms that are relevant to women of 
reproductive age(7, 28, 32).  The use of clinical language and the omission of symptoms that are important to 
women, also limited disclosure(16, 29, 30).  These findings are consistent with the outcomes from this thesis.
The development and validation of the BSQ included a comparison of findings between the Vaizey and 
Wexner scores, which are the preferred tools currently used by clinicians. This thesis demonstrated a that 
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there is disparity in reporting AI when utilising the current tools due to the omission of flatus incontinence, 
rectal urgency and soiling. The lack of a frequency scale for rectal urgency, and a timeframe for reporting, 
compounded by difficult terminology within current tools, further limited disclosure (chapters 4 and 5). 
Clinical tools that have had no consumer participation in their development often assign a higher 
weighting of solid stool severity and frequency compared with other types of leakage, and thus symptoms 
are often under-reported from the women’s’ perspective(20, 33, 34). The findings from this thesis have shown 
a higher reporting and frequency of rectal urgency when using the BSQ, compared with the Vaizey and 
Wexner scores. Rectal urgency is a known precursor for worsening function in subsequent births. It is 
indicative of damage to the external anal sphincter and the inability of the current tools to effectively 
screen this symptom limits their usefulness in screening(23, 24, 26, 35). Passive soiling, or faecal seepage, was 
identified by the BSQ, and is strongly associated with obstetric anal sphincter injury. Whilst the exact 
prevalence remains unknown, it is a common symptom within the general community (reported between 
7% and 23%)(36). Neither the Wexner nor Vaizey score included passive soiling from mucous or faeces 
in symptom selection, further limiting their purpose as a quick and easy tool to screen AI in this group 
of women(37, 38). 
This thesis has highlighted the importance of identifying both past and present symptoms of incontinence 
by women (chapters 5 and 6). The Wexner score and the initial version of the BSQ contained no 
timeframes, and only captured the historical perspective for reporting AI. This limited their usefulness 
in the identification of AI in the first trimester of pregnancy. The hormonal influences of pregnancy 
during this period slows gut transit and increases the risk of constipation, which often keeps AI hidden(39, 
40). Using the Vaizey score was also limited, as it only assessed the last four weeks, excluding the 
occurrence of symptoms outside this timeframe. Whilst no current clinical tools report symptoms over 
both timeframes, prospective cohort studies have provided evidence of the variable reporting of AI 
at different points in pregnancy and the postnatal period, reinforcing the importance of identifying a 
previous and current history(41, 42). The ability to assess a history prior to pregnancy is advantageous not 
only in the identification and planning of care, but also in the identification of causation(40). The revision 
of the BSQ to include a history greater than four weeks as well as current reporting (within the last four 
weeks) improved reporting of AI over both periods (chapter 6).
The qualitative findings from this thesis (chapter 5) have shown that the language used within the clinical 
screening tools (Wexner and Vaizey scores) is a main inhibitor to disclosing AI. Lower completion rates 
of the questionnaires using these tools was often a result of poor comprehension of terms such as “plug”, 
“incontinence”, and “urgency”. This finding is consistent with studies that have identified clinical 
terminology within bowel screening tools to be a potential barrier to a person’s health literacy, which 
further influenced their disclosure(30, 43-45). The benefits of including the perspective of those afflicted 
establishes a shared vocabulary and the identification of symptoms that are important to consumers 
but often missed by health professionals(29, 33, 37). Studies identified that 60% to 70 % of women do not 
understand clinical terms such as incontinence, which has resulted in under-reporting of AI(21, 30, 44). 
7.3 DEVELOPMENT OF THE BSQ
7.3.1 Strengths 
This thesis implemented a logical and systematic process to develop a new BSQ to identify common 
symptoms currently utilised in clinical screening tools. The test to re-test phases and qualitative interviews 
improved the content and clarity of the initial questionnaire items with the inclusion of frequency scales 
for all symptoms, the symptom of soiling, and the timeframes of reporting. 
The mixed method research design adopted in the development of the BSQ utilised consumer 
participation from the early development phase. This enhanced the validity of the tool through changes 
to the language at each test phase and further refinement following qualitative interviews (chapter 5). 
The benefits of the research design allowed the qualitative research findings to inform and complement 
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quantitative research findings. This process identified omissions or a misunderstanding of terms, and 
assisted in evaluating the findings, which is consistent with the literature(46, 47).
Rectal urgency was a predominant symptom reported by women within this thesis. It was under-reported 
by other tools as a result of its omission as a symptom, or the lack of a frequency scale. The qualitative 
findings from this thesis have shown that the variable nature of rectal urgency has a significant impact 
on a woman’s quality of life, and this is often difficult to capture. These findings assisted with further 
development of the BSQ, which included a frequency scale to assess these symptoms (chapter 6). 
The qualitative findings of this thesis identified soiling to be a common symptom identified by women, 
and therefore it should be included within the BSQ. Soiling had a negative impact on quality of life and 
was identified as a precursor for worsening function with future births and age. This finding is consistent 
with studies that have linked high reporting to multiparous women who had instrumental deliveries, and 
thereby had an increased risk of anal sphincter damage(48). There was limited evidence of this symptom 
being measured by current tools.
The development of new questionnaires requires consideration of whether the new questionnaire 
actually measures what it intends and if it assesses ways in which bias can be reduced. The validation 
and strength of a tool is further enhanced by its comparison with a ‘gold standard measurement’(49-52). 
This thesis employed this method of validation by comparing the BSQ with the Wexner and Vaizey 
scores. The latter two tools, while not labelled as ‘gold standard measurements’ for bowel incontinence, 
are the current preferred tools by clinicians, which justified their use in this study. The thesis findings 
demonstrated agreement between all tools, and that the BSQ was a reliable, valid and effective assessment 
of AI in the clinical and community settings. 
This study was undertaken at a tertiary birthing centre in a community with an increasing number of 
multicultural and socially disadvantaged women, where access to health care services and low literacy 
levels can negatively affect the disclosure of AI(53, 54). The thesis findings demonstrated that consumer 
participation was pivotal in the development of the BSQ, which was strongly reliant on the health 
literature being at an appropriate level for the intended population. Revisions included symptoms 
identified as relevant by women, using a shared vocabulary(55). The successful completion of the BSQ at 
each research stage demonstrated the reliability of the BSQ in reporting AI. The enhanced reporting was 
similar to studies that have included consumer participation in their development, an evaluation as to 
whether the new questionnaire was appropriate, and whether it contained words which were intelligible 
and questions that were unambiguous(49, 52, 56). 
There is limited evidence within that health literature to suggest that current screening tools report both 
a past and current history of symptoms. An exception is with mental health, which utilises two tools in 
conjunction with one another. The Antenatal Risk Questionnaire (ANRQ) and the Edinburgh postnatal 
depression scale (EPDS) screen women for a past and current history of depression(57). Screening with 
both tools at one point in time enhances clinical assessment, providing the clinician with a good indication 
of when a referral or subsequent review is required(57). The Beck Depression Inventory Primary Care 
scoring system (BDI-PC) measures symptoms within the past two weeks, including symptoms reported 
on the day of screening(58-61). This allows for the identification of depression when used in different 
stages of care, where there is variable reporting across the different trimesters of pregnancy (2.2% 
to 16.7%), and in the postnatal period (6% to 25%)(62). The ability to assess pre-existing and current 
symptoms is paramount for conditions such as depression and incontinence where symptoms are often 
variable and easily missed or underreported as a result of stigma(40). The thesis findings demonstrated 
this to be a major strength of the BSQ as it is an important aspect of risk assessment for all women of 
reproductive age presenting in the first trimester of a subsequent pregnancy. The early identification 
of AI improves the care and management of women during their successive pregnancies, births and 
with ageing, thereby improving a woman’s quality of life(63). Furthermore, the ability to assess both a 
history and current reporting of incontinence assists in identifying causation and improves care through 
modification of potential risk factors(40). 
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 7.3.2 Limitations
This thesis implemented the BSQ was within a low socio-economic population. The social determinants 
of health reflected high levels of unemployment, low levels of completion of secondary education, 
high levels of sole female parenting, and a reliance on public housing(35). Negative social determinants 
of health disadvantage this population, contributing to poor health-seeking behaviour and poor health 
literacy. The thesis findings may therefore not be applicable in different populations where the social 
and or cultural influences may affect participant reporting. Further research is therefore required to 
assess the responsiveness of the questionnaire in other populations. The findings from this thesis are 
similar to other studies that suggest that the translation of tools into other languages, and/or display 
cultural references, will improve accuracy of reporting(64-67). Furthermore, the literature also highlights 
the need to assess whether the tool truly communicated information at the right level of understanding 
for the study population as lower literacy levels may influence understanding and inability to follow 
instructions leading to inaccuracies in reporting(67). 
The BSQ was implemented as a mixed mode questionnaire. There remains debate within the literature 
as to the benefits and limitation of self-report questionnaires and questionnaires implemented by 
clinicians(45, 49). Self-report questionnaires are limited by social desirability, where conditions like AI 
with undesirable outcomes negatively influence reporting(49). Conversely, questionnaires implemented 
by clinicians can increase investigator bias(49). These factors may have inadvertently influenced the 
development of the BSQ. 
The initial BSQ did not contain a frequency scale for all symptoms; however, the intention of this stage 
was to identify AI (chapter 4). The  findings from this thesis have shown that the omission of frequency 
scales especially for rectal urgency in clinical tools contributed to the underreporting, and undervaluing 
of symptoms from the perspective of women. These findings are consistent with other studies that used 
qualitative interviews to evaluate items in quality of life tools(7, 26, 37). Cotterill’s(37) qualitative findings 
of interviews identified additional items that were previously excluded by health professionals, but 
identified by patients as having a significant impact on their quality of life. Following the qualitative 
interviews, a frequency scale for all symptoms was therefore included in the revised BSQ (chapter 6). 
7.4 IMPORTANT FINDINGS OF THE BSQ 
The overall prevalence of AI reported within this thesis is high relative to other studies that have also 
included the symptom of rectal urgency(6, 42, 48, 68). The findings varied to other studies, which reported 
lower rates, because of the different clinical screening tools used, study sample and size, and how 
incontinence was defined as either as AI or FI(40, 69, 70). 
The preceding chapters of this thesis have demonstrated the benefits of consumer participation in the 
development of the BSQ through the identification of symptoms important to women and the transient 
nature of AI that were not previously included in screening tools. Importantly, the findings identify 
the BSQ to be superior to current tools because of its ability to identify the pre-existing history and 
current history of AI together, at one point of screening. Current rates of reporting of AI were lower 
in all groups compared to historical rates but were of particular interest in pregnant women in their 
first trimester of pregnancy and consistent with previous research, which assessed AI across different 
stages of pregnancy(14, 42, 68, 71). The capability of the BSQ to establish a pre-existing history in the current 
context of symptom screening assists in determining the cause of AI, as there is a growing consensus 
that the cause of AI, and worsening AI symptoms, are a result of multiple predictors(2, 4, 72, 73). This is 
consistent with other studies of nulliparous women presenting with a history of AI in pregnancy where 
symptoms worsened postnatally(6, 14, 42, 68, 69). These studies identified that women who were experiencing 
one symptom during pregnancy, often suffered with the same symptom following birth, and that this 
symptom worsened with age(69). 
The findings from this thesis have shown a higher reporting of historical symptoms by antenatal women 
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compared with the women within the community. This difference may be a result of the compounding 
effects of multiple risk factors reported within the literature such as parity(74-76), instrumental birth(2, 
77), episiotomy(78-81), maternal age(48, 82), ethnicity(65, 83), foetal macrosomia(77, 84, 85), and prolonged second 
stage for > 1 hour(86-88). The findings have also demonstrated a link between factors that are not normally 
deemed to be risk factors such as caesarean section (LSCS), second-degree perineal tears, and intact 
perineum (chapters 3, 4 and 6). These findings are similar to those reported in previous studies that 
recognised the influence of additional pre-pregnancy factors, rather than linking causation solely to the 
consequences of labour and birth(89-91). Ageing and increased BMI were predominant factors associated 
with worsening AI in all stages within the thesis and adds to the existing literature(92, 93). Several studies 
have shown associations between increased BMI and AI and this was consistent with the thesis findings(2, 
94, 95). Symptomatic women with a normal BMI experienced a range of all symptoms; flatus incontinence 
and rectal urgency were reported by obese women. Similarities existed between the thesis findings 
and Macarthur et al.(2) who reported predominant symptoms of faecal incontinence (7.1%) and flatus 
incontinence (24%) in overweight women. This thesis has shown that over half the women surveyed 
(53%) were overweight, with 32% of women with a BMI of 30 or more (obese). Obese women are more 
likely to have obstetric complications including the risk of high blood pressure, gestational diabetes, 
larger babies, risk of instrumental delivery, perineal trauma and in particular OASIS, which are known 
risk factors for AI(96-98). 
7.5 HEALTH LITERACY IN TOOL DEVELOPMENT
The health literacy of a woman can affect her ability to understand the importance of disclosing AI, 
accessing care, and it influences her ability to understand written information(43, 99). Health literacy 
in the development of screening tools needs to be sensitive to a specific health group and utilisation 
of common terminology for bowel problems would be advantageous in improving the disclosure of 
symptoms in the screening and the identification of  anal incontinence(30, 100, 101). As previously outlined, 
the findings from this thesis have demonstrated that there is a lack of mutually agreed definitions, 
complex language and terms ascribed to AI, and is consistent with other studies(30, 100, 101).  Terms used 
in screening tools, which included incontinence, plug, and urgency were difficult to comprehend with 
many women opting to say no to symptoms, as they did not understand the questions. This contributed 
to the disparity between reporting with the BSQ and clinical tools in the quantitative research findings 
(chapter 4). The lower completion of clinical tools as a result of a lack of mutually shared language 
between health professionals and consumers was consistent with other studies where participants did 
not understand the term “faecal incontinence” although when the phrase “accidental bowel leakage” was 
used, reporting of AI increased(44, 102). Importantly, the previous study showed that consumer participation 
in tool development enhanced reporting of AI. This was consistent with the findings from this thesis, 
where a higher completion rate and reporting of rectal urgency and lower reporting of solid and liquid 
stool was seen with the BSQ when compared with the Wexner and Vaizey scores(44). 
7.6 IMPLICATIONS OF THE EARLY IDENTIFICATION OF AI FOR WOMEN
Health settings commonly undertake screening tests to detect specific conditions or disease in groups at 
risk, often when no symptoms exist thus improving treatment and management(103). Timely intervention 
reduces the worsening physical aspects of a condition, and the psychological, social and financial 
burden of conditions like AI(103, 104). The thesis findings demonstrated there was a high prevalence of AI 
in women of reproductive age, however, there was a lack of routine screening by health professionals 
within this at risk population (chapters 1, 3, 4, 5 and 6). 
Whilst pregnancy and childbirth pose the greatest risk for PFD and AI, women with a history of 
incontinence prior to conception and birth are at risk of worsening bowel function 5 to 10 years following 
their first birth(40,41,105). Women who are symptomatic of AI at 12 weeks of pregnancy or late in pregnancy 
are at increased risk of worsening function postnatally(6, 14, 18, 105, 106). Unlike other screening tools, the 
BSQ presented in this thesis has the ability to screen for both past and current symptoms of AI. In a 
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subsequent pregnancy, the early identification of AI assists in planning and management of a pregnancy 
and birth to reduce further damage to a compromised pelvic floor and anal sphincters(89, 90); however, 
the gastrointestinal influences on gut motility in early pregnancy increases the risk of constipation and 
therefore the accuracy in reporting AI. The BSQ in this thesis identified a lower reporting of flatus 
incontinence, rectal urgency, soiling and staining in the current period compared with the historical 
period. The ability of the BSQ to capture both current and past symptoms is vitally important in women 
who may present with no symptoms in their first trimester of pregnancy. 
7.7 LIMITATIONS OF THE RESEARCH
The findings of this thesis have shown that health-seeking is complex. It requires that a person has 
understanding that AI is a problem, and it is influenced by their social beliefs and ability to self-motivate 
to seek help. Poor health-seeking is often associated with infrequent episodes of AI, or the belief that 
AI is a normal consequence of birth. Likewise, worsening symptoms that are often associated with 
a worsening state of depression, are a strong motivator for health-seeking. This difference in heath-
seeking may account for variable reporting observed in each of the research stages of this thesis(20, 21, 27, 
107, 108). Additionally, Shrank et al.(109) described the healthy user effect as contributing to research bias. 
The findings of this thesis may have been influenced by these factors during the recruitment phases of 
the research; women receiving positive engagement about AI may have been motivated to participate in 
the research process(109). Conversely, the stigma associated with AI may have negatively influenced the 
accuracy in reporting and have attributed to social desirability bias(110).
Recall bias is common in studies that require participants to recall past events and often results in 
inaccurate reporting(110). The research literature extensively reports the effects of recall bias with 
most research undertaken in studies examining dietary intake, pain management and asthma, with 
few in obstetric care(110-117). This type of bias is often influenced by the length of time in recall period, 
characteristics of the disease, severity of the disease, the patient, and study design(110, 118). The findings 
from this thesis may have been influenced by recall bias where disclosure was influenced by stigma 
and the severity of symptoms, which is reported by other studies(19, 107). These findings are similar  to 
previous research, which investigated the level of agreement in reporting foetal loss, estimated date 
of last delivery and gestational age when compared with hospital records. Higher inaccuracies were 
associated with the severity of the health concern and longer periods between reporting(115-117). 
This thesis identified that past obstetric history, BMI, a history of AI symptoms, and results may have 
all been influenced by recall bias; however, the design of the research attempted to reduce recall bias. 
The thesis findings demonstrated good interrater reliability by cross-checking obstetric data in hospital 
records in 10% to 15% of the research (chapters 3 and 4).
The research presented in this thesis assessed women from a low socio-economic areas, which may be 
considered a further limitation. Low socio-economic status has been linked to inaccuracies in reporting 
due to poorer health literacy. Further research should assess if the BSQ is valid in other socio-economic 
settings(115, 118).
The thesis findings have shown that there is a link between AI, obstetric risk factors and demographic 
characteristics. The thesis findings were clinically significant, however, the research showed few 
statistical associations, excluding OASIS. Whilst the overall study and sample size was powered to 80% 
in relation to the previous year’s birth rate within the hospital, the thesis findings are similar to those 
from other studies, which suggests that more than one risk factor influences the risk of AI(14, 69, 119, 120). 
Importantly, there is growing recognition that pre-existing factors contribute to the development AI in 
the postnatal period(14, 42, 69, 120). Previous studies identified that a collagen deficiency or other presenting 
genetic factors may increase the risk of birth trauma and pregnancy or sub-clinical injury to the levator 
ani or chronic pudendal neuropathy following birth(4, 69, 121, 122). Many women may not be symptomatic 
in the short term, but weakened muscle tone increases risk with subsequent injury(121, 122). Therefore, the 
ability to assess pre-existing symptoms of AI and compare those with the current reporting of symptoms, 
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with a tool such as the BSQ, improves identification and management, and reduces risk for all women 
of reproductive age.
7.8 FUTURE DIRECTIONS
The findings of this thesis have identified that whilst disclosure relies on multiple factors, enquiry by a 
health professional either inhibits or enables disclosure, which is consistent with other studies(16, 23, 30, 107). 
Previous research is limited in that is does not derive a deeper understanding of the factors that influence 
screening from a health professional focus. Further research is therefore required in this area.
The BSQ is the first screening tool to report AI at initial screening for both a history of symptoms and 
current reporting of symptoms. Future prospective research should consider screening with the BSQ at 
different times to assess the reproducibility of both the historical and current reporting of AI. The known 
influence of pregnancy hormones at different stages of pregnancy identifies a need for further research 
with implementation of the BSQ pre-pregnancy, in each trimester of pregnancy and during the postnatal 
period. This would provide a comparison of reporting at different stages.
This thesis has demonstrated that the BSQ was responsive in the study populations (chapters 4, 5 
and 6) although further testing in different socio-economic populations is required to establish the 
responsiveness of the BSQ in other health settings in different demographic areas. 
Both existing research literature and the findings from this thesis have identified a relationship between 
AI and obstetric and demographic risk factors, many of which can coexist at birth(76). Our study did not 
differentiate between emergency or elective LSCS, nor the length of the second stage, which would have 
affected the findings. Therefore, further research is required to identify the associations between elective 
compared to emergency LSCS and AI.
The research in this thesis has identified a relationship between AI, second-degree tears and intact 
perineum. These findings are consistent with studies that identified women who sustained no perineal 
injury were symptomatic of AI(123, 124). The advent of endo anal ultrasound in screening for OASIS has 
increased the reporting from 20% to 41% of women who were previously undiagnosed(79). Therefore, 
routine screening for AI should occur for all women of reproductive age to ascertain the reliability of the 
BSQ in identification of AI. Future research may consider the identification of injury to anal sphincter 
muscles and relationship to AI through screening with the BSQ and endo anal ultrasound assessment in 
women with no perineal trauma(40). 
7.9 CLINICAL IMPLICATIONS AND CONCLUSION
There is a growing awareness of the high prevalence of anal incontinence and poor reporting across the 
lifespan for women(70). Primary prevention strategies play an important part in early screening and risk 
reduction(125, 126). The ability to identify a previous history of incontinence is advantageous in reducing 
further demise of the pelvic floor and assists in understanding factors that precipitate worsening 
incontinence such as pre-pregnancy issues, pregnancy or birth related trauma(40, 89). The thesis findings 
demonstrate that the BSQ is a valid and simple tool that effectively identifies the variable reporting of 
AI in women of reproductive age in a tertiary setting and within the community. The ability of the BSQ 
to report both a history of AI and current symptoms, together at the one point of screening, highlights 
that it is an important tool for use in everyday clinical practice, and in particular, within the obstetric 
setting.  The variable nature of symptoms such as flatus incontinence, staining and soling are typically 
not captured by current clinical tools, however, they are addressed by this new BSQ. This has resulted 
in improved assessment, and is likely to influence the management and care of women by minimising 
risk and worsening symptoms(20). 
The findings from this thesis have shown that the BSQ contained questions that could be easily understood 
by women in the community. Its simplicity allowed for higher completion rates, which is paramount 
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in increasingly busy clinical settings within the community and acute care settings(118). The use of non-
clinical terminology in the study improved engagement with women, allowed for earlier assessment 
of symptoms, and further discussion through engagement. This was consistent with other studies 
that recognised that positive engagement by health professionals led to improved rates of disclosure, 
implementing early referral to speciality clinics or review of obstetric care in particular discussion on 
the mode of birth(27).
In conclusion, the BSQ has proved itself to be is a reliable and validated tool in the reporting of AI across 
two timeframes for women of reproductive age. It has filled a gap within healthcare where no previous 
tool existed. Consideration of a woman’s health literacy in the development of the BSQ resulted in 
enhanced reporting of AI in women of reproductive age, especially in the first trimester of pregnancy. 
The transient nature of AI negatively influences reporting in the first trimester of pregnancy where there 
is the initiation of management and birth planning for women. It is paramount that tools such as the BSQ 
are utilised in this at-risk population where pelvic floor dysfunction may further compromise pelvic 
floor function and worsen AI across the lifespan. 
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Appendix 1. Extraction table for data. 
Does routine screening identify anal incontinence - coding definitions 
1 Primary referral - what’s written only 17 Martial status 
Urinary incontinence Sections 18 to 20 yes/no response 
Urinary incontinence- new/history 18 Employed 
Stress incontinence- new/history 19 Antenatal 
Urge Urine -new/history 20 Postnatal 
Anal incontinence (AI) Section 21 to 22 add number to box 
Anal incontinence (AI)- new/history 21 Gravida 
Rectal urgency Parity 
Other symptoms PFD  22 Gestation in weeks /40 
Incorrect referral 23 Delivery outcomes 
Questions 2 to 10 answers as follows Insert number for delivery type and 99 for no history 
YES Normal vaginal delivery 
NO Forceps 
Not stated Ventouse 
Not contactable Emergency caesarean section (LSCS) 
Not applicable Elective LSCS 
2 Vaizey score documented - case notes  m/c 
3 Vaizey score documented - database Top 
4 Previous disclosure AI to health provider Not applicable 
5 Vaizey score>0 Perineal outcomes 
6 Has literature been sent Insert number for outcome and 99 for no history 
7 Referral offered to CNS Intact 
8 Acceptance to referral Episiotomy 
9 Attendance to CNS booking Small tear not sutured 
10 Attendance to endo anal ultrasound 1degree tear 
11 Timeframe AI 2nd degree tear 
12 Pregnant 3rd degree tear 3A 
13 Obstetric review 3rd degree tear 3b 
14 Birth plan post obstetric review 3rd degree tear 3c 
Elective lower segment caesarean section 4th degree tear 
Vaginal delivery 25 Onset of AI following type of delivery 
Not applicable Sections 26 and 27 add response to box 
15 AGE (write age) YES 
16 Ethnicity No 
Caucasian not applicable 
Aboriginal not stated 
Asian 26 AI identified in consult 
Other 27 Rectal urge identified in consult 
 28 Vaizey score 0-24  (score in box or not stated) 
 29 Cleveland score 0-36  (score in box or not stated) 
 30 Referral source 
Appendix 1. Extraction table for data.
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INVITATION TO PARTICIPATE 
We invite you to participate in a research project which we believe is of importance.  
However, before you decide whether or not you wish to participate, we need to be sure that 
you understand 
  why we are doing the research and 
 what it would involve if you agree to participate. 
We are therefore providing you with the following information.  
Please read the following information carefully and be sure to ask any questions you have. 
The nurse researcher conducting the research will be happy to discuss this information with 
you and answer any questions that you may have. 
You are also free to discuss the information  with others if you wish. (E.g. family, friends, 
your local Doctor)  
You do not have to make an immediate decision. 
 
 
PARTICIPATION IS VOLUNTARY 
Participation in the research study is voluntary. If you do not wish to take part, you are not 
obliged to. Should you agree to take part in the research study, you may change your mind 
and withdraw at any stage. Your decision to take part, not to take part or to withdraw will not 
affect your routine treatment or your relationship with those treating you.  
 
 
BACKGROUND TO THE STUDY 
What is the research about? 
 
We are  investigating how many  women who have had a baby or are currently pregnant 
experience accidential loss of bowel control sometimes known as anal incontinence. 
Accidential loss of bowel control (anal incontinence) means not being able to hold on to a gas 
or poo/stool from the backpassage(anus). 
 
This research study will develop and use a screening tool to identify accidential loss of bowel 
control (anal incontinence) in women who have had a baby or are currently pregnant. 
 
In order to develop a bowel control screening tool we will need to identify women who 
experience accidential loss of bowel control. This will be done through an initial questionaire. 
We will then interview these women to help develop the bowel screening tool. The bowel 
Appendix 1A. Participant Information Sheet and Consent Form.
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control screening tool will be trialed at the Lyell Mc Ewin hospital antenatal clinic and the  
GP super clinics.  
 
 
Why is the research being done? 
Accidental loss of bowel control (anal incontinence) affects 1.3 million Australians. Anal 
incontinence can worsen over a person’s life and has a negative impact on their quality of life.  
Women are affected more than men, due to birthing and delivery. There are no recognised 
tools which screen anal incontinence in pregnant and postnatal women.  The research aims to 
develop a tool which can screen and identify women who have anal incontinence. Early 
assessment may improve quality of life in pregnancy and across the lifespan. 
 
Who is sponsoring this research? 
 
The research project is under the governance of the University of Adelaide, Robinson 
Institute, Lyell McEwin Hospital.  
 
How and why have I been chosen as a possible participant in the research? 
 
Group 1 
You have been asked to participate in the research if you have had at least one previous 
delivery and are pregnant attending the Lyell McEwin Hospital for your first antenatal 
appointment (ANEW). We are trying to find out if you have experienced accidental loss of 
control (anal incontinence). 
 
Group 2 
You have been invited to participate if you have had at least one previous delivery and are 
attending a GP Super Clinic. We are trying to find out if you have experienced accidental loss 
of control (anal incontinence). 
 
Group 3 
You have been asked to participate if you have had a previous delivery and have a history of 
accidental loss of bowel control (anal incontinence) and are attending the continence clinic at 
the Lyell McEwin Hospital. You are invited to participate in the pre-testing, re-testing and to 
provide feedback of the questionnaire assessment of bowel control and bowel control 
screening tool.  
 
How many other people have been asked to consider participating? 
 
The research has 5 stages and we are recruiting 1100 women throughout the research. Women 
will be recruited from ANEW bookings at the Lyell Mc Ewin Outpatient department, the 
Continence Nursing Service at the Lyell Mc Ewin Hospital and GP Super clinics. 
 
 
PROCEDURES AND TREATMENT 
Will I have to come back to the clinic more often or remain in hospital for longer than 
would normally be the case? 
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Bowel control questionnaire 
The research questionnaire will occur at your first antenatal booking, the ANEW. The 
questionnaire will take no longer than 5 minutes to complete. 
 
 Individual interview 
However If you wish to take part in an individual interview we will need to set a time 
convenient for you to attend the Lyell Mc Ewin Hospital. At this interview we would also like 
you to complete a questionnaire. The questionnaire asks questions about how accidental loss 
of bowel control (anal incontinence) affects your quality of life. The interview and 
questionnaire will take approximately 60 minutes. 
 
Group 2 
Bowel control screening tool 
Pilot testing of the bowel screening tool will occur during a routine visit to your health 
provider, either at the Lyell McEwin Hospital antenatal clinic or the GP Super clinic. The 
bowel control screening tool asks questions about bowel control and will take less than 5 
minutes for the health provider to complete. 
 
Group 3 
Questionnaire assessment of bowel control and bowel control screening tool 
The pre-test, re-test and providing feedback on the questionnaire assessment of bowel control  
and the bowel control screening tool will require an individual interview. This will take 
approximately 10-15 minutes for each session. A time will be set which is convenient for you 
to attend the Lyell Mc Ewin Hospital.  
 
 
What will I be asked to do? 
This depends on what you have consented for in the research. Listed below is more 
information for each group. 
 
Group 1 
1. The questionnaire assessment of bowel control  
The questionnaire will be undertaken at your ANEW booking and will take less than 5 
minutes to complete 
 
2. Individual interview 
If you consent to take part in an individual interview, this may take approximately 60 
minutes. We would like you to tell us what makes it easier and harder to tell others about 
accidental loss of bowel control (anal incontinence). We also would like you to complete a 
questionnaire on how your accidental loss of bowel control (anal incontinence) affects 
your quality of life. The quality of life questionnaire will take 10 minutes to complete. 
Group 2 
1. Bowel screening tool  
The bowel screening tool will be undertaken in a routine antenatal visit (ANEW) At the 
Lyell McEwin Hospital. The antenatal Midwife will ask several questions about your 
bowel control. This will take no longer than 5 minutes. 
 If you are attending the GP Super Clinic your doctor will ask several questions about 
your bowel control. This will take no longer than 5 minutes. 
 
Group 3  
       1.Questionnaire assessment of bowel control and bowel control screening tool 
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You will be asked to pre-test, re-test and provide written and or verbal feedback of the        
bowel control questionnaire and bowel control screening tool. 
 
How long will my participation in the study last?  
Group 1 
1. The initial questionnaire at ANEW booking will last 5 minutes. 
2. The individual interview will be arranged to take place at the Lyell McEwin Robinson 
Institute, at a time convenient to you, lasting approximately 60 minutes. 
 
Group2 
1. The bowel screening tool will be included in a routine visit to the ANEW appointment 




You will be asked to test, re-test and provide written and or verbal feedback for the 
questionnaire assessment of bowel control and bowel screening tool. 
What procedures will I be asked to submit to and what are the likely effects? 
Procedures are outlined above. 
 
If I decide not to take part what other treatments are available to me? 
 
Your decision to take part, not to take part or withdraw from the research study will not affect 
your routine treatment.  
 
Are there any factors which would exclude me from participating? 
 
Women who have not had a baby are ineligible to participate. We thank you for your interest. 
 
PARTICIPANT MANAGEMENT 
DISCOMFORTS, RISKS AND SIDE EFFECTS 
Are there likely to be side effects from the research procedures, and if so what are they? 
 
Disclosing personal information may cause you emotional concern. If this arises please 
inform the researcher or Midwife at your antenatal booking. You will be referred to 
appropriate counselling support within the Lyell McEwin Hospital. 
 
 
Who should I contact if I am worried about any effects that I experience? 
 




WHAT WILL HAPPEN TO THE INFORMATION COLLECTED? 
How will my confidentiality be protected? How will information and results be de 
identified? 
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Your confidentiality is ensured. Your information will be de-identified and linked with a 
study number. All information is password protected and is cross linked to the hospital 
medical record number. Contact information can only be accessed by the primary researcher. 
Participation is voluntary and you can withdraw from the study at any point in time with no 
penalties.  
 
Will I be informed about the results of the study? 
 
Data a collected will be published in research journals. If you would like a copy of the 
research findings, you will need to contact the primary researcher  
 
How long will information be stored for? 
 
Research information is kept for 5 years and then destroyed. This is keeping with the South 
Australian Heath  Policy and the NMHRC code for Responsible Conduct of research. 
 
WHAT ARE MY RIGHTS? 
If you become injured during this study, and your injury is a direct result of the effects of 
study procedures, The Lyell McEwin Hospital will provide reasonable medical treatment. 
Your participation in this study shall not affect any other right to compensation you may have 
under common law. 
 




Associate Professor Vicki Clifton 
Robinson Institute, Lyell Mc Ewin Hospital 
Phone 81332133 
 
PAYMENT FOR PARTICIPATION 
Will I be paid for my participation?  
Participation is voluntary.  
 
BENEFITS OF THE RESEARCH 
Is there any chance that the proposed research will be of benefit to me personally, or to 
future patients with the same condition? 
 
Whilst your direct involvement may not benefit you, your contribution to this research is 
valuable in developing a bowel control screening tool to assist other women. 
 
If you are identified to have anal incontinence you will be offered referral to a specialist 
service which deals with accidental loss of bowel control.  
 
The research aims to develop a bowel control screening tool to identify anal incontinence in 
women of childbearing age, early identification may lead to improved quality of life in 
pregnancy, birthing and across the lifespan. 
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WHAT IF I HAVE A QUESTION ABOUT THE STUDY? 
If you have any questions about this study, please contact one of the researchers: 
Julie Tucker 
Primary researcher 
University of Adelaide 
Robinson Institute, Lyell Mc Ewin Hospital 
Or  
Associate Professor Vicki Clifton 
Robinson Institute 
Lyell McEwin Hospital 
Ph 81332133 
 
The Human Research Ethics Committee (TQEH/LMH/MH) has approved this study. 
 
Should you wish to speak to a person not directly involved in the study in relation to:  
 matters concerning policies,  
 information about the conduct of the study  
 your rights as a participant, or 
 Should you wish to make a confidential complaint 
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Title: Development of a screening tool to identify anal incontinence in women of 
reproductive age  
  
Protocol Number:  
 
I, the undersigned................................................................................................  
hereby consent to my involvement in the research project explained above. 
Which is to participate in the (Circle those applicable) 
 
1. Pre-test, re-test and provide feedback of the research questionnaire: assessment of 
bowel control for women of reproductive age 
2. The questionnaire: assessment of bowel control for women of reproductive age 
3. Individual interview and quality of life questionnaire. 
4. Pre-test, re-test and provide feedback of bowel control screening tool.  
5. Bowel control screening tool at a ANEW antenatal booking LMH 
6. Bowel control screening tool at GP Super clinic 
 I have read the information sheet, and I understand the reasons for this study. The research 
worker has explained the ways in which it will affect me.  My questions have been 
answered to my satisfaction. My consent is given voluntarily.  
 
 I understand that the purpose of this research project is to improve the quality of medical 
care, but my involvement may not be of benefit to me. 
 
 The details of the research project have been explained to me, including: 
- The expected time it will take 
- The nature of procedures being performed, and number of times they will be 
performed 
- Any discomfort which I may experience 
 
 I have been given the opportunity to have an interpreter or member of family or a friend 
present while the project was explained to me. 
 My identity will be kept confidential, and nothing will be published which could possibly 
reveal my identity. 
 My involvement in the study will not affect my relationship with my medical advisers. I 
understand that I am able to withdraw from the study at any stage without having to give a 
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PATIENT SIGNATURE…………............................................  DATE …./……./……. 
WITNESS……………………………………………………….....  DATE …./……./……. 
I have given a verbal explanation of the implications of withdrawal from the research project 
and I believe that the participant has understood that explanation. 
INVESTIGATOR:.......................................................................DATE …/…../…….. 
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INVITATION TO PARTICIPATE 
We invite you to participate in a research project which we believe is of importance.  
However, before you decide whether or not you wish to participate, we need to be sure that 
you understand 
 why we are doing it, and 
 what it would involve if you agreed. 
We are therefore providing you with the following information.  
Please read the following information carefully and be sure to ask any questions you have. 
The nurse researcher conducting the research will be happy to discuss this information with 
you and answer any questions that you may have. 
You are also free to discuss it with others if you wish. (E.g. family, friends  your local Doctor)  
You do not have to make an immediate decision. 
 
PARTICIPATION IS VOLUNTARY 
Participation in  the research project is voluntary. If you do not wish to take part, you are not 
obliged to. Should you agree to take part in the research study, you may change your mind 
and withdraw at any stage.  
 
BACKGROUND TO THE STUDY 
What is the research about? 
 
We are  investigating how many  women who have had a baby or are currently pregnant 
experience accidential loss of bowel control  sometimes known as anal incontinence. 
Accidential loss of bowel control (anal incontinence) means not being able to hold on to a gas 
or poo/stool from the backpassage(anus). 
 
This study will develop and use a screening tool to identify accidential loss of bowel control 
(anal incontinence) for women who have had a baby or are currently pregnant. 
 
In order to develop a bowel control screening tool, we will need to identify women who 
experience accidential loss of bowel control. This will be done through an initial  
questionaire. We will then interview these women to help develop the bowel screening tool. 
The bowel control screening tool will be trialed at the Lyell Mc Ewin hospital antenatal clinic 
and the  GP Super clinics.  
 
Why is the research being done? 
Appendix 1B. Participant Information Sheet and Consent Form.
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Accidental loss of bowel control (anal incontinence) affects 1.3 million Australians. Anal 
incontinence can worsen over a person’s life and has a negative impact on their quality of life.  
Women are affected more than men, due to birthing and delivery. 
There are no recognised tools which screen anal incontinence in pregnant and postnatal 
women. The research aims to develop a tool which can screen and identify women who have 
anal incontinence. Early assessment may improve quality of life  in pregnancy and across the 
lifespan. 
 
Who is sponsoring this research? 
The research project is under the governance of the University of Adelaide, Robinson 
Institute, and Lyell McEwin Hospital.  
 
How and why have I been chosen as a possible participant in the research? 
 
You have been invited to participate as a health professional involved in the care of women of 
reproductive age.  
 
How many other people have been asked to consider participating? 
 
The research has 5 stages and we are recruiting 1100 women throughout the research. Women 
will be recruited from ANEW bookings at the Lyell Mc Ewin Outpatient department, the 
Continence Nursing Service at the Lyell Mc Ewin Hospital and GP Super clinics. 
Health professionals are invited to participate in the pre-test and re-test of the questionnaire 
assessment of bowel control for women of reproductive age and bowel screening tool. It is 
anticipated 30 health professional are required for each stage of the research. 
 
PROCEDURES AND TREATMENT 
Will I have to participate  more than the specified participation? 
 
No.  
The researcher will make a time convenient with you, the health professionals to pre-test, re-
test and gain feedback from the questionnaire assessment of bowel control and the bowel 
control screening tool. 
 
What will I be asked to do? 
This depends on what you consent for in the research.  You will be asked to pre-test and re-
test the questionnaire assessment of bowel control  and provide feedback. This should take 
approximately 10 minutes. 
 
 You will be asked to pre-test and re-test the bowel control screening tool and provide written 
and or verbal feedback. This will take approximately  10 minutes 
 
How long will my participation in the study last?  
 
The pre-test and re-test of the questionnaire assessment of bowel control and bowel control 
screening tool will take approximately 10 minutes for each session. 
What procedures will I be asked to submit to and what are the likely effects? 
Procedures are outlined above. 
 
What if  I decide not to take part? 
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The findings from this research study will be disseminated through educational sessions, 




DISCOMFORTS, RISKS AND SIDE EFFECTS 
Are there likely to be side effects from the research procedures, and if so what are they? 
 
 No there are no potential risks or side effects associated with the research. 
 
 
Who should I contact if I am worried about any effects that I experience? 
 
You can discuss your concerns with the researcher. Details can be found at the end of this 
information sheet. 
 
WHAT WILL HAPPEN TO THE INFORMATION COLLECTED? 
How will my confidentiality be protected – will information and results be de identified? 
 
Your confidentiality is ensured. Your information will be de-identified and linked with a 
study number. All information is password protected. Contact information can only be 
accessed by the primary researcher. Participation is voluntary and you can withdraw from the 
study at any point in time with no penalties.  
 
Will I be informed about the results of the study? 
 
Data a collected will be published in research journals. If you wish you can contact the chief 
researchers and we can send you a copy of the results.  
 
How long will information be stored for? 
 
Research information is kept for 5 years and then destroyed. This is keeping with the South 
Australian Heath  Policy and the NHMRC code for Responsible Conduct of research. 
 
WHAT ARE MY RIGHTS? 
If you become injured during this study, and your injury is a direct result of the effects of 
study procedures, The Lyell McEwin Hospital will provide reasonable medical treatment. 
Your participation in this study shall not affect any other right to compensation you may have 
under common law. 
 




Associate Professor Vicki Clifton 
Robinson Institute, Lyell Mc Ewin Hospital  Phone 81332133 
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PAYMENT FOR PARTICIPATION 
Will I be paid for my participation?  
Participation is voluntary.  
 
 
BENEFITS OF THE RESEARCH 
Is there any chance that the proposed research will be of benefit to me personally, or to 
future patients with anal incontinence? 
 
Whilst your direct involvement may not benefit you, your contribution to this research is 
valuable in developing a bowel control screening tool to assist women of reproductive age. 
 
The research aims to develop a bowel control screening tool to identify anal incontinence in 
women of childbearing age, early identification may lead to improved quality of life in 
pregnancy, birthing and across the lifespan. 
 
WHAT IF I HAVE A QUESTION ABOUT THE STUDY? 




University of Adelaide 
Robinson Institute, Lyell Mc Ewin Hospital 
Or  
Associate Professor Vicki Clifton 
Robinson Institute 




The Human Research Ethics Committee (TQEH/LMH/MH) has approved this study. 
 
Should you wish to speak to a person not directly involved in the study in relation to:  
 matters concerning policies,  
 information about the conduct of the study  
 your rights as a participant, or 
 Should you wish to make a confidential complaint 
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Appendix1B: Participant Information Sheet and Consent  
Title: Development of a screening tool to identify anal incontinence in women of reproductive age  
Version 2  date…22.5.14 











Title: Development of a screening tool to identify anal incontinence in women of 
reproductive age  
  
Protocol Number:  
 
I, the undersigned  ................................................................................................  
hereby consent to my involvement in the research project explained above. 
Which is to participate in the (Circle those applicable) 
 
1. Pre-test, re-test and provide written and or verbal feedback of the research questionnaire: 
assessment of bowel control for women of reproductive age 
 
2. Pre-test, re-test and provide written and or verbal feedback of bowel control screening tool.  
 
 I have read the information sheet, and I understand the reasons for this study. The research worker has 
explained the ways in which it will affect me.  My questions have been answered to my satisfaction. My 
consent is given voluntarily.  
 
 I understand that the purpose of this research project is to improve the quality of medical care, but my 
involvement may not be of benefit to me. 
 
 The details of the research project have been explained to me, including: 
- The expected time it will take 
- The nature of procedures being performed, and number of times they will be performed 
- Any discomfort which I may experience 
 
 I have been given the opportunity to have an interpreter or member of family or a friend present while the 
project was explained to me. 
 My identity will be kept confidential, and nothing will be published which could possibly reveal my 
identity. 
 My involvement in the study will not affect my relationship with my medical advisers. I understand that I 
am able to withdraw from the study at any stage without having to give a reason, and that by withdrawing it 
will not affect my treatment at this hospital in the future.  
 
PARTICIPANT SIGNATURE…………............................................  DATE …./……./……. 
 
 
WITNESS……………………………………………………….....  DATE …./……./……. 
I have given a verbal explanation of the implications of withdrawal from the research project and I 














































































































































































































































































































Appendix 2. Recruitment Pamphlet.
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Appendix 3A Professional letter of introduction 
Title: Development of a screening tool to identify anal incontinence in women of reproductive age. 
 Version 1. Date 22.5.14 
 
                                                                                  
Invitation to participate 
Dear Colleague 
As a health care professional who provides care to women of reproductive age, you are 
invited to participate in the current research, which aims to develop a screening tool, which 
identifies anal incontinence in women of reproductive age. Anal incontinence is often 
underreported and has a debilitating impact on a woman’s quality of life. Birthing women are 
at risk of pelvic floor injury resulting in a negative impact on pelvic floor functional reserve. 
Importantly minor injury following childbirth may be clinically significant with further 
vaginal delivery and ageing. The development of a screening tool will assist in the early 
identification, referral to appropriate health services and may improve quality of life for 
women in pregnancy and across the lifespan. We appreciate and acknowledge your time is 
valuable. 
This research is part of a PHD programme with the University of Adelaide department of 
Obstetrics and Gynaecology, School of Paediatrics and Reproductive Health. The title of the 
research is Development of a screening tool to identify anal incontinence in women of 
reproductive age. Ethics has been approved through two human research ethics committees 
If you agree to participate, you are invited to participate and provide written and/ or verbal 
feedback to the primary researcher in the development of   
1. The questionnaire assessment for bowel control for women of reproductive age. 
2. Bowel control screening tool for women of reproductive age. 
All research information is confidential, de-identified and accessed only by the primary 
researcher. Research findings will inform current health practice and be reported through 
relevant peer reviewed journals, conferences and education sessions. 
Thank you for taking the time to read this information. If you have any queries regarding the 
research or wish to participate in the research please contact the primary researcher Julie Tucker 
(details below)                                                                                      
Investigators: 
1. Primary Researcher: Julie Tucker , RN, RM, BN, MN, MNSc                  
PhD candidate Univeristy of Adelaide, Robinson Institute, School of Paediatrics and 
Reproductive Health, Elizabeth Vale, S.A julie.tucker@adelaide.edu .au. Ph. 81332133. 
2. Supervisor: Associate Professor Vicki clifton.Univeristy of Adelaide, Robinson Institute, 
School of Paediatrics and Reproductive Health Elizabeth Vale, S.A.Ph. 81332133.   
3. Supervisor: Dr Elizabeth Murphy. Colorectal consultant. Department of Surgery Lyell 
McEwin Hospital , Elizabeth Vale, S.A. Ph. 81829000. 
4. External advisor: Associate Professor Anne Wilson. School of Medicine, Flinders 
University, Bedford Park, SA. 
Appendix 3A. Professional letter of introduction.
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Appendix 3B:Pre-test questionnaire Assessment of bowel control for women of reproductive age 
HREC/14/TQEHLMH/58/AMO1 
Title: Development of a screening tool to identify anal incontinence in women of reproductive age 
Version 2 Date 22.5.14 
Dear Participant  
You have been invited to participate in this research, which aims to develop a tool for health 
professionals (Doctors/Nurses) to screen and identify accidental loss of bowel control (anal 
incontinence) in women of reproductive age.  
This research is part of a PHD programme with the University of Adelaide department of 
Obstetrics and Gynaecology, School of Paediatrics and Reproductive Health.  
The title of the study is Development of a screening tool to identify anal incontinence in 
women of reproductive age.  
Ethics has been approved through two human research ethics committees; Human Research 
Ethics Committee (TQEH/ LMH/ MH) Ethics number AU/15/0687119 and the University of 
Adelaide Human Research Ethics Committee.  
The development of a screening tool which identifies accidental loss of bowel control will 
assist in the early identification of this condition and referral to appropriate health services 
may improve the quality of life for women of reproductive age. Accidental loss of bowel 
control (anal incontinence) is often underreported and has a negative impact on a woman’s 
life. Childbirth increases the risk of accidental bowel loss. Further vaginal childbirth and 
ageing may worsen symptoms of accidental loss of bowel control (anal incontinence).  
The research process includes five stages. You have been invited to participate in part of stage 
1, the pre-test and re-test of the questionnaire assessment for bowel control for women of 
reproductive age and two bowel screening forms. You are requested to complete the 
questionnaire and screening forms and provide feedback on the sheet provided. Each session 
should take approximately 5-10 minutes.  
Your participation is voluntary. All research information is de-identified, stored on a USB 
which is password protected and accessed only by the primary researcher. Findings will be 
disseminated through relevant peer reviewed journals, conferences and education sessions to 
relevant health professionals. 
Your participation and time is valued. If you require further information regarding this 
research please contact Associate Professor Vicki Clifton Robinson Institute Ph. 81332133  
Or 
 Julie Tucker  
RN, RM, BN, MN, MNSc 
Principal researcher  Julie Tucker   Robinson Institute ph. 81332133. 
                                            
Appendix 3B. Pre-test questionnaire.
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Appendix 3B:Pre-test questionnaire Assessment of bowel control for women of reproductive age 
HREC/14/TQEHLMH/58/AMO1 
Title: Development of a screening tool to identify anal incontinence in women of reproductive age 
Version 2 Date 22.5.14 
   Feedback sheet 
The questionnaire assessment of bowel control for women of reproductive age and two 
bowel-screening forms aim to 
1. Identify women who are pregnant and have accidental loss of bowel control (anal 
incontinence). 
2. The questionnaire aims to identify women who would like to participate in an interview 
about disclosing accidental bowel loss (anal incontinence). 
To indicate your response please place a circle around Yes or No.  A comments section is 
provided if you require more space to provide written feedback. 
3. Before you begin, please note the time. 
1. Did you find the questionnaire easy to follow? 
Please circle one of the following   Yes        No 
Comment           
            
            
            
            
           
2. Did you find the questionnaire easy to understand? 
Please circle one of the following   Yes      No 
Comment           
            
            
            
            
           
3. Did you find the language was appropriate? 
Please circle one of the following   Yes        No 
Comment           
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Appendix 3B:Pre-test questionnaire Assessment of bowel control for women of reproductive age 
HREC/14/TQEHLMH/58/AMO1 
Title: Development of a screening tool to identify anal incontinence in women of reproductive age 
Version 2 Date 22.5.14 
4. In your opinion were there any questions that should not have been asked? 
Please circle one of the following   Yes        No 
Comment           
            
            
            
            
           
5. In your opinion were there any other questions which should be asked? 
Please circle one of the following   Yes        No 
Comment           
            
            
            
            
           
6. Do you think the questionnaire helps to identify accidental loss of bowel control in 
pregnant women? 
 Please circle one of the following   Yes        No 
Comment           
            
            
            
            
           
7. Do you think the questionnaire helps to identify women who may want to participate in 
an interview? 
Please circle one of the following   Yes        No 
Comment           
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Appendix 3B:Pre-test questionnaire Assessment of bowel control for women of reproductive age 
HREC/14/TQEHLMH/58/AMO1 
Title: Development of a screening tool to identify anal incontinence in women of reproductive age 
Version 2 Date 22.5.14 
8. Do you have any other comments or suggestions? 
Please circle one of the following   Yes        No 
Comment           
            
            
            
            
            
            
            
            
            
            
            
           
9. How long did the questionnaire take to complete?             minutes 
 
 
Thank you for your time in completing the feedback form. Please return the questionnaire 
and feedback form in the addressed envelope provided to the researcher. 
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Appendix 3B:Pre-test questionnaire Assessment of bowel control for women of reproductive age 
HREC/14/TQEHLMH/58/AMO1 
Title: Development of a screening tool to identify anal incontinence in women of reproductive age 
Version 2 Date 22.5.14 
The two bowel screening forms; the St Mark’s incontinence score “Vaizey” and the 
Wexner score are provided at the end of the questionnaire section. 
To indicate your response please place a circle around   Yes or No.  A comments section is 
provided if you require more space to provide written feedback. 
 
Before you begin, please note the time. 
 
1. Did you find the Vaizey and Wexner scores easy to follow? 
Please circle one of the following   Yes        No 
Comment           
            
            
            
            
           
2. Did you find the Vaizey and Wexner scores easy to understand? 
Please circle one of the following   Yes        No 
Comment           
            
            
            
            
           
3. Did you find the language was appropriate? 
Please circle one of the following   Yes        No 
Comment           
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Appendix 3B:Pre-test questionnaire Assessment of bowel control for women of reproductive age 
HREC/14/TQEHLMH/58/AMO1 
Title: Development of a screening tool to identify anal incontinence in women of reproductive age 
Version 2 Date 22.5.14 
4. In your opinion were there any questions that should not have been asked? 
Please circle one of the following   Yes        No 
Comment           
            
            
            
            
           
5. In your opinion were there any other questions which should be asked? 
Please circle one of the following   Yes        No 
Comment           
            
            
            
            
           
6. Do you think the screening forms help to identify accidental loss of bowel control in 
pregnant women? 
 Please circle one of the following   Yes        No 
Comment           
            
            
            
            
           
Please explain which screening form you prefer and why?    
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Appendix 3B:Pre-test questionnaire Assessment of bowel control for women of reproductive age 
HREC/14/TQEHLMH/58/AMO1 
Title: Development of a screening tool to identify anal incontinence in women of reproductive age 
Version 2 Date 22.5.14 
7. Do you have any other comments or suggestions? 
Please circle one of the following   Yes        No 
Comment           
            
            
            
            
            
            
            
            
            
            
            
           
8. How long did the questionnaire take to complete?             minutes 
 
 
Thank you for your time in completing the feedback form. Please return the questionnaire 
and feedback form in the addressed envelope provided to the researcher. 
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Appendix 3B:Pre-test questionnaire Assessment of bowel control for women of reproductive age 
HREC/14/TQEHLMH/58/AMO1 
Title: Development of a screening tool to identify anal incontinence in women of reproductive age 
Version 2 Date 22.5.14 
 
ID number      Ethics ID    
            
   
Questionnaire assessment of bowel control for Women of Reproductive Age 
This questionnaire is part of a research study being undertaken through the 
University of Adelaide and asks about control of your bowel. We are 
interested in identifying how many women of reproductive age experience 
accidental loss of bowel control, known as anal incontinence. Anal 
incontinence is loss of a liquid stool/poo; solid stool/poo or gas/wind by 
accident. Early identification of bowel problems may improve quality of life 
for pregnant women and women across the lifespan  
We invite you to participate in this questionnaire. Your participation is 
voluntary and nonparticipation will not affect your antenatal care. The 
questionnaire should take approximately 5 minutes to complete. 
All information is treated with the strictest confidence. If you have any 
questions or concerns about the questions please speak to the 
researcher who has given you the questionnaire.  
 
Please place the completed questionnaires in the envelope provided and 
return it to the Red box at the booking desk .Thank you for participating in 
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Appendix 3B:Pre-test questionnaire Assessment of bowel control for women of reproductive age 
HREC/14/TQEHLMH/58/AMO1 
Title: Development of a screening tool to identify anal incontinence in women of reproductive age 
Version 2 Date 22.5.14 
Please respond to the questions by placing a tick in a box and/ or writing in the spaces 
provided. 
Section A: Background Information         
About you the person completing the 
questionnaire 
1. Please tell me your age?  
 
2. Are you? 
 Never married  Married/defacto 
 Single  Divorced 
 Widowed  Separated 
           
3. What is the usual postcode where you 
live?        
 
4. How would you describe your 
employment situation? 
 Fulltime  Unemployed   
 Part-
time 
 Student   
 Casual  Home duties   
 Other     
 
5. What is your ethnicity?  
Caucasian  Asian  
Aboriginal  African  
Torres Strait  
Islander 
 Middle Eastern  
Other    
    
6. For each of your deliveries could you 
indicate whether you delivered vaginally 
or by caesarean section?  
Please tick either vaginal delivery or 
caesarean section in box 1 for your first 
delivery, box 2 for second delivery and 
following boxes for subsequent deliveries. 
Baby 1 2 3 4 5 6 
Vaginal       
Caesarean       
 
7. For each of your deliveries please tick in a 
box whether you had a  normal 
delivery, forceps or Ventouse delivery 
Delivery 1 2 3 4 5 6 
Normal       
Forceps       
Ventouse       
 
8. For each of your deliveries could you tick 
in a box if you had an episiotomy (a cut 
between the vagina and back passage) or 
tear following vaginal delivery or 
deliveries? 
Delivery 1 2 3 4 5 6 
Intact  
(no tears) 
      
Episiotomy       
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Appendix 3B:Pre-test questionnaire Assessment of bowel control for women of reproductive age 
HREC/14/TQEHLMH/58/AMO1 
Title: Development of a screening tool to identify anal incontinence in women of reproductive age 
Version 2 Date 22.5.14 
Section B: Bowel control.  
Could you provide information about your bowel 
control? 
Please respond to each of the following 
questions by a placing a tick    or a cross    
in a box and writing in the spaces provided.  
9. Have you ever had a solid poo (solid 
stool) slip out by accident?   
 
 
10. Have you ever had a liquid poo (liquid 
stool) slip out by accident? 
 
11. Have you ever had wind or gas slip out by 
accident?  
 
12. Do you have to rush to the toilet to do a 
poo or pass wind or gas? 
Yes  
No   
 
If you answered NO to all questions 9 to 12 
you have completed the questionnaire. 
Please place the questionnaire in the envelope 
provided and place in the RED Box on the 
booking desk in Family clinic.  
Thank you for your participation. 
If you answered YES to any of the questions 
9 -12 please continue with the questionnaire. 
Section C: Information seeking. 
The following questions ask you about who 
you have told of your accidental loss of bowel 
control (anal incontinence).  
Please respond to the questions by placing a 
tick  or a  in a box and writing in the 
spaces provided 
13. Have you discussed your accidental loss 
of bowel with a health professional (e.g. 
nurse, doctor, and/ or specialist?) 
Yes  Please go to question 
14  
No  Please go to question 
16 
14. Which health professional did you discuss 
your concerns with? 
Family doctor  Colorectal (Bowel) 
doctor                       
 
Obstetrician  Continence Nurse      
Midwife  General Practitioner 
(GP)         
 
Gynaecologist  Physiotherapist  
Other   Please Specify  
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Appendix 3B:Pre-test questionnaire Assessment of bowel control for women of reproductive age 
HREC/14/TQEHLMH/58/AMO1 
Title: Development of a screening tool to identify anal incontinence in women of reproductive age 
Version 2 Date 22.5.14 
15. Why did you choose to talk to your health 
professional?  
  Please go to question 18. 
16. Why did you choose not to talk to your 
health professional?  
 
17. If you were to seek assistance or talk to 
someone about your accidental bowel 
loss, who would you choose? 
Family doctor  Colorectal (Bowel) 
doctor                       
 
Obstetrician  Continence Nurse      
Physiotherapist  Gynaecologist  
Midwife  General Practitioner 
(GP)         
 
Don’t Know    
Other  Please Specify  
    
    
    
18. In your opinion what would make it easier 
to tell someone about your accidental loss 
of bowel control? 
Directly asked by health professional at 
health visit 
 
Questionnaire/ survey  
Information provided to you before birth  
Information provided to you after birth  
Using common everyday words  




          
Section D: Research information 
The information you have provided will assist 
in continuing research seeking to improve 
healthcare for women with accidental loss of 
bowel control. 
Please respond to a question by placing a 
tick or  in a box provided… 
19. Would you like more information about a 
clinic that specialises in accidental loss of 
bowel control (anal incontinence)?  
 








She/he asked me about it  
Felt comfortable to talk   
I have been worried for sometime  
I know other women with the problem  
  
Other (please specify)  
  
  
I don’t lose control often  
Didn’t think it was a problem  
Embarrassed  
Health professional didn’t ask  
I hoped it would go away  
Health professional disinterested  
Other (please specify)  
  
  
Yes  Please ask the Midwife at your 
appointment today or provide your 
name and contact number in the 
space below 
No   
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Appendix 3B:Pre-test questionnaire Assessment of bowel control for women of reproductive age 
HREC/14/TQEHLMH/58/AMO1 
Title: Development of a screening tool to identify anal incontinence in women of reproductive age 
Version 2 Date 22.5.14 
20. Would you like to be referred to a clinic 
which specialises in accidental loss of 
bowel control? 
Yes  Please ask the Midwife at your 
appointment today or provide 
your name and contact number 
in the space below 





   
21. Would you like to participate in an 
interview to talk about how accidental 
loss of bowel control affects your life?   
Yes  Please provide your name and 
phone number so the researcher 
can contact you 









Thank you for taking the time to complete the 
questionnaire. Your information is important 
for our research and improving healthcare for 
women with accidental loss of bowel control. 
Please place your completed questionnaire in 
the envelope provided and return to the RED 




















Chapter 2 Materials and Methods
179
                             
Questionnaire 
 Assessment of bowel control for women of reproductive age 
Appendix 4: Questionnaire Assessment of bowel control for women of reproductive age 
HREC/14/TQEHLMH/58/AMO1.Title: Development of a screening tool to identify anal incontinence in women 





Questionnaire assessment of bowel control for Women of Reproductive Age 
This questionnaire is part of a research study being undertaken through the University of 
Adelaide and asks about control of your bowel. We are interested in identifying how many 
women of reproductive age experience accidental loss of bowel control, known as anal 
incontinence. Anal incontinence is loss of a liquid stool/poo; solid stool/poo or gas/wind by 
accident. Early identification of bowel problems may improve quality of life for pregnant 
women and women across the lifespan.  
We invite you to participate in this questionnaire. Your participation is voluntary and 
nonparticipation will not impact on your antenatal care. The questionnaire should take 
approximately 5 minutes to complete. 
All information is treated with the strictest confidence. If you have any questions or 
concerns about the questions please speak to the Midwife or researcher who has given 
you the questionnaire.  
 
Please place the completed questionnaires in the envelope provided and return it to the Red 
box at the booking desk .Thank you for participating in this questionnaire. We appreciate 





Appendix 4. Questionnaire: assessment of bowel control for women of reproductive age.
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Appendix 4: Questionnaire Assessment of bowel control for women of reproductive age 
HREC/14/TQEHLMH/58/AMO1.Title: Development of a screening tool to identify anal incontinence in women 
of reproductive age Version 1 Date 21.10.14 
 
 
Please respond to the questions by placing a tick in a box and/ or writing in the spaces 
provided. 
Section A: Background Information
 About you the person completing the 
questionnaire 
1. Please tell me your age?           
2. Are you? 
 
 
Never Married  Separated  
Single  Divorced  
Married/Defacto  Widowed  
 
3. What is the usual postcode where you live?
    
4. How would you describe your employment 
situation? 
 
5. What is your ethnicity? 
Caucasian  African  






Other    




6. For each of your births could you indicate 
whether you delivered vaginally or by caesarean 
section? Please tick either vaginal birth or 
caesarean section in box 1 for your first birth, 





7. For each of your vaginal births please tick in a 
box whether you had a vaginal birth, forceps or 










Full-time   Student  
Part-time  Unemployed  
Casual  Home duties  
Other    
(Please explain)    
Baby 1 2 3 4 5 6 
Vaginal birth       
Caesarean section       
Birth 1 2 3 4 5 6 
Vaginal       
Forceps       
Ventouse       
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Appendix 4: Questionnaire Assessment of bowel control for women of reproductive age HREC/14/TQEHLMH/58/AMO1.Title: 
Development of a screening tool to identify anal incontinence in women of reproductive age Version 1 Date 21.10.14 
 
 
8. For each of your births could you tick in a box 
if you had an episiotomy (a cut between the 




Section B: Bowel control.  
Could you provide information about your bowel 
control? 
Please respond to each of the following 
questions by a placing a tick  in a box and 
writing in the spaces provided.  
9. Have you ever had a solid poo (solid stool) slip out 




10. Have you ever had a liquid poo (liquid stool) slip 
out by accident? 
 






12. Have you ever needed to rush to the toilet to do a 





13. Have you ever soiled or stained your underwear 




If you have answered NO to all questions 9 to 13 
you have completed the questionnaire. 
Please place the questionnaire in the envelope 
provided and place in the RED Box on the 
booking desk in Family Clinic. 
If you answered YES to any of the questions 9-
13 please continue with the questionnaire. 
 
Delivery 1 2 3 4 5 6 
Intact (no tears)       
Episiotomy       
Small tear (no stitches) 
 
      
1st degree tear 
 
      
2nd degree tear 
 
      
3rd/4th degree tear  
 
      
Yes  
No  
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Appendix 4: Questionnaire Assessment of bowel control for women of reproductive age HREC/14/TQEHLMH/58/AMO1.Title: 
Development of a screening tool to identify anal incontinence in women of reproductive age Version 1 Date 21.10.14 
 
 
Section C: Information seeking 
The following questions ask you about who you 
have told of your accidental loss of bowel control 
(anal incontinence). 
Please respond to the questions by placing a tick  
 in a box and writing in the spaces provided. 
14. Have you discussed your accidental loss of bowel 
control with a health professional? (e.g. nurse, 
doctor, and/or specialist?) 
15. Which health professional did you discuss your 
concerns with?(tick all that apply) 
Family doctor  Colorectal doctor  
Obstetrician  Continence Nurse  
Midwife  General Practitioner   
Gynaecologist  Physiotherapy  
Other     
(please explain)    
 
16. Why did you choose to talk to your health 
professional? (tick all that apply) 
She/he asked me about it  
Felt comfortable to talk  
I have been worried for sometime  
I know other women with the problem  
Other   
(please explain)  
Please go to question19 
17. Why did you choose not to talk to your health 
professional? (tick all that apply) 
I don’t lose control often  
Didn’t think it was a problem  
Embarrassed  
Health professional didn’t ask  
I hoped it would go away  
Health professional disinterested  




18. If you were to seek assistance or talk to someone 
about your accidental loss of bowel control, who 
would you choose? (tick all that apply) 
Family doctor  Colorectal doctor  
Obstetrician  Continence nurse  
Physiotherapist  Gynaecologist  
Midwife  General Practitioner  
Don’t know    
Other     
(please 
explain) 
   
    
 
Yes  Please go to question 15. 
No  Please go to question 17. 
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Appendix 4: Questionnaire Assessment of bowel control for women of reproductive age HREC/14/TQEHLMH/58/AMO1.Title: 
Development of a screening tool to identify anal incontinence in women of reproductive age Version 1 Date 21.10.14 
 
 
19. In your opinion what would make it easier to tell 
someone about your accidental loss of bowel 
control? (tick all that apply) 
Directly  asked by health professional  
at health visit.  
Questionnaire/ survey  
Information provided to you before birth  
Information provided to you after birth  
Using common everyday words  
Other   
(please explain)  
 
Section: Research information 
The information you have provided will assist in 
continuing research seeking to improve healthcare 
for women with accidental loss of bowel control. 
 
Please respond to a question by placing a 
Tick in a box provided… 
20.  Would you like more information about a clinic 




Phone number  
 
21. Would you like to be referred to a clinic, which 
specialises in accidental loss of bowel control? 
Yes  Please ask the Midwife at your 
appointment  
  today and/ or provide your name 
and contact 
  number in the spaces below 
   
No   
 
 
22. Would you like to participate in an interview to 
talk about how accidental loss of bowel control 
affects your life? 
Yes  Please provide your name and 
phone number so the 
No  Researcher can contact you 
 
Name   





Phone number  
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Questionnaire 
 Assessment of bowel control for women of reproductive age 
Appendix 4: Questionnaire Assessment of bowel control for women of reproductive age HREC/14/TQEHLMH/58/AMO1.Title: 
Development of a screening tool to identify anal incontinence in women of reproductive age Version 1 Date 21.10.14 
 
 
Thank you for taking the time to complete the questionnaire. Your information is important for our research 
and improving healthcare for women with accidental loss of bowel control. 
 
Please place your completed questionnaire in the envelope provided. 
Then place the envelope in the RED BOX located on the booking desk at Family Clinic. 
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Appendix 5 Semi-formal interview guide  
Title: Closing the gap: Identifying anal incontinence in women of reproductive age 
Version1.1 
Date 26.2.14 Page 1 
 
 
Semi-formal interview guide for women with accidental loss of 
bowel control (anal incontinence) 
 
Objective 1: To identify what impacts on disclosing anal incontinence to a health 
professional   
Problem statement:  Some people express concerns about talking to their doctor or 
nurse about accidental loss of bowel control- how do you feel about this?  
Question 1: Can you tell me more about what it is like to live with anal incontinence?  
Question 2: Can you tell me who you have discussed your accidental loss of bowel control 
with? 
Question 3: Tell me more about what made that easier? 
Question 3: Can you tell me more about what made telling others more difficult? 
Question 4: Can you describe to me what factors you think would help women to tell others 











Appendix 5. Semi-formal interview guide.
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Participant Information Sheet/Consent Form 
Non-Interventional Study - Adult providing own consent 
 
The University Of Adelaide 
 
Title Development of a screening tool to identify anal incontinence in women of reproductive. age. 
Short Title Development of a screening tool to identify anal incontinence 
Protocol Number HREC/14/TQEHLMH/58  
  
Coordinating Principal Investigator/ Principal 
Investigator Ms Julie Tucker PhD candidate University of Adelaide 
Associate Investigator(s) 
 
Principal Supervisor Dr Vicki Clifton 
Dr Elizabeth Murphy 
Associate Professor Anne Wilson 
Location  
Family Clinic Lyell Mc Ewin Hospital 









You have been invited to take part in this research project, “Development of a screening tool to identify anal 
incontinence in women of reproductive age”. This is because you have had a baby or are currently pregnant. 
Accidental loss of bowel control (anal incontinence) is associated with pregnancy and childbirth and is often 
underreported. Further vaginal childbirth and ageing may worsen symptoms of accidental loss of bowel control.  
The research project is aiming to develop a tool for health professionals (Doctors/Nurses) to screen and identify 
accidental loss of bowel control (anal incontinence) in women of reproductive age. 
 
This Participant Information Sheet/Consent Form tells you about the research project. It explains what this research 
involves. Knowing what is involved will help you decide if you want to take part in the research. 
 
Please read this information carefully. Ask questions about anything that you don’t understand or want to know 
more about. Before deciding whether or not to take part, you might want to talk about it with a relative, friend or 
local doctor. 
 
Participation in this research is voluntary. If you don’t wish to take part, you don’t have to. You will receive the best 
possible care whether or not you take part. 
 
Appendix 5A. Participant Information Sheet/Consent Form.
Chapter 2 Materials and Methods
188
Participant Information Sheet/Consent Form 12.5.17 Page 2 of 5 
Appendix 5A version 1.3 
If you decide you want to take part in the research project, you will be asked to sign the consent section. By signing 
it you are telling us that you: 
• Understand what you have read 
• Consent to take part in the research project 
• Consent to the completing a bowel screening tool 
• Consent to the use of your personal and health information as described. 
 
 
2  What is the purpose of this research? 
 
This research aims to develop a bowel-screening tool to identify accidental loss of bowel control (sometimes known 
as anal incontinence) in women who have had a baby or are pregnant. Anal incontinence affects 1.3 million 
Australians and affects more women than men due to birthing and delivery. Early identification of anal incontinence 
in women who are pregnant or had babies, may improve quality of life in pregnancy and the postnatal period. 
Currently there is no recognised screening tool that is used to screen for anal incontinence for women who are 
pregnant or had babies.  
In order to develop a bowel-screening tool we need to recruit women who have had a baby.  
The results of this research will be used by the study researcher, Julie Tucker to obtain a Doctor of Philosophy 
(PhD) Medicine degree. 
 
 
3 What does participation in this research involve? 
 
If you consent to take part in the research study a consent form will be signed prior to any study assessments being 
performed. 
 
Who is included in the research study? 
 
• You may only participate in the research study if you are aged between 15 and 44 years and have had a baby. 
• Women who are pregnant and attending the Family clinic at the Lyell McEwin Hospital for a first antenatal 
appointment will be invited to take part in the research study. 
• Women attending Unihealth Playford and Highbury FPU clinics (Highbury and Elizabeth) who have had a baby 
will be invited to take part in the research study. 
 
What do I need to do? 
 
• You will be asked to complete a few questions about your bowel control. The questions will be included in a 
routine visit to the Lyell Mc Ewin antenatal clinic or Unihealth Playford and Highbury FPU clinic. Your health 
care professional (Doctor or Nurse) will ask you several questions about your bowel control and the questions 
will take less than 5 minutes to complete. 
• You will need to complete this on one occasion. 
 
This research project has been designed to make sure the researchers interpret the results in a fair and appropriate 
way and avoids study doctors or participants jumping to conclusions.   
 
There are no costs associated with participating in this research project, nor will you be paid.  
 
 
4 Other relevant information about the research project 
 
The research study will include approximately 350 women from the Lyell McEwin Hospital antenatal clinic and 350 
women from the Unihealth Playford and Highbury FPU clinics. 
 
 
5 Do I have to take part in this research project? 
 
Participation in any research project is voluntary. If you do not wish to take part, you do not have to. If you decide to 
take part and later change your mind, you are free to withdraw from the project at any stage. 
 
If you do decide to take part, you will be given this Participant Information and Consent Form to sign and you will 
be given a copy to keep. 
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Your decision whether to take part or not to take part, or to take part and then withdraw, will not affect your routine 
treatment, your relationship with those treating you or your relationship with the Lyell Mc Ewin Hospital and 
Unihealth Playford and Highbury FPU clinics. 
 
 
6 What are the possible benefits of taking part? 
 
We cannot guarantee or promise that you will receive any benefits from this research; however, possible benefits 
may include the development of a screening tool to identify anal incontinence in other women. If you are identified 




7 What are the possible risks and disadvantages of taking part? 
  
While this research does not involve any treatment. Disclosing personnel information may cause emotional 
concerns. If this happens, you will be offered counselling or other appropriate support. Any counselling or support 
will be provided by qualified staff who are not members of the research project team. This counselling will be 
provided free of charge. If you are worried about any effects from participation in this research, you can talk with 
your study researcher. 
 
 
8 What if new information arises during this research project? 
 
If new information becomes available that a similar study has been done, we may need to stop the study. 
 
 
9 Can I have other treatments during this research project? 
 
Whilst you are participating in this research project, you may take all of the medications or treatments you have 
been taking for your condition or for other reasons.  
 
 
10 What if I withdraw from this research project? 
 
If you decide to withdraw from this research project, please notify a member of the research team before you 
withdraw. Your decision to not participate in the research study will not affect your routine care or treatment by 
your health care professional. 
 
If you do withdraw your consent during the research project, the study doctor and relevant study staff will not 
collect additional personal information from you, although information already collected will be retained to ensure 
that the results of the research project can be measured properly and to comply with law. You should be aware that 
data collected by the investigator up to the time you withdraw will form part of the research project results.  If you 




Part 2 How is the research project being conducted? 
 
11 What will happen to information about me? 
 
By signing the consent form, you consent to the study doctor and relevant research staff collecting and using 
personal information about you for the research project. Any information obtained in connection with this research 
project that can identify you will remain confidential. Your information will be stored in a de-identified form (that is 
no identity details are attached and given a study number). All information is linked to a study number to identify 
details on a separate sheet and stored separately, securely and only accessible by the investigator. All information is 
password protected and only accessible by the investigator. Your information will only be used for the purpose of 
this research project and it will only be disclosed with your permission, except as required by law. Research 
information will be kept for 5 years and then destroyed. 
 
It is anticipated that the results of this research project will be published and/or presented in a variety of forums. In 
any publication and/or presentation, you will not be able to be identified.  
 
Chapter 2 Materials and Methods
190
Participant Information Sheet/Consent Form 12.5.17 Page 4 of 5 
Appendix 5A version 1.3 
12 Complaints and compensation 
 
If you have any concerns because of this research project, you should contact the study team as soon as possible and 




13 Who is organising and funding the research? 
 
This research project is being conducted under the governance of the University of Adelaide, Robinson Research 
Institute, Lyell Mc Ewin Hospital. 
 
No member of the research team will receive a personal financial benefit from your involvement in this research 
project (other than their ordinary wages). 
 
 
14 Who has reviewed the research project? 
   
All research in Australia involving humans is reviewed by an independent group of people called a Human Research 
Ethics Committee (HREC).  The ethical aspects of this research project have been approved by the HREC of The 
Queen Elizabeth Hospital, Lyell Mc Ewin Hospital, Modbury Hospital (TQEH/LMH/MH).  
This project will be carried out according to the National Statement on Ethical Conduct in Human Research (2007). 
This statement has been developed to protect the interests of people who agree to participate in human research 
studies. The research will be undertaken in the Family clinic at the Lyell Mc Ewin Hospital and Unihealth Playford 
and Highbury FPU clinic (Highbury and Elizabeth) 
 
 
15 Further information and who to contact 
 
The person you may need to contact will depend on the nature of your query.  
If you want any further information concerning this project, you can contact the principal study researcher on 
81332133  
 
 Clinical and Complaints contact person 
 
If you have any complaints about any aspect of the project, the way it is being conducted or any questions about 




Reviewing HREC approving this research and HREC Executive Officer details 
 
Local HREC Office contact (Single Site -Research Governance Officer) 
Name Julie Tucker 
Position Study Researcher 
Telephone 81332133 
Email Julie.tucker@adelaide.edu.au 
Reviewing HREC name Heather O’Dea 
HREC Executive Officer HREC Executive officer TQEH 
Telephone 0882224139 or 82226841 
Email Healther.Odea@sa.gov.au 
Name Alison Barr 
Position Research Governance Officer 
Telephone 0881829346  
Email Alison.barr@sa.gov.au 
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Consent Form - Adult providing own consent 
 
Title Development of a screening tool to identify anal incontinence in women of reproductive age 
Short Title Development of a screening tool to identify anal incontinence  
Protocol Number HREC/14/TQEHLMH/58  
Coordinating Principal Investigator/ 
Principal Investigator Julie Tucker 
Associate Investigator(s) 
 
Professor Vicki Clifton, Dr Elizabeth Murphy, Associate 
Professor Anne Wilson 
Location  Family clinic Lyell Mc Ewin Hospital and Unihealth Playford and Highbury FPU clinic  
 
Declaration by Participant 
 
I have read the Participant Information Sheet or someone has read it to me in a language that I understand.  
 
I understand the purposes, procedures and risks of the research described in the project. 
 
I have had an opportunity to ask questions and I am satisfied with the answers I have received. 
 
I freely agree to participate in this research project as described and understand that I am free to withdraw at any time 
during the project without affecting my future health care. 
 
I understand that I will be given a signed copy of this document to keep. 
 
 
 Name of Participant (please print)     
 





 Name of Witness* to Participant’s 
Signature (please print) 
  
 
 Signature   Date   
 
* Witness is not to be the investigator, a member of the study team or their delegate.  In the event that an interpreter is 
used, the interpreter may not act as a witness to the consent process.  Witness must be 18 years or older. 
 
Declaration by Study Doctor/Senior Researcher† 
I have given a verbal explanation of the research project, its procedures and risks and I believe that the participant has 
understood that explanation. 
 
 Name of Study Doctor/ 
Senior Researcher† (please print) 
  
  
 Signature   Date   
 
† A senior member of the research team must provide the explanation of, and information concerning, the research project.  
 
Note: All parties signing the consent section must date their own signature.
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Declaration by Participant 
 
I wish to withdraw from participation in the above research project and understand that such withdrawal will not affect 
my routine treatment, my relationship with those treating me or my relationship with the Lyell Mc Ewin Hospital or  
Unihealth Playford and Highbury FPU clinics. 
 
 
 Name of Participant (please print)     
 









Declaration by Study Doctor/Senior Researcher† 
 
I have given a verbal explanation of the implications of withdrawal from the research project and I believe that the 
participant has understood that explanation. 
 
 
 Name of Study Doctor/ 
Senior Researcher† (please print) 
  
  
 Signature   Date   
 
† A senior member of the research team must provide the explanation of and information concerning withdrawal from 
the research project.  
 
Note: All parties signing the consent section must date their own signature. 
Title 
Development of a screening tool to 
identify anal incontinence in women 
of reproductive age 
 
Short Title Development of a screening tool to identify anal incontinence   




Julie Tucker  
Associate Investigator(s) 
 
Professor Vicki Clifton, Dr Elizabeth 




Family clinic Lyell Mc Ewin 
Hospital and GP Super clinic 
(Highbury and Elizabeth) 
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Appendix 6: Excerpt from researcher’s journal for qualitative interviews 
Interview 3 field notes 
Kelly (pseudonym) is 26 years old; she is not pregnant but recounts her last birth and resultant 3rd 
degree tear. She actively engaged in the interview, her body relaxed and using hand gestures to 
emphasise her point. 
The researcher noticed Kelly using the bowel screening tools as a divide between the researcher and 
herself. She holds them upright as she described what it is like living with anal incontinence (AI).  
Kelly had been symptomatic of wind incontinence and urge since delivery. Her voice was quiet during 
the exchange in dialogue, there were long pauses and her body language changed as if she wanted to be 
smaller or hide. The researcher provided verbal acknowledgement of her concerns but recognised a 
sense of grief and sadness through Kelly’s recount. Holding the paper as a barrier was this a sign of 
difficulty to disclose? Or was it due to disgust? 
The researcher facilitated the discussion further to find deeper meaning asking Kelly what makes it 
easier to disclose AI. 
There was almost a sigh of relief from Kelly, the paper barrier softened and she lifted her gaze and 
moved her hand slowly; “It’s being asked”. Tears filled her eyes but she pushed on describing the 
embarrassment surrounding AI. As a young mother, she was saddened that she should not have to deal 
with this. She stated, “I feel dirty and I cannot tell anyone”. She articulated that she was scared of the 
future, her voice became louder and hands moved chaotically articulating her concerns. The softly 
spoken response of the researcher acknowledged her frustration and there was a need to facilitate 
discussion around disclosure. 
There was a sense of despair in her voice as she described wanting the health professional to ask 
questions. Her voice became angry as she described the lack of professional enquiry was a result as she 
believed health professionals assume it is not something that happens to young women. The researcher 
questioned was this a plea in her voice for professionals to take time to wait for an answer, as it was not 
easy to disclose?  
Her voice softened and she lifted her eyes to clarify that it was easier telling a female, as they understood 
as they have had babies. Kelly’s comments challenged the researcher’s role as a health professional; the 
researcher acknowledged this discomfort and further discussion helped to clarify Kelly’s anger. 
Kelly’s hand gently picked up the bowel screening tools, pointing to each as she described these tools 
would make it easier to disclose. Her voice was engaging, her body language now relaxed facing the 
researcher she described what she thinks about each tool. 
The change in her body language and vocal tone was amazing, as it has been 30 minutes in the interview 
before she actively engaged. What did this tell the researcher? Does she feel heard and was that why 
she wanted to engage? 
The screening tools now flat on the table, Kelly picked up a pen scribbling over the tools are described 
what would inhibit or enable disclosure. Circling several times words like incontinence and plug, 
(Vaziey score). Her pen tapping on these words as she laughed and stated what does it mean? If I do 
not know the meaning then I will put no, even if I have symptoms. 
Kelly’s voice softened again when she talked about the variability of her symptoms; as she looked up 
she uses the screening tools to emphasis her frustration in disclosing AI. She puts a very large arrow 
across the page of the Wexner score and stated… see no question about not holding on. The same 
forceful marking on the Vaizey score where she asked what does urge mean? In addition, she stated it 
does not even give her options it is just a yes or no. She smiled briefly and pointed to the BSQ stating 
this is her kind of language but there is no scale (she raised her eyebrows and smiled). 
Appendix 6. Excerpt from researcher’s journal for qualitative interviews.
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At the end of the interview, Kelly looked tired but relieved. She smiled at the researcher and thanked 
her for the opportunity to tell her stories. Kelly stated that she felt better being able to share her thoughts.  
Commonalities across all sixteen field notes included the social disgust surrounding AI, the lack of 
enquiry by health professionals and confusion in understanding questions when asked. The availability 
of the screening tools within the interviews provided women with a medium to describe their feelings 
and experience. The journaling undertaken in the research process added depth to the transcribed text 
and audio tape providing clarity and understanding of the phenomenon at hand, where text alone would 
have not reflected the depth of information. 
The interviews challenged the researcher’s preconceived beliefs of the role of the health professional. 
Acknowledging the comments by women, the researcher brought to the foreground their prior beliefs, 
challenged by current interview findings and reformulated a deeper understanding in disclosing AI. 
 
Appendix 6 (cont.). Excerpt from researcher’s journal for qualitative interviews.







Appendix 7:  Bowel control screening tool for women of reproductive age - antenatal and community setting   
Title: Development of a screening tool to identify anal incontinence in women of reproductive age  
Version 1.2 Date12/05/2017 
ID 
number




Bowel control screening tool 
 
 
Questionnaire assessment of bowel control for Women of Reproductive Age 
This questionnaire is part of a research study being undertaken through the University of 
Adelaide and asks about control of your bowel. We are interested in identifying how many 
women of reproductive age experience accidental loss of bowel control, known as anal 
incontinence. Anal incontinence is loss of a liquid stool/poo; solid stool/poo or gas/wind by 
accident. Early identification of bowel problems may improve quality of life for pregnant 
women and women across the lifespan.  
We invite you to participate in this questionnaire. Your participation is voluntary and 
nonparticipation will not impact on your antenatal care. The questionnaire should take 
approximately 5 minutes to complete. 
All information is treated with the strictest confidence. If you have any questions or 
concerns about the questions please speak to the Midwife or researcher who has given 
you the questionnaire.  
 
Please place the completed questionnaires in the envelope provided and return it to the 
Midwife or researcher at the clinic desk .Thank you for participating in this questionnaire. 
We appreciate your time.   
  
Appendix 7. Bowel control screening tool.







Appendix 7:  Bowel control screening tool for women of reproductive age - antenatal and community setting   
Title: Development of a screening tool to identify anal incontinence in women of reproductive age  
Version 1.2 Date12/05/2017 
Please place information or a tick   in the YES or NO box for the woman’s response to 

















Age   
BMI   
Ethnicity   
Pregnant Yes No 
Gravida   
Parity   
Delivery history   
Vaginal Yes No 
Caesarean Yes No 
Forceps Yes No 
Ventouse Yes No 




Episiotomy Yes no 
Other state   
Answer the questions by placing 
a tick  in the column. Never Rarely Sometimes Weekly Daily 
Have you ever lost by accident? 0 1 2 3 4 
Solid poo (Stool)      
Liquid poo (Stool)      
Wind (gas)      
Stained your underwear      
Soiled your underwear      
Do you need to rush to the toilet      
Total score  >0 consider referral          
Past history                      = (  /24)        
     
Answer the questions by placing 
a circle in the column if in the last 
4 weeks, have you had an 
accident?  
Current Score                   = (  /24) 
     
Would you like to be referred to a 
specialist bowel Doctor? (Circle 
response) 
Yes  No 
  

